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CHAPTER 1
GENERAL INTRODUCTION 
AIMS AND OUTLINE OF THE THESIS

General Introduction
1.1. The Retina: A Window to the Brain
The retina is an important sensory organ which is easily accessible for examination 
through imaging techniques. It is considered an extension of the central nervous 
system (CNS) owing to their common embryological origin, neuronal organization, 
and metabolic substrates. The retina also exhibits similarities to the brain in terms of 
development, functionality, and immunology. 
The retina is structured across three main levels. The first level decomposes the output 
of the photoreceptors into informational streams. The second connects these streams 
to specific types of retinal ganglion cells. The third combines bipolar and amacrine cell 
activity to create the encoding which is transmitted to the brain through the optic tract. 
The retina being an extension of the diencephalon, shares a similar vascularization 
pattern too1-4. Nutrition to the outer retina (photoreceptors) is passively supplied by 
the choroidal vasculature. However, the retinal vasculature that supplies the inner 
retina is comparable to the CNS vasculature, and employs a tightly regulated cellular 
barrier5. The microvascular and macrovascular blood supply to the brain and retina 
have similarities in structure and regulatory process of the vascular system. There is 
also a close correlation between the anatomy of the vascular system and metabolic 
needs of the tissue in both the brain and the retina1,6-8.
Both the retina and the brain constitute metabolically highly active tissues that exert 
exceptional demands on metabolic substrates via vascular networks. Unlike tissues of 
other organs, the brain and retina are exclusively restricted to glucose as a substrate 
for their energy metabolism9.
The difficulty in accessing the brain poses a major challenge in examining it. Several 
imaging techniques such as transcranial Doppler ultrasound, positron emission 
tomography (PET), single photon emission computed tomography (SPECT) and 
magnetic resonance imaging (MRI) are available for examining brain pathophysiology. 
However, their use is restricted as these are expensive, rarely accessible, and available 
only in specialised centres. These are therefore not suitable options for widespread 
screening of patients at risk of cerebrovascular disease. Hence, we need simpler, more 
accessible, and less expensive techniques. 
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Fundoscopic imaging of the retina is a non-invasive and completely safe method of 
obtaining images of the posterior chamber of the eye. Light from a low-power camera 
flash enters the eye through the pupil, is reflected back from the retina along the same 
path, and collected by the machine. This creates an image of the retina that can be 
stored in the computer (Figure 1). 
Figure 1.  
Acquisition of retinal fundus images using a non-mydriatic fundus camera.
Another widely used tool to assess the retina is Optical Coherence Tomography (OCT). 
This primarily measures, the retinal nerve fibre layer thickness (RNFL) along with other 
parameters. OCT generates cross sectional images by analysing the time delay and 
magnitude change of low coherence light when it is backscattered by ocular tissues. An 
infrared scanning beam is split into a sample arm (directed toward the subject) and a 
reference arm (directed toward a mirror). The sample beam that returns to the instrument 
is compared with the reference arm in order to determine distance and signal change 
via photodetector measurement. The resultant change in signal amplitude allows for 
tissue differentiation through analysis of the variations in reflective properties, which 
are matched to a false colour scale. As the scanning beam moves across tissues, the 
sequential longitudinal signals, or A-scans, are reassembled into a transverse scan 
yielding cross-sectional images, or B-scans, of the patient (Figure 2).
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Figure 2.  
A typical RNFL OCT image
Studies using OCT have shown that RNFL thinning is associated with alterations in the 
microstructure and volume of the brain10. The RNFL thickness correlated with age and 
axial length of the eye11. The RNFL was thickest in the inferior quadrant, followed by 
the superior, nasal, and temporal quadrants of the retina respectively. It has also been 
found that the RNFL thickness reduces with increase in age11, but does not vary across 
gender12-14. Changes in RNFL thickness have also been demonstrated to be associated 
with changes in brain structure in pathological conditions. A thin RNFL was found to 
be related to brain atrophy in multiple sclerosis15 and degeneration of the brain in 
Alzheimer’s disease16,17. The RNFL thickness has been shown to differ across dementia, 
mild cognitive impairment, and healthy controls18. Retinal haemorrhages have also 
been found to be associated with brain haemorrhages in children dying of malaria19,20. 
Microvascular abnormalities in the retina are defined as the presence of haemorrhages, 
cotton wool spots, aneurysms, exudates, macular oedema, arteriolar narrowing, or 
venular widening (Figure 3). The blood vessels in the retina and the brain share many 
similarities in anatomy and physiology; abnormalities of these blood vessels may occur 
concomitantly in the retina and the brain. Easy access to the cerebral vasculature 
continues to pose challenges; the small vessels in the brain are not easily visualized. 
The retinal vasculature has hence often been used as a non-invasive in vivo surrogate 
marker to study vascular brain diseases. Although advances in neuroimaging have 
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improved our understanding of the role of cerebral vasculature in brain physiology 
and pathology21, these sophisticated imaging modalities are expensive and time-
consuming. Retinal fundus photography, being a non-invasive and non-expensive 
technique, is ideal for directly visualizing the retinal microvasculature1,22,23. Since the 
retinal microvasculature shares commonalities with cerebral microvasculature, it could 
serve as an ideal surrogate platform.
Figure 3.  
Retinal vascular abnormalities in relation to brain structure and cerebrovascular 
abnormalities 24
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1.2. Utility of Retinal Vasculature in studying 
Systemic, Vascular, and Neurodegenerative 
diseases
Retinal vasculature has been studied in several cardiovascular and neurodegenerative 
disorders including hypertension, diabetic retinopathy, stroke, cognitive impairment, 
Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.
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1.2.1.  Retinal Vasculature in Diabetes and Hypertension
The Atherosclerosis Risk In Communities study (ARIC) is a large population-based 
study that explored the relation between microvascular abnormalities and cognitive 
impairment. They reported that retinopathy, microaneurysms, and exudates are 
independently associated with a decrease in cognitive function25. In addition, narrowing 
of retinal arterioles and the presence of retinal exudates correlated with cerebral 
white-matter lesions on MRI26. Literature also indicates that there are abnormalities 
in retinal vascular calibre in cardiovascular diseases. Narrower central retinal arteriolar 
equivalents (CRAE) and wider central retinal venular equivalents (CRVE) were associated 
with various systemic diseases like diabetes, obesity, hypertension, and depression 
(Figure 4). The cardiovascular contributions of these disorders are believed to predict 
mortality27-29.
Figure 4.  
Narrow retinal arterioles (solid arrow) and wider retinal venules (dashed arrow) are 
indicators of various systemic diseases like hypertension and diabetes
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1.2.2. Retinal Vasculature in Stroke
Stroke is a major neurological illness in which the retinal microvasculature has been 
extensively examined. Several studies suggest that retinal microvascular anomalies 
reflect cerebrovascular changes related to stroke30-35. Even after adjusting for other 
risk factors (age, sex, race, blood pressure, diabetes), the ARIC study found retinal 
microvascular anomalies to be predictive of incident stroke as well as MRI-detected 
subclinical stroke36. The strongest relationship was demonstrated by microaneurysms 
and soft exudates. Another population study, the Cardiovascular Health Study found a 
similar relationship between retinal microvascular changes and stroke, after controlling 
for blood pressure and other risk factors37. Likewise, the Beaver Dam Eye Study also 
found the presence of retinal microaneurysms, haemorrhages, and retinal arteriolar 
narrowing to be associated with 10-year risk of stroke and coronary heart disease 
mortality38. The Blue Mountains Study which was prospective found an increased 
relative risk of stroke for all forms of retinopathy39, and unlike previous studies, the 
association with generalized arteriolar narrowing was as strong as the association 
with focal microaneurysms and haemorrhages. End diastolic and mean velocities on 
Central Retinal Artery doppler have also been found to be related to severity of cerebral 
small vessel disease, independent of ageing40. Post mortem studies in patients who 
had died of stroke have shown correlations between changes in retinal and cerebral 
vasculature41. Other investigators have found relationships between lacunar infarcts and 
retinal microvascular abnormalities42,43. In addition, a prospective study has suggested 
that 78% of patients with lacunar stroke had retinal microvascular abnormalities44. 
Interestingly, another study did not find any difference in the prevalence of retinal 
lesions across patients with lacunar infarcts and cortical strokes45.
1.2.3. Retinal Vasculature in Neurodegenerative disorders
A few studies have explored the relation between retinal microvascular changes 
and cognitive impairment25,46,47. They support the use of retinal vascular imaging 
for the screening of cerebral small vessel disease as a potential surrogate marker for 
patients at risk of cognitive impairments. Studies in Alzheimer’s disease have shown 
characteristic cerebral arteriolar changes including attenuation, increased tortuosity, 
and increased capillary microaneurysms48-52. Retinal morphological abnormalities in 
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Alzheimer’s disease include depletion of optic nerve ganglion cells, loss of retinal nerve 
fibre layer, and abnormal patterns of ElectroRetinoGram (ERG) responses (reduced 
implicit time and amplitude)53-58. Beta-amyloid and amyloid-associated proteins related 
to the pathogenesis of Alzheimer’s disease have also been isolated in retinal ganglion 
cells and nerve fibers59. This indicates a possible common vascular pathway in the 
neurodegenerative process of Alzheimer’s disease and the resultant neuronal loss both 
at the cerebral and the retinal levels16,60. Reduced retinal microvascular density has been 
demonstrated in Parkinson’s disease patients. These retinal microvascular abnormalities 
are postulated to be contributary to the neurodegeneration in these patients61. In 
addition to neurodegenerative diseases, the association between the retinal vascular 
abnormality and cognitive dysfunction has also been observed in diabetic retinopathy. 
Diabetic retinopathy has also been found to be associated with small focal white-matter 
hyperintensities in the basal ganglia62. However, it is important to note that some of 
these findings are confounded by the presence of comorbid hypertension63-65. 
Retinal imaging can also assess the amount of brain damage in patients with multiple 
sclerosis (MS)66; the degree of inflammation and swelling in the retinae reflected the 
severity of inflammation in the brain MRIs. This correlation affirms the value of retinal 
scans as a stand-alone surrogate for brain damage67.
1.3. Retinal Vascular abnormalities in Psychoses
Retinal vascular abnormalities in cardiovascular, neurological, and metabolic diseases 
have been well researched; however, their association with psychiatric disorders 
remains under-examined. Schizophrenia (SCZ) and Bipolar Disorder (BD) have high 
global prevalence and morbidity68. 
SCZ is a severe mental disorder characterized by positive symptoms such as 
hallucinations and delusions, negative symptoms such as amotivation and anhedonia, 
and cognitive deficits. Estimates of the international prevalence of schizophrenia 
among non-institutionalized persons ranges from 0.33% to 0.75%.69,70. SCZ is usually 
classified as Type I and Type II based on predominance of positive symptoms 
(hallucinations, delusions, paranoid thoughts) or negative symptoms (decreased social 
affiliation, lack of motivation or initiative, diminished speech, decreased emotions) 
respectively71-73. Symptoms usually begin during late adolescence and early adulthood. 
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The developmental progression of the disorder indicates that early symptoms could 
be cognitive impairment with unusual behaviours, while later stages would be 
characterized by multiple such symptoms. This possibly reflects the disruptions in brain 
development and the contributory influences of environmental factors. Cognitive 
deficits are a core feature of SCZ; this includes impairments in attention, working 
memory, verbal learning, processing speed, visual learning, problem-solving, and 
social cognition74. Several studies have suggested that cognitive deficits are important 
determinants of functional outcomes in SCZ74,75. As is the case with most disorders, early 
detection and timely interventions help to improve life while severe disability results if 
the disease is left untreated. Treatment for SCZ is often lifelong and has to be continued 
even after symptoms have subsided. 
Another important psychosis, BD, also has a high prevalence of around 1% in the 
general population76. It is characterized by drastic changes in the mood, energy, and 
activity levels of the person. These shifts in mood and energy levels are severe and affect 
daily activities77,78. For this reason, it is also referred to as manic-depressive disorder. 
Manic episodes are characterized by elated mood, irritability, increased energy and 
activity levels, and reduced need for sleep. During depressive episodes the person is 
sad, has low energy and motivation, and loss of interest in day to day activities along 
with impairment in socio-occupational functions. Patients may also have suicidal 
ideas during the episodes. Each episode can last from weeks to months79. More severe 
episodes, symptoms, comorbidities, and functional impairments accompany the 
adolescent-onset form of BD than the adult-onset form80. Studies also have suggested 
that cognitive deficits adversely affect functional outcomes in bipolar disorder74. 
Treatment of BD involves medications to both control symptoms during the episode 
and prevent the occurrence of further episodes while the patient is asymptomatic. 
As shown in Figure 5, the retina has its embryonic origins from neural tissue and is 
connected to the brain through the optic nerve. The optic nerve consists of axons that 
transmit visual signals to the lateral geniculate nucleus, a thalamic relay centre for the 
visual pathway. From there, signals are transmitted to the visual cortex where visual 
stimuli are processed. As the retina and brain are developmentally and structurally 
connected, global brain damage may manifest as thinning of the retinal layers24.
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Figure 5.  
Illustration of the connections of retinal nerve tissue to the brain and its use as biomarker 
for neurodegenerative brain disorder24
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1.3.1. Retinal Structure abnormalities in SCZ and BD
Multiple structural and functional disturbances have been observed in the eyes of 
patients suffering from SCZ, including retinal venular widening, retinal nerve fibre layer 
(RNFL) thinning, abnormal output of retinal cells as measured by ERG, maculopathies, 
retinopathies, cataracts, poor acuity, and strabismus. Although some of these findings 
may be due to medications and comorbidities, others could serve as biomarkers for 
neural pathology and progression of SCZ81. One of the widely published retinal structure 
abnormalities in psychoses occurs in the RNFL. A typical RNFL OCT image is shown in 
Figure 2. As the RNFL consists of the axonal origins of the visual pathway and is not 
myelinated, it provides insight into the pathophysiological processes of diseases that 
have a neurodegenerative component82. Retinal layer abnormalities in SCZ detected 
using OCT have been found to be correlate with negative symptoms of SCZ in addition 
to the visual function of the eye83. Patients with BD have significantly quantifiable 
thinning in the macular RNFL, ganglion cell layers, inner plexiform layers, and inner 
nuclear layer compared to controls84,85. Studies that have examined RNFL thickness in 
SCZ and BD have derived its relation to brain abnormalities86,87.
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1.3.2. Retinal Vascular abnormalities in SCZ and BD
Several studies have suggested vascular risk factors and vascular anomalies in these 
two major psychoses. Abnormal capillary beds in nail folds88, abnormal vascular 
responses to niacin89, and abnormalities in the genes regulating cerebral blood flow90 
have been reported in SCZ. Patients with BD have a higher incidence of vascular 
disorders and premature mortality; this may include contributions by suicide and 
other related comordibidities91. However, an increased prevalence of deep white 
matter hyperintensities on magnetic resonance imaging (MRI), indicates cerebral 
microvascular disease in patients with BD92. Neuroimaging studies have reported 
reduced cerebral blood flow in the anterior brain regions in both SCZ93 and BD94. 
Subsequently, the examination of cerebral microvascular abnormalities in SCZ and BD 
has gained considerable interest. Researchers have explored the retina for potential 
biomarkers for SCZ and cognitive impairments81. 
Of these only a few studies have worked on the analysis of retinal images of patients with 
psychoses. Direct imaging of the retinal microvasculature has been performed only in 
members of the Dunedin birth cohort at 38 years of age. It was found that patients with 
SCZ had significantly wider venular calibres when compared to other cohort members. 
The dilated microvenules could not be explained by measurable confounders of 
illness, including antipsychotic treatment and other comorbidities found in SCZ such 
as hypertension, diabetes, and tobacco dependence. This demonstrated that retinal 
imaging could improve our understanding of the etiopathogenesis of schizophrenia, 
and that it could be a potential biomarker for SCZ95. Another study by the same group 
explored whether these retinal microvascular changes reflected familial vulnerability 
to psychotic symptoms. The retinal venular diameters of those with psychosis and their 
unaffected twins were analysed along with controls. It was found that the psychotic 
patients had larger venular diameters compared to controls, while the unaffected twins 
demonstrated intermediate values after adjusting for confounders like smoking, blood 
pressure, and body mass index96. This suggests that the width of retinal venules may 
serve as a proxy measure for familial vulnerability to psychotic symptoms. 
Another group compared retinal vessels in patients with BD and healthy controls. The 
retinal vascular abnormalities reflected excessive and premature cardiovascular disease. 
Retinal vascular calibres are correlated with mood and cognition, vascular risk factors, 
and endothelial function in adolescent BD. However, there was no significant difference 
in the retinal vessel calibres between patients with adolescent BD and healthy controls97. 
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Apart from the three above-mentioned studies, none have examined retinal vascular 
abnormalities in SCZ and BD. However, these studies were preliminary and their 
measurements were restricted to vessel calibre. They have not examined other vascular 
parameters such as tortuosity, fractal dimension (Df), or trajectory. 
Tortuosity refers to the geometric pattern of the retinal vasculature layout (Figure 6) 
and reflects the adequacy of the microcirculation status and level of ocular perfusion98. 
Researchers have opined that retinal vascular tortuosity is a more stable marker 
than retinal vascular calibre as it is not affected by pulse variations99,100 and has high 
heritability101,102. Retinal tortuosity has been studied in various diseases but have 
not provided consistent findings100. Hypertension has been shown to be associated 
with increased retinal venular tortuosity103. However, retinal arteriolar tortuosity in 
hypertension has shown contradictory findings across studies104,105. Studies have 
demonstrated increased tortuosity of retinal vessels in cerebrovascular diseases 
like ischemic stroke106, cognitive dysfunction, Alzheimer’s disease107, and metabolic 
disorders like increased body mass index and diabetes108. 
Figure 6.  
Tortuosity measurement in retinal fundus images109
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Blood vessels repeatedly subdivide into smaller blood vessels with similar network 
patterns. This phenomenon can be quantified using fractal dimension (Df), which 
expresses the degree of complexity of blood vessel geometry as a single value 
(Figure 7)110,111. Retinal vascular Df depends on the number of bifurcations, angle of 
bifurcations, and length of vessels between two consecutive bifurcations112. It is not 
affected by factors which may confound the measurement of vascular calibre 21, such 
as variations in the pulse cycle or ocular and camera magnification113 and is hence more 
advantageous. Several studies have reported that retinal vascular Df correlates with 
diabetes and diabetic retinopathy, hypertension, cardiovascular disorder, stroke, and 
dementia 114-127; Df has been proposed as a biomarker for these conditions123.
Figure7.  
Decreasing fractal dimension values based on complexity of the retinal vasculature128
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Figure8.  
Retinal vascular trajectory marked in a retinal fundus image
Yet another retinal vascular parameter is the retinal vascular trajectory (Figure 8) 
measured as retinal artery angle (angle between the supratemporal and infratemporal 
arteries). A recent study has reported a significant relation of retinal arterial trajectory 
to RNFL thickness129. The retinal arterial trajectory130,131, thus provides an opportunity to 
indirectly examine abnormalities in RNFL thickness. Despite its relationship with RNFL 
abnormalities, studies are yet to examine the trajectory of retinal vessels in patients with 
SCZ and BD.
While these studies have provided the first line of evidence for abnormal retinal vessels in 
SCZ and BD, the findings have not been replicated and there have been no comparisons 
of these parameters across the two major psychoses. In addition, the retinal vascular 
parameters have also not been examined in relation to cognitive impairment. The 
employment of machine learning in the assessment of retinal vascular abnormalities 
as biomarkers in SCZ and BD is also yet to be researched. Retinal vascular changes are 
potential markers of future cardiovascular morbidity and could help in identifying at-risk 
individuals at an earlier stage.
Outline of the Thesis
This thesis investigates retinal microvasculature abnormalities in two major psychoses, 
SCZ and BD, and explores the potential usage of the retina as a surrogate examination 
platform. Retinal imaging features including retinal vascular calibre, tortuosity, fractal 
dimension, and trajectory were assessed. In addition, their relation with cognition was 
also explored. 
The outline of this thesis across the upcoming 
chapters is provided below
CHAPTER TWO describes the measurement of retinal vascular calibre (retinal vessel 
thickness) in patients with SCZ and BD, and Healthy Volunteers (HV). It demonstrates 
that retinal vasculature provides a window to the brain circulation. This study is the first 
of its kind to compare retinal vascular calibre across two disorders (BD and SCZ).
CHAPTER THREE illustrates the use of retinal tortuosity which is another measurable 
parameter on the retinal fundus image in SCZ, BD, and HV. Retinal tortuosity is 
described as the ratio of arc length to chord length in retinal vessels. The variations of 
retinal arteriolar tortuosity across SCZ, BD, and HV are discussed along with its potential 
as a biomarker for assessing the risk of future adverse vascular events.
CHAPTER FOUR covers the importance of fractal dimension of retinal vasculature in 
SCZ, BD, and HV. The retinal vascular fractal dimension represents the complexity of the 
entire retinal vascular tree, and was measured with the help of an automated algorithm 
using the box counting method. The potential implications of abnormal Df in psychoses 
are also discussed.
CHAPTER FIVE demonstrates the measurement of retinal vascular trajectory in SCZ, 
BD, and HV. The use of machine learning to evaluate retinal vascular trajectory is also 
described in this chapter, along with the implications of varied findings across patient 
and control groups. 
CHAPTER SIX discusses the correlation between cognitive function as assessed by the 
one back identification test and retinal vascular calibre in SCZ, BD, and HV. One back 
test is a standard cognitive test that assesses the working memory of an individual. The 
chapter also discusses the relation between retinal vascular calibre and memory. 
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CHAPTER SEVEN provides an overview of retinal vasculature abnormalities in SCZ 
and BD patients. It also illustrates the challenges associated with the use of techniques 
that were employed. In addition to discussing how the thesis has contributed to the 
existing knowledge base, the chapter also cites recent research advances in this area 
and directives for future studies.
CHAPTER EIGHT summarizes the thesis. The background of the study, procedures 
employed, major findings, and their clinical implications are outlined in this chapter. 
Special emphasis has been given to the utility of the retina as a proxy examination 
platform and retinal vascular parameters as biomarkers for cerebrovascular disorders.
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Abstract
Objectives: The examination of retinal microvascular abnormalities through fundus 
photography is currently the best available non-invasive technique for assessment 
of cerebral vascular status. Several studies in the last decade have reported higher 
incidences of adverse cerebrovascular events in Schizophrenia (SCZ) and bipolar 
disorder (BD). However, retinal microvasculature abnormalities in SCZ and BD have 
remained under-explored, and no study has compared this aspect of SCZ and BD 
till date. 
Methods: Retinal Images of 100 SCZ patients, BD patients, and healthy volunteers each 
were acquired by trained individuals using a non-mydriatic camera with a 40-degree 
field of view. The retinal images were quantified using a valid semi-automated method. 
The average of left and right eye diameters of the venules and arterioles passing 
through the extended zone between 0.5 and 2 disc diameters from the optic disc 
were calculated. 
Results: The groups differed significantly with respect to average diameters of both 
retinal venules (p<0.001) and retinal arterioles (p<0.001), after controlling for age and 
sex. Both SCZ and BD patients had significantly narrower arterioles and wider venules 
compared to HV. There were also significant differences between SCZ and BD patients; 
patients with BD had narrower arterioles and wider venules. 
Conclusion: Considering the affordability and easy accessibility of the investigative 
procedure, retinal microvascular examination could serve as a potential screening 
tool to identify individuals at risk for adverse cerebrovascular events. The findings of 
the current study also provide a strong rationale for further systematic examination of 
retinal vascular abnormalities in SCZ and BD.
Keywords: cerebrovascular event, fundus, neurodevelopment, peripheral marker, 
psychoses, retinal vessel
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2.1. INTRODUCTION
The retina and brain have common developmental origins and share anatomical, 
physiological, and autoregulational properties1-3. Examination of retinal microvascular 
abnormalities using fundus photography is currently the best available non-invasive 
technique to assess the status of systemic vascular health; narrower arterioles are 
associated with hypertension and obesity, while wider venules are linked to diabetes 
and altered lipid profiles4. Several studies in the last decade have reported that retinal 
vascular abnormalities reflect cerebral vascular abnormalities, with wider venules being 
predictive of stroke and other cerebrovascular diseases5. Narrower arterioles and wider 
venules have additionally been linked to poorer cognitive function and increased risk 
of dementia1.
Interestingly, vascular abnormalities have also been implicated in psychiatric 
disorders. Abnormal capillary bed in nail folds6, abnormal vascular response to niacin7, 
and abnormalities in genes regulating cerebral blood flow8 have been reported in 
schizophrenia (SCZ). Patients with bipolar disorder (BD) have a higher incidence of 
vascular disorders and related premature mortality9, and an increased prevalence of 
deep white matter hyperintensities on magnetic resonance imaging (MRI), indicating 
cerebral microvascular disease10. Neuroimaging studies have reported reduced cerebral 
blood flow in the anterior brain regions in both SCZ11 and BD12. However, despite the 
analogies between cerebral and retinal vasculatures, and easy access to the latter, 
retinal microvascular abnormalities have not been adequately examined in SCZ and BD. 
A single study that examined retinal vascular abnormalities in participants with SCZ, 
reported wider retinal venules compared to controls2. A related study examined twins 
discordant for psychotic symptoms with controls, and reported that abnormalities in 
retinal vessels reflect familial vulnerability to psychotic symptoms13. The only study in 
BD that has examined the retinal microvasculature had adolescent participants, and 
showed no abnormality14. The status of retinal vasculature in adults with BD remains 
unexplored. 
While these studies have provided the first line of evidence for abnormal retinal vessels 
in SCZ and BD, the findings have not been further replicated. In addition, there have been 
no comparisons of such abnormalities across these two major psychoses. Considering 
the shared vascular co-morbidity in SCZ and BD15,16 it is important to ascertain whether 
the retinal vascular abnormality is seen in all psychoses or specific to SCZ. The retinal 
vascular changes if found, are potential markers of future cardiovascular risk and could 
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help in identifying at risk individuals. Hence, in the current study, we measured retinal 
microvascular parameters in patients with SCZ and BD, and healthy volunteers. 
While previous studies in schizophrenia have reported wider retinal venules, studies 
in other neurological disorders have reported narrower retinal arterioles to be linked 
to stroke, cerebral small vessel disease and dementia1,17. Based on these studies we 
hypothesized that, both SCZ and BD patients would have retinal vascular abnormalities, 
with wider venules and narrower arterioles, when compared to healthy volunteers; 
and that there would be no difference between SCZ and BD patients, considering the 
shared etiopathogenesis and shared vascular comorbidity. 
2.2. METHODOLOGY
2.2.1. Subjects
One hundred patients with SCZ and 100 patients with BD were recruited from the 
outpatient and inpatient services of the National Institute of Mental Health and 
Neurosciences, Bangalore, India. Patients were clinically interviewed by a certified 
psychiatrist, and all patients meeting the diagnostic criteria for SCZ or BD according to 
the International Classification of Disorders (ICD-10)18 were recruited. Patients with a 
diagnosis of substance use disorder (except nicotine), comorbid psychiatric disorders, 
medical or neurological illness namely hypertension, diabetes, cerebrovascular 
accident or history of ocular trauma were excluded. One hundred healthy volunteers 
(HV) were also recruited from same geographical location via flyers and word of mouth. 
Relatives of patients were not included as these measures could be endophenotypes. 
All HV were interviewed by a trained psychiatrist to rule out syndromal axis I psychiatric 
diagnosis. All HV underwent a clinical evaluation by a trained psychiatrist and were 
administered self-reported versions of the DSM-5 Cross cutting Symptom measures 
developed by the DSM-5 Task Force and Work Groups19. None of the HV had diagnoses 
of psychiatric disorder, substance use disorder, diagnosis of hypertension, diabetes, 
cerebrovascular accident, major neurological illness or history of eye trauma. All 
participants were between 18 and 50 years of age. The study was approved by the 
Institute Ethics Committee and all participants were recruited after valid documented 
informed consent.
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2.2.2. Assessments
The severity of clinical symptoms in SCZ was assessed using the Brief Psychiatric Rating 
Scale (BPRS)20, which is designed to measure the severity of positive and negative 
symptoms, and general psychopathology. Young’s Mania Rating Scale (YMRS)21, a 
valid instrument to measure severity of mania, and Hamilton Depression Rating 
Scale (HDRS)22, a sensitive tool to measure the severity of depression were used in BD. 
Functioning was assessed using Global assessment of functioning (GAF)23 and Clinical 
Global Impression (CGI)24 in both SCZ and BD. 
2.2.3. Retinal image acquisition
The process of retinal image acquisition was explained to the participants before the 
procedure. Images were acquired by trained individuals using a non-mydriatic camera 
with a 40-degree field of view, the ‘3nethra classic’, which is manufactured by Forus 
Health Pvt ltd, India. Participants were seated in dark room for 5 minutes before the 
procedure to facilitate dark adaptation and pupillary dilatation. Optic disc centered 
posterior retinal images were captured using a valid method described by previous 
authors25. Images were acquired from both the eyes separately and the average of 
vessel calibers from the right and left eyes was taken as the primary outcome measure 
as described in a former study2.
2.2.4. Measurement of retinal vasculature
The retinal images were quantified using the semi-automated software VAMPIRE 
(Vessel Assessment and Measurement Platform for Images of the REtina)26. The images 
were coded, and the person who performed the grading was blind to the diagnosis. 
VAMPIRE is a well validated tool for measurement of retinal vasculature and has been 
used in many studies. The tool provides automatic detection of retinal landmarks (optic 
disc) and quantifies frequently investigated key parameters such as vessel diameter 
and vessel branching coefficients. Details of the tool and computation process have 
been described elsewhere27. In brief, we computed the vessel diameter as the cross-
sectional span of the vessel mask perpendicular to the vessel’s estimated axis. Using 
Guos thinning algorithm, the vessel regions were initially converted to 1-pixel width. 
The arteriolar and venular diameters passing through the extended zone between 0.5 
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and 2 disc diameters from the optic disc were measured (Figure 1); as extended zone 
(0.5 to 2 disc diameters) measurements have been shown to have higher reliability 
compared to restricted zone (0.5 to 1-disc diameters) measurements2,28. 
Based on revised Knudtson-Parr-Hubbard formula, the six largest arterioles and 
venules present in this extended zone were chosen for calculations29, as this has been 
demonstrated to have better accuracy compared to 3 vessel measurements14. The 
Central Retinal Artery Equivalent (CRAE) for arterioles and Central Retinal Vein Equivalent 
(CRVE) for venules were calculated using an iterative process, by progressively replacing 
the largest and smallest vessel diameters at W1 and W2 in the formula mentioned in the 
equations (1) and (2) until a single number was reached.
Figure 1.  
Representative figure showing zone-wise measurement of retinal vascular calibers
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To convert the values obtained in pixels to micrometers (μm) we used a calibration 
factor. This calibration factor adjusted for the magnification differences due to optics 
of fundus camera, image resolution and refractive errors of the patient as reported by 
previous study. First, we measured the distance between the centre of the optic disc 
and centre of the macula for each individual subject’s fundus image in pixels. Next, the 
calibration factor was calculated by using the formula
The value, 4500 µm represents the average disc diameter in micron and was calculated 
based on previous studies; the average disc diameter measured by fundus camera was 
assumed to be 1800 μm and distance from the center of the optic disc to the center 
of the macula to be two and half times the disc diameter, i.e., 4500μm30. Next this 
calibration factor was multiplied by individual CRAE and CRVE of individual images 
obtained using equation 1 and 2 to convert the vessel caliber from pixel to μm.
A sub-sample of 30 participants images were graded and analyzed by two persons to 
check the inter-rater reliability and a good inter-rater reliability of 0.8 was obtained for 
both CRVE and CRAE (Intra Class Correlation –Average vein – 0.86, Average artery-0.84). 
2.2.5. Statistical Analysis
All analyses were performed using the Statistical Package for Social Sciences (SPSS) 
version 25. After establishing normative distribution of data using Shapiro-Wilk test, 
parametric statistical tests were used. Sex distribution across groups was examined 
using chi-square test and age difference was analyzed using one-way analysis of variance 
(ANOVA). As we measured two primary outcome measures, a Bonferroni corrected 
α=0.025 was considered significant. Age and sex-ratio being different across groups, 
our main outcome measures, i.e., group differences in average CRVE and average CRAE 
were compared using multiple linear regression after adding age and sex as additional 
regressors to the model. To examine the relation between retinal vascular measures 
and clinical-demographic variables, separate stepwise linear regression analyses were 
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conducted, with average CRVE and average CRAE as dependent variables, and scores on 
BPRS, YMRS, HDRS, number of episodes, and duration of illness as predictor variables. 
Table 1.
Comparison of demographic and clinical details between the groups
HV
(n=92)
SCZ
(n=98)
BD
(n=87) F/t/χ2 P
Age 30.2±7.8 32.7±6.0 32.9±6.0 4.536 0.012
Gender ratio (M/F) 41/51 64/34 54/33 9.479 0.009
Age at onset (y) - 25.2±5.3 23.7±5.9 2.584 0.11
Duration of illness 
(y) - 7.6±5.1 9.0±5.6 2.3 0.13
BPRS - 28.7±6.9 - - -
HDRS - - 3.9±5.3 - -
YMRS - - 1.9±3.1 - -
Abbreviations: χ2, Chi square test; BD, patients with bipolar disorder; BPRS, Brief 
Psychiatric rating scale; HDRS, Hamilton depression rating scale; YMRS, Young’s 
mania rating scale; F, Analysis of Variance; HV, healthy volunteer; SCZ, patients with 
schizophrenia; t, Independent t test.
Table 2.
Retinal vascular diameters in the three groups
Parameter HV(n=92)
SCZ
(n=98)
BD
(n=90) F P
CRVE 196.5±21.7 213.4±27.4 227.6±26.3 33.8 <0.001
CRAE 110.7±21.7 102.5±15.8 95.8±16.9 14.9 <0.001
Abbreviations: BD, patients with bipolar disorder; CRAE, Average Central Retinal Artery 
Equivalent.; CRVE, Average Central Retinal Vein Equivalent; HV, healthy volunteer; SCZ, 
patients with schizophrenia.
2.3. RESULTS
2.3.1. Comparison of demographic variables
A total of 300 participants were recruited consisting of 100 healthy controls, 100 
patients with SCZ and 100 patients with BD. Twenty-three of them were excluded 
following quality check of retinal images. The remaining 277 (98 patients with SCZ, 87 
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patients with BD and 92 healthy volunteers) were taken up for analyses. Demographic 
details and clinical variables are given in Table 1. We found significant differences in age 
and gender distribution across the three groups. Duration of illness and age at onset of 
illness were not significantly different between patients with SCZ and BD. 
2.3.2. Differences in retinal vascular measures between groups 
There were significant differences across the three groups in both CRVE and CRAE 
(p<0.001) (Table 2 and Figure 2). Further post-hoc analysis revealed that, both patients 
with BD (p<0.001), and patients with SCZ (p<0.001) had significantly wider CRVE in 
comparison to healthy volunteers. In addition, BD patients had significantly wider CRVE 
than SCZ patients (p<0.001) (Figure 2). The CRAE on the other hand was significantly 
narrower in both patients with BD (p<0.001) and patients with SCZ (p=0.002) 
compared to healthy volunteers; and significantly narrower in BD patients compared 
to SCZ patients (p=0.014) (Figure 2 and supplement Table S1). Since the groups 
were heterogeneous with respect to age and sex-ratio, we used them as additional 
regressors to control for possible confounding effects. Table 3 shows the regression 
analysis results between groups for both CRAE and CRVE, with and without adjustment 
for age and sex. The regression coefficient was comparable even after controlling for 
these confounding variables (further details in supplement Table S2). In addition, to 
rule out the confounding effects of the age and sex, we selected a sub-sample matched 
on these measures. 66 HV (M:F =32:34 ; age = 30.6±5.4 years), 92 SCZ (M:F =60:32 ; age 
= 32.3±5.5 years) and 78 BD (M:F =50:28 ; age = 32.24±5.0 years) were selected. These 
three groups were matched on age (F =2.33; p =0.1) and sex (χ2 =5.24; p =0.07). On 
regression analysis, there was still a significant difference between the three groups 
on CRVE (HV:197.5±22.4, SCZ:212.8±28.0, BD: 228.8±26.4; F=52.0, β=0.4, p<0.001) 
and CRAE (HV: 106.5±21.0; SCZ: 102.6±16.1, BD: 95.2±17.1; F=14.7, β =-0.24, p<0.001). 
Further, the two patient groups were examined using this sub-sample. The two groups 
were matched on age (t = 0.035; p =0.158) and sex (χ2 =0.023; p =0.88). On regression 
analysis, these two patient groups had significant difference in CRVE (F =14.47; β =0.3, 
p <0.001) and CRAE (F = 8.63; β =-0.2, p =0.004). On stepwise linear regression between 
average CRAE, CRVE, and clinical variables, none of the clinical variables showed 
significant contribution to the model suggesting absence of relationship between 
clinical variables and retinal vascular diameters (p>0.05).
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2.4. DISCUSSION
To the best of our knowledge, this is the first study to have assessed retinal 
microvasculature abnormalities in both SCZ and BD in comparison with healthy 
individuals. Results from the study show that patients with both SCZ and BD have 
microvascular abnormalities, i.e., wider venular and narrower arteriolar diameters when 
compared to healthy volunteers. Interestingly, patients with BD had significantly wider 
venules and narrower arterioles than patients with SCZ. 
Our findings are in accord with, and support the only previous study on SCZ which 
also reported wider venules and narrower arterioles2. However, in contrast to a previous 
negative study in adolescent BD14, we have found that BD patients have wider venules 
and narrower arterioles in the retina. This could be due to a larger sample size (n=100 
vs. n=30) and the inclusion of adult patients in the current study. Our sample also 
had a higher proportion of patients with type I BD (65/100 vs. 9/30). It is possible that 
retinal vascular abnormalities in BD have a progressive nature which could explain the 
findings in our adult sample with long duration of illness (9.3±5.6 years) as opposed to 
adolescents with BD.
The mechanisms underlying retinal venular and arteriolar abnormalities are not 
completely known. Several theories have been proposed and epidemiological studies 
have shown that changes in retinal arteriolar and venular diameters are reflective of 
a wide range of environmental, genetic, and systemic influences31 such as aging, 
inflammation, nitric oxide–dependent endothelial dysfunction, and hypoxia/ischemia. 
Impaired fasting glucose, diabetes, dyslipidemia, obesity, elevated systemic markers of 
inflammation, endothelial dysfunction, and cigarette smoking are also associated with 
narrower arteriolar and wider venular diameters 8. In the background of these findings, 
the results of the current study, suggests that patients with BD and SCZ are at a higher 
risk of cerebrovascular accidents. A significantly increased risk of stroke in patients 
with BD and SCZ has also been reported in previous studies32,33. Examination of retinal 
microvasculature could prove to be an easy and affordable method to identify such 
patients at risk of adverse vascular events; the reliability of this investigative procedure 
needs to be explored in future studies.
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Figure 2.  
Representative boxplot diagrams showing mean comparison of CRVE and CRAE 
between groups
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Table 3.
Mean difference of vascular diameter between groups adjusted for age and sex
Group
Not adjusted for age and sex Adjusted for age and sex
β (95% CI) P β (95% CI) P
CRVE
HV SCZ 0.3(9.7 to 23.9) <0.001 0.3 (9.4 to 24.2) <0.001
HV BD 0.5 (23.9 to 38.2) <0.001 0.5 (22.8 to 37.6) <0.001
SCZ BD 0.3 (6.4 to 22.04)) <0.001 0.3 (6.4 to 22.1) 0.001
CRAE
HV SCZ -0.2 (-13.6 to -2.8) 0.003 -0.2 (-12.8 to -1.6) 0.012
HV BD -0.4 (-20.7 to -9.1) <0.001 -0.3 (-19.3 to -7.5) <0.001
SCZ BD -0.2 (-11.4 to-1.9) 0.006 -0.2 (-11.5 to -2.1) 0.004
β, regression coefficient; 95% CI, 95% confidence interval; BD, patients with bipolar 
disorder; CRAE, Average Central Retinal Artery Equivalent; CRVE, Average Central 
Retinal Vein Equivalent; HV, healthy volunteer; SCZ, patients with schizophrenia.
The significant difference between SCZ and BD patients with respect to the retinal 
vessel diameters was an unexpected finding. Several studies in the recent past suggest 
shared risk factors and considerable overlap in pathophysiological processes between 
SCZ and BD15. Considering the common developmental origin between these disorders, 
we expected similarities, but the study results suggest significant difference between 
the disorders. The presence of a considerable number of BD-II and non-psychotic BD-I 
patients in our sample may explain the group differences demonstrated between SCZ 
and BD; while previous studies have reported considerable overlap between psychotic 
BD-I and SCZ34, it is yet unclear whether similar overlap is present between BD-II/
non-psychotic BD-I and SCZ. It is also important to note that similar cross diagnostic 
differences between SCZ and BD have been reported by several previous studies that 
have examined neurocognition35,36, functional magnetic resonance imaging (fMRI)37 
and prevalence of metabolic syndrome38. Studies have reported that patients with SCZ 
have greater impairment in cognitive functions compared to BD36,39. A recent study 
has reported decreased volume of the CC (corpus callosum) associated with a lower 
degree of left hemispherical asymmetry for language in BD which was not replicated 
in SCZ. The authors have suggested that such distinct anomalies in both SCZ and BD 
may be considered specific biomarkers40. Hence, although some susceptibility genes 
are shared between SCZ and BD, one cannot rule out the possibility that other genetic 
and environmental factors may have differential effects41. 
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Findings of our study could have potential implications. The interesting observation 
of difference between SCZ and BD needs to be further examined and if replicated, has 
potential utility as a differential marker. It is important to note that patients who have 
psychotic symptoms during their first illness episode in BD are commonly misdiagnosed 
as SCZ or other psychotic disorders 42,43. This could result in delay in initiation of specific 
treatment for BD resulting in more number of hospitalizations and poorer functional 
outcomes42. Hence, a biomarker which can differentiate BD from SCZ could aid early 
initiation of prompt treatment and better outcomes. A few studies have suggested that 
brain morphometric measures are potential biomarkers to differentiate BD from HV44 
and unipolar depression45. Further studies are required to ascertain whether retinal 
imaging measures have similar potential as neuroimaging measures to be used as 
biomarkers. However, in the background of several confounding factors it is important 
to note that our findings at this stage need to be considered preliminary and do not 
definitively suggest that retinal vascular changes are markers for psychosis but markers 
which may indicate risk for vascular events.  
The following limitations of our study need to be considered while interpreting the 
results. All patients were on treatment with medications and hence the confounding 
effect of medication on CRVE or CRAE cannot be ruled out. However, there was no 
correlation between the antipsychotic dose used and retinal vascular measures 
(p>0.05; details in supplement) suggesting absence of significant confounding effect 
of medication. Although study subjects were young adults and those subjects with 
known hypertension or diabetes mellitus were excluded to avoid their confounding 
effects, blood glucose levels and blood pressure were not documented for all 
participants on the day of retinal image acquisition. Hence one cannot rule out the 
possible confounding effect of pre-diabetic or pre-hypertensive status46. We excluded 
the diagnosis of medical disorders based on the history, which may risk the possibility 
of undiagnosed condition. However, in the sub-group of patients for whom the BMI and 
systolic blood pressure was available, there was no significant difference between the 
groups, and the results remained significant even after controlling for these variables 
(details in supplement). Future studies need to consider measuring the blood pressure, 
fasting glucose and renal functions using blood tests on the day of examination to 
control for their confounding effects. We did not collect the information regarding the 
lifestyle of subjects. As patients might have had sedentary lifestyle compared to HV, this 
could be a potential confounding factor increasing the risk for vascular events. Future 
studies need to include assessment of lifestyle factors like diet, exercise etc. As it was 
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not the primary aim of the study, we did not have equal representation of BD-I and BD-II 
patients; this may have affected the results in the BD group as previously discussed. The 
groups were not age and sex matched. However, even after inclusion of age and sex as 
covariates the results have remained significant. Also, as seen in Table 3, the regression 
coefficient was comparable with and without age and sex as additional regressors in 
the model. Seventeen patients had documented nicotine use which may have affected 
their retinal vascular measures. However, even after excluding these 17 patients the 
results remained significant (details in supplement). Finally, while our study suggests 
abnormalities in retinal vasculature in BD and SCZ, the study population had varying 
lengths of illnesses. With the cross-sectional nature of the study design it is not possible 
to determine whether the retinal micro-vascular changes were static or progressive. 
In our study, there was no significant relation between retinal vascular diameters 
and clinical variables including duration of illness, number of episodes, or severity 
of symptoms. However, a few longitudinal studies have reported changes in brain 
morphometric measures in individuals with BD47 as well as those with high familial risk 
for BD48. Similarly, a few studies have also suggested an association between epigenetic 
factors and specific symptoms in BD49. Considering that the concept of staging in 
BD43,50 is a relatively recent development, future longitudinal studies need to probe for 
changes in retinal vascular measures with progression of the illness. 
2.5. Conclusion
To summarize, our study indicates significant differences in retinal microvascular 
diameters in patients with SCZ and BD when compared to HV; patients with BD and 
SCZ have narrower arterioles and wider venules in comparison to HV, and patients with 
BD have narrower arterioles and wider venules in comparison to SCZ patients. This line 
of investigation has important implications as these findings suggest an increased risk 
of adverse vascular events in patients with SCZ and BD. Considering the affordability 
and easily accessible nature of the investigative procedure, retinal microvascular 
examination could serve as a potential screening tool to identify individuals at risk for 
adverse vascular events. However, with the cross-sectional design of the study we were 
not be able to determine the threshold value for identifying at risk individuals. Future 
longitudinal studies will be able to provide the threshold value which may differentiate 
those at risk of cerebro/cardiovascular risk and the sensitivity, specificity metrics. The 
findings of current study provide a strong rationale for further systematic examination 
of retinal vascular abnormalities in patients with SCZ and BD.
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Supplementary Materials
Table S1.
Mean difference between groups on CRVE and CRAE (Bonferroni post-hoc analysis)
Group Group Mean Difference Std. Error Sig.
CRVE
HV
SCZ -16.8* 3.7  <.001
BD -31.0* 3.8 < .001
SCZ
HV 16.8* 3.7  <.001
BD -14.2* 3.7 .001
BD
HV 31.0* 3.8 < .001
SCZ 14.2* 3.7 .001
CRAE
HV
SCZ 8.2* 2.7 .007
BD 14.9* 2.7 < .001
SCZ
HV -8.2* 2.7 .007
BD 6.7* 2.7 .042
BD
HV -14.9* 2.7 .000
SCZ -6.7* 2.7 .042
Table S2: Details of regression coefficient between groups with and without age 
and sex as predictor variables
S2a – Mean difference between HV and SCZ without age and sex as predictors
CRVE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 196.5 2.6 75.904 < .001
Group 16.8 3.6 .322 4.667 < .001
CRAE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 110.7 2.0 56.114 < .001
Group -8.2 2.7 -.213 -2.993 .003
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S2b – Mean difference between HV and SCZ with age and sex as predictors
CRVE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 193.5 10.5 18.507 < .001
Group 16.8 3.8 .321 4.472 < .001
Age .07 .26 .018 .255 .799
Gender .6 3.7 .012 .165 .869
CRAE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 120.7 7.9 15.277 < .001
Group -7.2 2.8 -.188 -2.551 .012
Age -.4 .2 -.129 -1.789 .075
Gender .5 2.8 .013 .181 .856
S2c – Mean difference between HV and BD without age and sex as predictors
CRVE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 196.5 2.5 78.316 < .001
Group 31.0 3.6 .544 8.625 < .001
CRAE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 110.7 2.0 54.368 < .001
Group -14.9 2.9 -.358 -5.101 < .001
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S2d – Mean difference between HV and BD with age and sex as predictors
CRVE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 194.5 10.1 19.187 < .001
Group 30.2 3.7 .529 8.098 < .001
Age .17 .3 .044 .685 .494
Gender -2.1 3.7 -.038 -.587 .558
CRAE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 118.0 8.1 14.502 < .001
Group -13.4 3.0 -.321 -4.462 < .001
Gender 2.9 3.0 .069 .978 .329
Age -.4 .2 -.133 -1.877 .062
S2e – Mean difference between SCZ and BD without age and sex as predictors
CRVE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 213.4 2.7 78.505 < .001
Group 14.2 4.0 .256 3.588 < .001
CRAE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 102.5 1.7 62.080 < .001
Group -6.7 2.4 -.201 -2.774 .006
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S2f – Mean difference between SCZ and BD with age and sex as predictors
CRVE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 214.5 11.7 18.344 < .001
Group 14.3 4.0 .257 3.583 < .001
Gender -2.0 4.2 -.035 -.481 .631
Age .04 .3 .011 .143 .886
CRAE Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 103.02 7.0 14.798 < .001
Group -6.8 2.3 -.206 -2.885 .004
Age -.3 .2 -.105 -1.433 .154
Gender 6.7 2.5 .194 2.653 .009
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Relation between CRVE, CRAE and medications:
Out of the 185 patients, 128 patients were on treatment with antipsychotics. Dose 
of individual antipsychotics were noted and chlorpromazine equivalents for these 
antipsychotics were calculated (Woods SW. Chlorpromazine equivalent doses for the 
newer atypical antipsychotics. J Clin Psychiatry. 2003 Jun;64(6):663-7). There was no 
significant relation between the chlorpromazine equivalents of antipsychotics used 
and average CRVE (r=-0.08; p=0.36) or CRAE (r=0.13; p=0.14).
Relation between CRVE, CRAE, body mass index and blood 
pressure:
For a subgroup of patients height and weight was measured and body mass index 
(BMI) was calculated on the day of retinal examination. BMI details were available for 
48 healthy volunteers, 81 patients with SCZ and 60 patients with BD. Mean BMI for HV 
was 23.8±4.2, for SCZ was 25.2±4.8 and for BD was 25.8±4.4. On analysis of variance, 
there was no significant difference between the groups on BMI (F=2.65, p=0.07). As 
mentioned in the manuscript patients with hypertension were excluded from the 
study. Among those who participated blood pressure was recorded in 28 patients 
with SCZ and 57 patients with BD on the day of retinal examination. On independent t 
test, mean systolic blood pressure between the groups was not significantly different 
[SCZ=115.2±7.5, BD=118.1±12.1; t=1.38, p=0.24]. 
Even after inclusion of the BMI and blood pressure as covariates, the results remained 
significant. There was significant difference between SCZ and BD on average CRVE 
(SCZ=214.1±31.8; BD=230.1±25.1; F=4.68; p=0.03) and average CRAE (SCZ=113.4±15.4; 
BD=94.0±17.5; F=20.23; p<0.001)
Effect of nicotine use on retinal vascular measurements:
While subjects with nicotine dependence were not included in the study, 13 subjects 
with SCZ and 4 subjects with BD had nicotine use. Analysis of variance was conducted 
to examine the differences between groups after exclusion of these subjects to rule 
out the possible confounding effect of nicotine use. There were significant differences 
between groups in average CRVE (SCZ=213.3±28.2; BD=228.0±26.3; HV=196.5±21.7; 
F=33.48; p<0.001) and average CRAE (SCZ=103.1±15.9; BD=95.9±17.2; HV=110.7±21.7; 
F=14.04; p<0.001).
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Abstract
The micro-vasculature of retina and brain share common morphological, physiological, 
and pathological properties. Retina being easily accessible, retinal vascular examination 
provides an indirect assessment of cerebral vasculature. Considering the high 
prevalence of vascular morbidity in SCZ and BD a few studies have examined retinal 
vascular caliber and have reported increased retinal venular caliber in schizophrenia 
(SCZ). Retinal vascular tortuosity could serve as a better structural measure than caliber 
as it is static and less susceptible to pulse period variations. However, to date, no study 
has examined retinal vascular tortuosity in SCZ and bipolar disorder (BD). Hence, we 
examined retinal vascular tortuosity in comparison with healthy volunteers (HV). We 
included 255 subjects (78 HV, 79 SCZ, and 86 BD) in the age range of 18 to 50 years. 
Trained personnel acquired images using a non-mydriatic fundus camera. To measure 
the average retinal arteriolar tortuosity index (RATI) and retinal venular tortuosity index 
(RVTI), we used a previously validated, semi-automatic algorithm. The results showed 
significant differences across the three groups in RATI but not in RVTI; both BD and SCZ 
had significantly increased RATI compared to HV. There was also a significant difference 
between SCZ and BD, with BD having higher RATI. If shown to be of predictive utility in 
future longitudinal studies, it has the potential to identify patients at risk of development 
of adverse vascular events. As retinal vascular imaging is non-invasive and inexpensive, 
it could serve as a proxy marker and window to cerebral vasculature.
Keywords: 
Retinal vascular tortuosity; Fundus; Schizophrenia; Bipolar disorder; Psychoses; 
Cerebrovascular
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3.1. INTRODUCTION
Retinal small vessels share common embryologic origins and have similar anatomical and 
physiological properties with cerebral small vessels, thus providing a unique “window” 
to study cerebrovascular disease1,2. Several studies have demonstrated a link between 
presence of retinal microvascular abnormalities and clinical (e.g., stroke, dementia) 
and subclinical (white matter lesions on magnetic resonance imaging) cerebrovascular 
disease3-7. Considering the increased prevalence of vascular abnormalities and higher 
incidence of adverse cerebro/cardiovascular events in Schizophrenia (SCZ) and Bipolar 
disorder (BD)8-13, retinal microvasculature has been examined in SCZ and BD. Increased 
retinal venular caliber has been found in SCZ14 and twins discordant for psychosis 
symptoms15. A significant association has also been reported between retinal vascular 
caliber, diastolic blood pressure, and endothelial function in adolescents with BD, 
although no differences in vascular caliber were noted between adolescents with BD 
and healthy volunteers (HV)16.  Recently, we examined the retinal vascular caliber in 
SCZ and BD and reported significantly narrower arterioles and wider venules in SCZ 
and BD compared to HV. In addition, there were also significant differences between 
SCZ and BD patients; patients with BD had narrower arterioles and wider venules17. The 
increased prevalence of comorbid metabolic risk factors is possibly the pathophysiology 
underlying retinal vascular abnormality. However, the contribution of shared genetic 
factors cannot be ruled out as wider venules have been observed in discordant twins 
of patients with psychosis symptoms also suggesting that retinal microvasculature may 
reflect a familial vulnerability to psychosis symptoms15.
Another key parameter measured using fundus imaging is retinal vascular tortuosity or 
curvature. Tortuosity describes the geometric pattern of the retinal vasculature layout 
and indicates the adequacy of the state of microcirculation and level of ocular perfusion18. 
A few studies have reported that retinal vascular tortuosity is a more stable marker as it 
is not affected by pulse variations19,20 and has high heritability21,22. Alterations in genetic 
factors, angiogenesis, blood flow, blood pressure and degeneration of vasculature 
are implicated in the formation of vessel tortuosity. With vascular disease and aging 
the internal lamina and tunica media of vessel wall degenerate and gets replaced by 
fibrous tissue. The resulting mechanical instability may give rise to the development of 
blood vessel tortuosity2,23-25. Mutations in genes responsible for formation of basement 
membrane proteins, namely LAMA1 and COL4A1, are reported to cause retinal vascular 
tortuosity26,27. 
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Interestingly, evidence from several lines of research including genetic, neuroimaging 
and neuropathology suggests a significant role of microvascular anomaly and 
angiogenesis in the pathogenesis of schizophrenia28. It is important to note that a 
few congenital syndromes with retinal vascular tortuosity have high comorbidity 
of psychoses, SCZ and BD. Previous studies have reported increased retinal vascular 
tortuosity in 22q11.2 microdeletion syndromes29. Tortuosity of the retinal vessels, 
affecting both arterioles and venules, is a common finding and is present in about 
30% of patients with 22q11.2 microdeletion syndrome30. It is important to note that 
22q11.2 microdeletion syndromes, namely DiGeorge syndrome and Velo-cardio-facial 
syndrome (VCFS), are associated with an increased risk of SCZ31. Similarly, retinal vascular 
tortuosity is reported in Moyamoya disease in which psychoses and mood disorders 
are common neuropsychiatric comorbidities32-34. In addition, significant association has 
been reported between retinal vascular tortuosity and cardiovascular risk factors like 
carotid intima-medial thickness (CMIT)22, metabolic syndrome, and diabetes mellitus35. 
Studies have implicated increased tortuosity of retinal vessels in cerebrovascular 
diseases like ischemic stroke36, cognitive dysfunction, Alzheimer’s dementia37, and 
metabolic disorders like high blood pressure, body mass index, and diabetes35.
Considering the possible shared genetic vulnerability and the high prevalence of 
vascular morbidity in SCZ and BD, we examined retinal vascular tortuosity in SCZ and 
BD in this study. It is important to note that no study has examined retinal vascular 
tortuosity in SCZ and BD. We hypothesized that both SCZ and BD would have increased 
retinal vascular tortuosity compared to healthy volunteers (HV). As SCZ and BD both 
have increased vascular morbidity11,38-40 and shared pathogenic mechanisms41,42 we also 
hypothesized that there would be no difference in retinal vascular tortuosity between 
SCZ and BD.
3.2. METHODOLOGY
3.2.1. Sample
One hundred patients each with SCZ and BD were recruited from the National Institute of 
Mental Health and Neurosciences (NIMHANS), Bengaluru, India, a tertiary care hospital. 
We recruited patients between 2015 and 2018. Both inpatients and out-patients 
59CHAPTER 3
were recruited. One hundred healthy volunteers (HV) were recruited from the same 
geographical location through flyers and by word of mouth. All study participants were 
adults aged between 18 and 50 years. All patients were examined by a board-certified 
psychiatrist; they met criteria for SCZ or BD as per the International Classification of 
Disorders 10 (ICD-10). Those patients with concurrent substance abuse or dependence 
(except nicotine) and comorbid Axis I psychiatric disorders were excluded. All HV were 
clinically evaluated and administered cross cutting symptom measure checklist by a 
certified psychiatrist to rule out Axis I psychiatric diagnoses43,44. HV were also excluded if 
they had history of substance use disorder. Participants with serious medical conditions 
including hypertension, diabetes, stroke, or history of eye trauma and surgery were 
excluded from the study. The study was approved by the institutional ethics committee 
and all participants provided written informed consent.
3.2.2. Assessments
After recruitment, the SCZ patients were assessed for severity of clinical symptoms 
using the Brief Psychiatric Rating Scale (BPRS)45 to measure the severity of positive and 
negative symptoms and general psychopathology. Young’s Mania Rating Scale (YMRS)46, 
and Hamilton Depression Rating Scale (HDRS)47 were used to assess the severity of 
manic and depressive symptoms respectively in BD. Functioning was assessed using 
the Global Assessment of Functioning (GAF)48 and Clinical Global Impression (CGI)49. 
3.2.3. Retinal image acquisition
After the procedure of retinal image acquisition was explained, the participants were 
seated in a dark room for 5 min to facilitate auto dilation of the pupil. Images were 
acquired by a trained individual using a non-mydriatic camera with 40 degrees field of 
view, 3nethra classic manufactured by Forus Health Pvt Ltd, Bengaluru, India. Optic disc 
centred retinal images of both the eyes were acquired using a valid method described 
elsewhere50; the colour fundus image was acquired by illumination of light flashes. A 
representative image of the acquisition of retinal images is given in Supplementary 
Figure S1.
3.2.4. Measurement of retinal vasculature
An initial quality check was conducted to examine the suitability of images for 
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measurement of tortuosity. Forty-five out of 300 images were excluded following 
quality check due to inadequate illumination and the remaining 255 images were 
considered for analysis. These included 78 HV, 79 SCZ, and 86 BD. We calculated a 
measure known as Simple Tortuosity (ST) which is defined as the mean ratio of the arc 
length (actual traced length of the vessel) to the chord length (length of the straight 
line drawn from the starting to ending point of the vessel) of vessels in the radial zone 
between 0.5 to 2disc diameters from the optic disc51,52 (Supplementary Figure S2). 
Arteries and veins were identified and labeled manually. All arteries and veins in the 
above-said zone were considered for calculation of ST. The arc length and chord length 
of these vessels were then determined using customized semi-automated software for 
tortuosity created using MATLAB 2018a (by The MathWorks, Inc., Natick, Massachusetts, 
United States), similar to other proprietary software20. ST was calculated for left and 
right eyes separately. Finally, the average of the left and right eye tortuosity indices was 
calculated. Average retinal venular tortuosity index (RVTI) and average retinal arteriolar 
tortuosity index (RATI) were calculated separately. A sub-sample of 30 participant 
images were analyzed by two raters to check inter-rater reliability. A good inter-rater 
reliability was obtained between the graders (Intra Class Correlation for RVTI-0.81 and 
RATI-0.82).
3.2.5. Statistical Analysis
All statistical analyses were performed using the Statistical Package for Social Sciences 
(SPSS) version 25. The data was initially examined for normative distribution using 
the Shapiro-Wilk test and parametric tests were applied as the data was normatively 
distributed. The sex distribution across the three groups was examined using the chi-
square test and the age difference was analyzed using one-way analysis of variance 
(ANOVA). As there was a significant difference across groups with respect to age and sex, 
these were used as covariates in the further analysis. Differences in RVTI and RATI across 
the three groups were examined using analysis of co-variance (ANCOVA) with age and 
sex as covariates. As there were two primary outcome measures, a Bonferroni correction 
of α=0.05/2=0.025 was considered significant. Post-hoc analysis was conducted to 
examine differences between pairs of groups. To calculate the extent of contribution 
by age and sex on RVTI and RATI, we also conducted linear regression analyses with 
RATI and RVTI as dependent variables and group, age, and sex as predictor variables. To 
examine the relation between ST and clinical variables, Pearson’s correlation analyses 
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were performed with RATI, RVTI and BPRS, YMRS, HDRS, age at onset of illness, duration 
of illness, and chlorpromazine equivalent of antipsychotic dose53. As a subgroup of 
patients had nicotine dependence, a sub-analysis was conducted after excluding 
these patients to avoid the confounding effect of nicotine use on retinal vascular 
tortuosity54-56. In addition, a sub-analysis was conducted for sub-group of patients for 
whom BMI and systolic blood pressure were recorded.
3.3. RESULTS
3.3.1. Comparison of demographic variables
The differences in demographic and clinical variables across the groups are shown in 
Table 1. There was a significant difference across the three groups in age and gender 
distribution. Duration of illness and age at onset of illness were not significantly different 
in patients with SCZ and BD.
Table 1.
Comparison of demographic and clinical details between the groups.
HV
(n = 78)
SCZ
(n = 79)
BD
(n = 86) F/t/χ
2 p
Age 30 ± 7.6 32.7 ± 6 33.2 ± 6.2 5.57 0.004*
Gender ratio (M/F) 35/43 55/24 50/36 9.86 0.007*
Age at onset (years) - 25.1 ± 5.5 23.7 ± 6 1.7 0.19
Duration of illness 
(years) - 7.7 ± 5.1 8.7 ± 5.3 1.16 0.28
BPRS - 28.3 ± 5.1 - - -
HDRS - - 3.5 ± 4.7 - -
YMRS - - 1.7 ± 3.0 - -
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; BPRS-Brief Psychiatric rating scale, HDRS- Hamilton depression rating scale, 
YMRS-Young’s mania rating scale; F- Analysis of Variance; t – Independent t test; χ2 – Chi 
square test; *Significant difference.
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Table 2.
Retinal vascular tortuosity in the three groups.
HV
(n = 78)
SCZ
(n = 79)
BD
(n = 86) F p
RVTI 1.031 ± 0.02 1.027 ± 0.01 1.026 ± 0.01 2.23 0.051
RATI 1.023 ± 0.01 1.0312 ± 0.01 1.038 ± 0.02 18.87 <0.001*
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; F – ANCOVA with age and sex as covariates; RVTI- Average retinal venular 
tortuosity index; RATI- Average retinal arteriolar tortuosity index; *Significant difference.
3.3.2. Differences in RATI and RVTI between groups 
On ANCOVA, there was a significant difference across the three groups only in RATI (p 
< 0.001) but not in RVTI (p = 0.051) (Table 2). On further post-hoc ANOVA both SCZ (p 
= 0.003) and BD (p < 0.001) had significantly higher RATI compared to HV. BD patients 
also had significantly higher RATI compared to SCZ (p = 0.017) (Supplement Table S3). In 
addition, we calculated the effect size to quantify the magnitude of difference between 
the groups in RATI. The effect size calculation showed a large effect size between BD 
and HV (d = 0.91; r = 0.41), a medium effect size between SCZ and HV (d=0.73; r = 0.33); 
and a small effect size between BD and SCZ (d = 0.39; r = 0.19). To calculate the extent of 
the contribution of age and sex and to delineate their possible confounding effects on 
group-wise comparisons, regression analysis was conducted with and without age and 
sex as additional regressors. The group differences were significant in both instances 
and the regression coefficients were comparable (Table 3).
In addition, subgroup analyses were done on age and sex-matched sample to rule out 
confounding effects. 61 HV (M:F = 30:31; age = 30.4 ± 6.0 years), 68 SCZ (M:F = 44:24; 
age = 32.4 ± 5.3 years) and 77 BD (M:F = 46:31; age = 32.53 ± 5.2 years) were selected. 
These three groups were matched on age (F = 2.89; p = 0.06) and sex (χ2 = 3.3; p = 0.19). 
On ANOVA, there was still a significant difference across the three groups on RATI (HV: 
1.0232 ± 0.0099; SCZ: 1.0312 ± 0.0128; BD: 1.0367 ± 0.0194; F = 13.91, p < 0.001). As 
expected, there was no significant difference on RVTI (HV: 1.0302 ± 0.0136; SCZ: 1.0278 
± 0.0136; BD: 1.0260 ± 0.0125; F = 1.68, p = 0.19).
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The results continued to remain significant after excluding the 15 participants who had 
nicotine dependence (11 SCZ and 4 BD); there was a significant difference between 
groups on RATI (HV: 1.023 ± 0.01; SCZ: 1.031 ± 0.013; BD: 1.038 ± 0.019; F = 18.49; p < 
0.001) but no significant difference on RVTI (HV = 1.03 ± 0.15; SCZ = 1.027 ± 0.013; BD = 
1.026 ± 0.12; F = 2.36; p = 0.097) (Details in Supplementary Table S1). In a subgroup of 
patients, BMI [HV (n = 41) - 23.33 ± 3.4; SCZ (n = 66) - 25.14 ± 5.2; BD (n = 52) - 25.93 ± 
4.4]  and systolic blood pressure [HV (n=23) - 115.87 ± 8.0; SCZ (n = 49) - 118.12 ± 11.6; 
BD (n = 72) - 117.4 ± 10.6] were recorded on the day of the retinal vascular examination. 
Even after controlling for these variables in the regression analysis, there was no 
significant difference in the findings and results remained significant for RATI (Table 4). 
On Pearson’s correlation analysis, there was no significant correlation between the RATI 
and clinical variables BPRS, YMRS, HDRS, age at onset of illness and duration of illness 
(p>0.05) (Supplementary Table S2).
Table 3.
Mean difference of retinal tortuosity between groups adjusted for age and sex.
Variable Group
Not adjusted for age and 
sex Adjusted for age and sex
β (95%CI) p β (95%CI) p
RVTI 
HV SCZ -0.003 ( -0.008 to 0.001) 0.124
0.004 
( -0.009 to 0.000) 0.054
HV BD -0.004 ( -0.008 to 0.000) 0.044*
-0.005
(-0.009 to -0.001) 0.021*
SCZ BD -0.001( -0.005 to 0.003) 0.65
-0.001
( -0.005 to 0.003) 0.741
RATI 
HV SCZ 0.008 (0.004 to 0.011) 0.001*
0.007 
(0.002 to 0.012) <0.005*
HV BD 0.014 (0.019 to 0.009) <0.001*
0.014 
(0.009 to 0.018) <0.001*
SCZ BD 0.006 (0.002 to 0.011) 0.006*
0.007 
(0.002 to 0.011) 0.005*
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; β - regression coefficient, 95% CI - 95% confidence interval; *Significant 
difference
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Table 4.
Details of regression coefficient between groups with BMI and Systolic blood pressure 
as covariates.
Retinal arterial 
Tortuosity Index 
(RATI)
Unstandardized 
Coefficients
Standardized 
Coefficients
t Sig.
B Std. Error Beta
(Constant) 0.988 0.029 34.67 < .001*
Group 0.014 0.005 0.304 2.546 0.013*
Body mass index 0.000 0.001 0.042 0.343 0.733
Systolic Blood pressure 0.000 0.000 0.094 0.761 0.450
*Significant difference
3.4. DISCUSSION
To the best of our knowledge, this is the first study to examine retinal vascular tortuosity 
in patients with SCZ and BD in comparison to HV. Results of the study suggest 
significantly increased RATI in both BD and SCZ compared to HV. However, there was no 
significant difference across the groups with respect to RVTI. Studies which examined 
retinal vascular caliber in SCZ and BD have reported abnormalities in the vascular 
caliber14,15,17,57. Our findings of increased retinal arteriolar tortuosity provide added 
evidence for retinal vascular abnormalities in SCZ and BD.
A few studies have reported associations between neuropsychiatric conditions and 
retinal vascular tortuosity; increased RATI has been reported to be associated with 
ischemic stroke36 and Alzheimer’s disease37. Although retinal vascular tortuosity 
has not been examined earlier in SCZ or BD, a previous case report has reported 
increased retinal vascular tortuosity in a patient with SCZ and DiGeorge syndrome29. 
Interestingly, previous studies have also reported increased retinal vascular tortuosity 
in a considerable proportion of individuals with 22q11.2 deletion and duplication 
syndromes58-60. These syndromes have a significantly increased prevalence of SCZ 61. 
Our finding of increased tortuosity in retinal arterioles of BD and SCZ provides further 
support to its association with neuropsychiatric syndromes. 
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Several studies have suggested that retinal vascular measures are reliable surrogate 
markers for increased risk of adverse vascular events20,62. It is important to note 
that patients with SCZ and BD have significantly increased rates of adverse cardio/
cerebrovascular events63-66 and this increased rate exceeds what can be explained 
by traditional cardiovascular risk factors and life style67. Examination of retinal 
microvascular tortuosity could prove to be an easy and affordable method to identify 
these patients. Although our study is cross-sectional in design, it provides a rationale 
for further examination of retinal vascular tortuosity using longitudinal study designs. 
This could examine whether increased retinal arteriolar tortuosity confers greater risk 
of adverse vascular events in SCZ and BD. If predictive utility can be demonstrated, 
retinal examination for arteriolar tortuosity could help in screening individuals with 
SCZ and BD at risk for developing adverse vascular events. 
The pathophysiology behind retinal venular and arteriolar abnormalities is still unclear. 
Several genetic and environmental theories have been proposed. Vascular tortuosity 
has been shown to have a high degree of heritability21,22. While retinal vascular caliber 
has strong associations with cardiovascular biochemical markers and hypertension, 
retinal vascular tortuosity is less influenced by these measures21,22. On the other 
hand, Carotid intima-medial thickness (CMIT) has significant associations with retinal 
vascular tortuosity22. Considering the direct relation of CIMT with stroke and myocardial 
infarction68, the association between retinal vascular tortuosity and CIMT supports the 
use of retinal vascular tortuosity as a non-invasive surrogate marker for stratifying the 
risk of future adverse cardio/cerebrovascular events20. In addition to these genetic 
factors, several inflammatory factors associated with metabolic syndrome and diabetes 
mellitus are also associated with increased retinal vascular tortuosity35. Whether similar 
mechanisms operate in patients with SCZ and BD is yet to be examined. At this stage, 
we are unclear whether increased retinal arteriolar tortuosity seen in our study may 
be reflective of the risk of higher prevalence of metabolic syndrome and cardio/
cerebrovascular adverse events in SCZ and BD65,66. However, other mechanisms also 
need to be considered as studies in children with 22q11.2 deletion syndrome have 
reported increased retinal vascular tortuosity even in the absence of vascular adverse 
events58. Familial retinal arteriolar tortuosity, a disorder with autosomal dominant 
inheritance is caused by mutations in gene COL4A1, which codes for a major basement 
membrane27,69. Interestingly, mutations in COL4A1 gene are also known to cause 
cerebral cortical malformations and neuronal localization defects70. Interestingly, the 
same gene is implicated in altered synaptic elements in superior temporal cortex of 
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schizophrenia patients71. Hence, at this stage it is not possible to confidently infer 
whether the increased retinal arteriolar tortuosity in SCZ and BD is the consequence of 
comorbid cardiovascular risk factors or manifestation of shared genetic vulnerability. 
Future studies need to incorporate genetic testing in addition to examination of retinal 
vascular tortuosity for further clarity.
The significant difference in RATI between SCZ and BD was not expected and did not 
conform to our hypothesis. Considering the shared pathogenic factors41 and increased 
prevalence of vascular adverse events66 in both SCZ and BD, we did not expect any 
difference between SCZ and BD. Only a few studies have reported differences in 
cognitive functions, brain structure/ function, comorbidities between SCZ and BD72-
76; most other studies have reported significant overlap between SCZ and BD in 
genetics, brain structure and function41,77. We do not have a definitive explanation for 
this difference at this stage. At this stage our finding of difference between SCZ and 
BD must be considered preliminary, requiring further examination in future studies. 
Similarly, we do not have definitive explanations for the absence of difference between 
groups in RVTI measurements. A few studies have suggested differential association 
between retinal arteriolar and venular tortuosity and cardiovascular risk factors and 
diabetes78,79. Though tortuosity can be measured in both retinal arteries and veins, but 
arteriolar tortuosity is examined more frequently than venular tortuosity. Arteriolar 
tortuosity changes have been related to arteriosclerosis80 and venular tortuosity have 
been connected to vascular obstruction/occlusion81. Anatomically, presence of tunica 
media makes arteriolar wall thicker and less compliant than venular wall82. Whether 
the difference between arterioles and venules seen in our study is due to mechanical 
reasons only or not need to be examined in the future.
The following limitations need to be considered while interpreting the results of the 
study. All patients were on pharmacological treatment and the effects of medication on 
retinal arteriolar tortuosity are not known. Although there was no correlation between 
the dosage of antipsychotic and retinal arteriolar tortuosity, the confounding effects of 
medications cannot be definitively ruled out with the current study design. Examining 
drug-naïve patients needs to be considered in future studies. We did not record blood 
pressure and glucose levels on the day of the assessment. As the participants were 
young, those with hypertension or diabetes were excluded based on history; one 
cannot rule out the confounding effect of Pre-diabetic or pre-hypertensive status 
which may be missed in history51,83. The relation between retinal vascular tortuosity 
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and hypertension is still debated; while no association was reported between blood 
pressure and retinal vascular tortuosity in one study22, significant association has been 
reported in other studies78,84. Future studies need to consider recording blood pressure, 
fasting blood glucose, renal functions, and life style factors like diet and exercise at 
the time of retinal vascular assessment. We did not collect the information of family 
history of cardio/cerebrovascular disorders in study participants which could affect the 
findings. Future studies need to consider collecting the family history of cardiovascular 
disorders.  Although individual group differences could be detected using the current 
sample size, larger studies are required for sub-group analysis (ex: BD-I vs BD-II vs SCZ; 
BD with psychotic symptoms vs BD without psychotic symptoms VS SCZ etc.). Finally, 
we used the Fagerstrom test for nicotine dependence (FTND) scores as covariate in 
the analysis. While this could control for the nicotine dependence, this will not control 
for the confounding effect of the non-dependence pattern of nicotine use which may 
influence retinal vessel tortuosity as it is shown to be related to venular diameter85. 
Future studies could use smoking status as a covariate instead of or in addition to FTND.
We recruited participants with no current comorbid psychiatric conditions as the effect 
of comorbid conditions on retinal vascular tortuosity is not known. While this resulted in 
a homogeneous sample with SCZ and BD, this could affect generalizability of findings. 
Similarly, as the retinal image acquisition required participant to sit still in a dark room 
for 5 min, a major portion of the participants were in euthymic phase. This could 
have resulted the absence of relation between retinal vascular tortuosity and clinical 
symptoms. Future studies need to consider inclusion of participants in different stages 
of illness and comorbidities so that the relation between retinal vascular parameters 
and acute symptoms, course of the illness in preceding years and sleep disturbances 
could be examined. Such analyses could potentially reveal the factors underlying the 
difference between BD and SCZ seen in the current study. Considering that the retinal 
vascular caliber and tortuosity measure different aspects of vascular abnormality and 
provide complementary information, future studies could consider simultaneous 
measurement of different retinal vascular parameters to arrive at a composite index in 
SCZ and BD. 
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3.5. Conclusion
Our study indicates significantly increased retinal arteriolar tortuosity in patients with 
BD and SCZ when compared to HV, and possible differences between SCZ and BD. These 
preliminary findings provide a strong rationale for further systematic examination 
of retinal arteriolar tortuosity in patients with SCZ and BD. Considering the easy 
accessibility, non-invasive nature of the examination, and affordability, retinal arteriolar 
tortuosity examination can be conducted even in outpatient psychiatry settings and 
could serve as a surrogate marker for abnormalities in the cerebral vasculature. If shown 
to be of predictive utility in future longitudinal studies, examination of retinal arteriolar 
tortuosity has the potential to identify BD and SCZ patients at risk of developing adverse 
vascular events.
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Supplementary Materials
Supplementary Figure S1: 
Representative image of retinal image acquisition
Supplementary Figure S2: 
0.5 to 2-disc diameter radius zone for calculation of Tortuosity
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Table S1.
Retinal vascular tortuosity in the three groups after excluding participants who had 
nicotine dependence
Retinal 
Tortuosity
HV
(n=78)
SCZ
(n=68)
SCZ
(n=68)
BD
(n=82) P
RVTI 1.0307±0.015 1.0271±0.013 1.0264±0.012 2.36 0.097
RATI 1.0234±0.01 1.0312±0.013 1.0375±0.019 18.49 <0.001*
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; F-ANOVA ; p- Bonferroni post-hoc analysis; RVTI- Average retinal venular 
tortuosity index; RATI- Average retinal arteriolar tortuosity index; *significant difference
Post Hoc Analysis
Retinal 
Tortuosity Group
Mean 
Difference Std. Error p
RVTI
HV SCZ 0.0037 0.0022 0.298
SCZ BD 0.0043 0.0021 0.129
BPAD BD 0.0006 0.0021 1.000
RATI
HV SCZ -0.0078 0.0024 0.005*
SCZ BD -0.0141 0.0023 <0.001*
BPAD BD -0.0063 0.0024 0.027*
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; p- Bonferroni post-hoc analysis; RVTI- Average retinal venular tortuosity 
index; RATI- Average retinal arteriolar tortuosity index; *Significant difference
Table S2: 
Correlation between RATI, RVTI and clinical variables
Clinical variable N RVTI RATI
r p r p
BPRS 154 0.02 0.86 -0.14 0.08
YMRS 152 0.15 0.07 0.01 0.94
HDRS 154 0.14 0.09 -0.02 0.82
CPZ Equivalent 107 0.11 0.26 -0.17 0.86
Age at onset 127 0.06 0.50 0.03 0.71
Duration of illness 125 -0.15 0.01 -0.08 0.39
RATI- Average retinal arteriolar tortuosity index; RVTI- Average retinal venular tortuosity 
Index; BPRS- The Brief Psychiatric Rating Scale (BPRS); YMRS- Young Mania Rating Scale 
(YMRS); HDRS - Hamilton Depression Rating Scale (HDRS); CPZ – Chlorpromazine; r- 
correlation coefficient
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Table S3: 
Mean difference between groups and retinal vascular tortuosity on analysis of variance
Retinal 
Tortuosity Group
Mean 
Difference Std. Error p
RVTI
HV SCZ 0.0033 0.0022 0.372
SCZ BD 0.0043 0.0021 0.131
BPAD BD 0.0001 0.0021 1.000
RATI
HV SCZ -0.0078 0.0024 0.003*
SCZ BD -0.0142 0.0023 <0.001*
BPAD BD -0.0064 0.0023 0.017*
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; p- Bonferroni post-hoc analysis; RVTI- Average retinal venular tortuosity 
index; RATI- Average retinal arteriolar tortuosity index; p – not controlled for age and 
sex; *Significant difference
79CHAPTER 3

CHAPTER 4
RETINAL VASCULAR FRACTAL  
DIMENSION IN BIPOLAR DISORDER 
AND SCHIZOPHRENIA 
Abhishek Appaji, Bhargavi Nagendra, Dona Maria Chako, 
Ananth Padmanabha, Chaitra V Hiremath, Arpitha Jacob,  
Shivarama Varambally, Muralidharan Kesavan,  
Ganesan Venkatasubramanian, Shyam Vasudeva Rao,  
Carroll A.B. Webers, Tos T.J.M. Berendschot, Naren P. Rao
JOURNAL OF AFFECTIVE DISORDERS 2019; 259: 98 - 103

Abstract
Background:
Bipolar disorder (BD) and schizophrenia (SCZ), are associated with greater vascular 
co-morbidities and adverse vascular events. Owing to shared developmental origins 
and morphology, retinal vasculature is a proxy assessment measure of the cerebral 
vasculature. Although retinal vascular fractal dimension (Df), a measure of vascular 
geometry and complexity of branching, has been shown to be directly associated with 
cerebrovascular pathology, it has not been examined in SCZ and BD. 
Methods:
We studied 277 participants (92 healthy volunteers, 98 SCZ, and 87 BD) from 18 to 50 
years of age. Images were acquired by trained personnel using a non-mydriatic fundus 
camera and the retinal vascular Df was calculated by the box-counting method using 
an automated algorithm. The average Df across the left and right eyes were calculated. 
Results:
Both SCZ and BD had significantly increased Df compared to HV despite controlling for 
possible confounding factors. However, there was no significant difference between 
SCZ and BD. These findings suggest abnormal retinal vascular Df in psychoses. 
Limitations:
The study design was cross sectional, and patients are on medications. Confound of 
lifestyle factors such as diet and exercise, if any was not controlled. Sub-group analysis 
between BD-I and BD-II was not performed in view of the small sample.
Conclusions:
Considering the easy accessibility, affordability, and non-invasive nature of the 
examination, retinal vascular Df could serve as a surrogate marker for cerebral vascular 
abnormality and could potentially identify BD and SCZ patients at risk of developing 
adverse vascular events.
Keywords: Retinal vasculature; Fractal dimension; Fundus; Schizophrenia; Bipolar 
disorder; Psychoses; Neurodevelopment
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4.1. INTRODUCTION
The major psychoses, schizophrenia (SCZ) and bipolar disorder (BD), are associated with 
increased prevalence of vascular co-morbidities and increased incidence of adverse 
cerebrovascular events1,2. Understandably, examination of cerebral microvascular 
abnormalities in these disorders has gained considerable interest in the recent past. 
However, the need for specialized and expensive techniques, and the invasive nature 
of some of these techniques have posed challenges for the same3. 
As retinal and cerebral vasculatures share common embryology and have comparable 
anatomical, physiological, and pathological properties, retinal vasculature is 
considered an indirect marker of abnormalities in cerebral vasculature4,5. Several 
studies have reported relations of retinal vascular abnormalities with cerebrovascular 
disorders and neurodegenerative disorders6,7. A few studies have examined retinal 
vascular abnormalities in psychoses. In one of these, authors examined retinal vascular 
images from participants of the Dunedin birth cohort and reported wider venules in 
individuals who developed schizophrenia8. In another study, those with symptoms of 
psychosis and their unaffected co-twins had wider venular diameters compared to the 
healthy, suggesting association of retinal venular diameter with familial vulnerability to 
psychosis9. Compared to SCZ, retinal vascular abnormalities are underexamined in BD; 
one study reported absence of difference between BD and healthy volunteers (HV) but 
reported a significant association of the arterio-venular ratio (AVR) with blood pressure 
and vascular endothelial function in adolescent BD10. Recently, we reported both SCZ 
and BD patients to have significantly narrower arterioles and wider venules compared 
to HV11. 
All these studies examined retinal vascular calibre. Yet another important structural 
marker, fractal dimension (Df), has not been examined in SCZ or BD. Larger blood 
vessels, including retinal blood vessels, subdivide into smaller branches which in 
turn also subdivide and so on. This self-similar branching pattern is quantified by a 
mathematical concept called fractals. Fractals were introduced to ophthalmology12 
as retinal vasculature is similar on all kinds of scales from the larger vessels coming 
from the optic disc till the microvasculature near fovea. Hence, this complex branching 
pattern of retinal vasculature is better quantified by Df than conventional geometrical 
measures13.  Df is a single value that indicates the degree of branching complexity of 
blood vessels14,15. Df depends on the number of bifurcations, angles of bifurcations, and 
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the length of vessels between two successive bifurcations16.  A higher Df indicates a 
greater level of complexity in retinal branching pattern and lower Df indicates absence 
or decrease in number of branches. Importantly, retinal vascular Df measure is not 
affected by pulse cycle which may confound the measurement of vascular calibre3. 
Moreover, variations in the ocular and camera magnifications could influence the 
retinal vessel calibre values but not Df
17. It is important to note that several studies 
have reported association of retinal vascular Df with diabetes and diabetic retinopathy, 
hypertension, cardiovascular disorder, stroke, and dementia18-25. 
However, despite its significance, retinal vascular Df in SCZ and BD is yet to be examined. 
Hence, we aimed to investigate retinal vascular Df in SCZ and BD. Based on the existing 
literature, we hypothesized that patients with SCZ and BD would have increased retinal 
vascular Df when compared to HV. As both SCZ and BD are associated with increased 
vascular morbidity and have shared pathogenic mechanisms, we also hypothesized 
that there would be no difference in Df between SCZ and BD.
4.2. METHODOLOGY
4.2.1. Study participants 
One hundred patients each with SCZ and BD were recruited from the clinical services 
of the National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, 
India. One hundred matched healthy volunteers (HV) were also recruited from the 
same geographical location through flyers and word of mouth. All participants were 
aged between 18 and 50 years. The patients were examined by a board-certified 
psychiatrist (BN); and those who met the criteria for SCZ or BD as per the International 
Classification of disorders 10 (ICD-10)26 were recruited. Patients with substance abuse 
or dependence other than nicotine were excluded. Those with concurrent comorbid 
psychiatric disorders were also excluded. All HV completed self-reported cross cutting 
symptom measure27 and were interviewed by a certified psychiatrist (BN) to rule out 
Axis I psychiatric diagnoses. Participants with history of hypertension, diabetes, stroke, 
and trauma or surgery to the eye were excluded from the study. The study was carried 
out in accordance with the latest version of the Declaration of Helsinki. Written informed 
consent was obtained from all participants and the study was approved by the institute 
ethics committee. 
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4.2.2. Clinical assessments
The severity of clinical symptoms was assessed by a board certified psychiatrist using 
the Brief Psychiatric Rating Scale (BPRS) in patients with SCZ28, and Young Mania Rating 
Scale(YMRS)29 and Hamilton Depression Rating Scale (HDRS)30 in patients with BD. The 
global severity and functioning was assessed using the Clinical Global Impression (CGI)31 
and Global Assessment of Functioning (GAF)32. To control for the potential confounding 
effect of systolic blood pressure and body mass index (BMI) on retinal vascular Df, we 
measured the same in a subgroup of individuals; systolic blood pressure was measured 
in 28 SCZ and 57 BD and BMI was measured in 48 HV, 81 SCZ and 60 BD on the day of 
acquisition of retinal images.
4.2.3. Retinal image acquisition
The procedure of retinal image acquisition was explained to all participants. They 
were seated in a dark room for approximately 5 min to enable auto-dilation of the 
pupil through accommodation. The images were acquired using a non-mydriatic 
fundus camera, the 3nethra classic by a trained individual. The 3nethra fundus camera 
illuminates the eye using light flashes to obtain colour images of the fundus. Optic disc 
centred retinal images of both the eyes were acquired using a valid method described 
elsewhere33.
4.2.4. Measurement of retinal vascular fractal dimension
An initial quality check was performed to examine the suitability of images for 
calculation of the fractal dimension. Twenty-three out of 300 image pairs (left and 
right eye) were excluded following quality check due to inadequate illumination; the 
remaining 277 image pairs were considered for analysis. These included 98 SCZ, 87 
BD, and 92 HV. A fully automated software was designed to calculate Df using MATLAB 
2018a (The MathWorks Inc, Natick, Massachusetts, USA). The algorithm used to design 
this customized software was adopted from previous studies and employed the box-
counting method described elsewhere34,35. Examination of retinal vascular Df is an 
advancing field and novel analyses techniques are rapidly emerging36-38. We opted for 
the box-counting method as it is one of the commonly employed methods. 
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The following is a brief overview. The image was first enhanced in terms of intensity 
to aid extraction of the vessels. The acquired retinal images had a spatial resolution 
of 2048 ×  1536 pixels and they were suitably scaled for easy calculation of fractal 
dimension. The measured area was standardized within the region between 0.5 and 
2.0-disc diameters from the optic disc. The retinal vessels (both arteries and veins) were 
automatically traced and segmented to generate a skeletonized image. We calculated 
the fractal dimension using the box-counting dimension method. In the box counting 
method, the retinal image was divided into multiple equally sized square boxes. The 
number of boxes containing the skeletonized line tracing was counted and the process 
was repeated for different sized squares. The fractal dimension (Df) was calculated as 
the gradient of logarithms of the number of boxes and the size of the boxes. Larger 
values of Df indicate more complex branching patterns. Df was calculated for left and 
right eyes separately; the average of left and right eye Df was used as the primary 
outcome measure in the study. The calculation of Df was completely automated; hence, 
group bias did not confound the analysis (HV or SCZ or BD).
4.2.5. Statistical analysis
The statistical analyses were performed using the Statistical Package for Social Sciences 
(SPSS) version 25 (SPSS Inc., Chicago, Illinois, USA). The data was found to be normatively 
distributed on applying the Shapiro Wilk test and hence, parametric tests were applied. 
The age difference across the three groups was examined using one-way analysis of 
variance (ANOVA) and the sex distribution using chi-square test. As the age and sex 
distribution were not similar across the three groups and these were used as covariates 
for further analyses. Differences in Df across the three groups were examined using 
analysis of co-variance (ANCOVA) with age and sex as covariates. Bonferroni post-hoc 
analysis was conducted to examine differences between pairs of groups. To examine 
the relation between Df and clinical variables, Pearson’s correlational analyses were 
performed for Df with scores on BPRS, YMRS, and HDRS, age at onset of illness, duration 
of illness, and chlorpromazine equivalent of antipsychotic dose39. 
To calculate the extent of contribution of age and sex on Df, we also conducted linear 
regression analysis with Df as dependent variable and group, age, and sex as predictor 
variables. As a subgroup of patients had nicotine dependence, analysis was repeated 
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after excluding these patients to avoid the possible confounding effect of nicotine 
use on retinal vascular Df
40. In addition, to rule out the confounding effects of BMI and 
systolic blood pressure, analysis was also conducted in another sub-group of patients 
in whom these had been recorded.
4.3. RESULTS
4.3.1. Comparison of demographic variables
Demographic and clinical variables from the three groups are shown in Table 1. There 
was a significant difference across the three groups in age and sex distribution. Duration 
of illness and age at onset of illness were not significantly different in patients with SCZ 
and BD.
Table 1.
Comparison of demographic and clinical details between the groups.
HV
(n = 92)
SCZ
(n = 98)
BD
(n = 87) F/t/χ
2 p
Age 30.2 ± 7.8 32.7 ± 6 32.9 ± 6 4.54 0.012
Gender ratio (M/F) 41/51 64/34 54/33 9.48 0.009
Age at onset (years) - 25.1 ± 5.3 23.7 ± 5.9 2.58 0.11
Duration of illness 
(in years) - 7.6 ± 5.1 9.0 ± 5.6 2.3 0.13
BPRS - 28.7 ± 6.9 - - -
HDRS - - 3.9 ± 5.3 - -
YMRS - - 1.9 ± 3.1 - -
SCZ, patients with schizophrenia; BD, patients with bipolar disorder; HV, healthy 
volunteer; BPRS, Brief Psychiatric rating scale; HDRS, Hamilton depression rating scale; 
YMRS-Young’s mania rating scale; F, analysis of variance; t, Independent t test; χ2, Chi 
square test.
4.3.2. Differences in Df between groups 
On ANCOVA, there was a significant difference across the three groups in left eye Df 
(p< 0.001), right eye Df (p = 0.003), and average Df (p < 0.001) (Table 2). Further post-
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hoc analysis showed that both SCZ (left eye Df = 0.015; right eye; Df = 0.006; average 
Df = 0.001) and BD (left eye Df < 0.001; right eye Df = 0.003; average Df p < 0.001) had 
significantly higher Df compared to HV; however, there was no significant difference 
between SCZ and BD (p>0.05) (Table 3 and Figure S1). 
To calculate the extent of contribution of age and sex and to delineate their possible 
confounding effects on group wise comparisons, regression analyses were conducted 
with and without age and sex as additional regressors. The group differences were 
significant in both instances and the regression coefficients were comparable, 
suggesting that age and sex did not have any significant effects (Table 4). We also 
conducted a subgroup analysis with a sample of 66 HV (M:F = 32:34; age = 30.4 ± 
6.0 years), 92 SCZ (M:F = 60:32; age = 32.4 ± 5.3 years) and 78 BD (M:F = 50:28; age = 
32.53 ± 5.2 years) matched on age (F = 2.33; p = 0.10) and sex (χ2 = 5.3; p = 0.073). On 
ANOVA, there was still a significant difference across the three groups on Df (F = 7.88, 
p < 0.001) (details in Supplementary Table S1). As 17 patients (13 SCZ and 4 BD) had 
nicotine dependence, we compared the groups after excluding these patients to rule 
out possible confounding effects of nicotine use. There was still a significant difference 
between groups on left eye Df, right eye Df, and average Df (details in Supplementary 
Tables S2A and S2B). In a sub-group of participants, we had measured BMI and recorded 
blood pressure on the day of retinal image acquisition. ANCOVA and regression analysis 
with BMI and blood pressure as a covariate demonstrated that the results were still 
significant (details in Supplement S3 and Supplementary Tables S4 and S5).
Table 2.
Retinal vascular fractal dimension across the three groups.
Fractal 
dimension
HV
(n = 92)
SCZ
(n = 98)
BD
(n = 87) F p
Left Df 1.281 ± 0.096 1.321 ± 0.093 1.339 ± 0.01 6.08 <0.001
Right Df 1.266 ± 0.082 1.31 ± 0.089 1.316 ± 0.123 4.05 0.003
Average Df 1.273 ± 0.081 1.316 ± 0.069 1.327 ± 0.087 7.52 <0.001
SCZ, patients with schizophrenia; BD, patients with bipolar disorder; HV, healthy 
volunteer; F, ANCOVA with age and sex as covariates; Left Df, left eye fractal dimension; 
Right Df, right eye fractal dimension; Df, average fractal dimension.
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Table 3.  
Post-hoc analysis showing group differences in retinal vascular fractal dimension.
Fractal 
dimension Group
Mean 
Difference Std. Error p
Left Df
HV SCZ -0.039 0.014 0.015
HV BD -0.058 0.014 <0.001
SCZ BD -0.019 0.014 0.568
Right Df
HV SCZ -0.045 0.014 0.006
HV BD -0.05 0.015 0.003
SCZ BD -0.01 0.015 1.000
Average Df
HV SCZ -0.042 0.011 0.001
HV BD -0.054 0.012 <0.001
SCZ BD -0.012 0.012 0.917
SCZ, patients with schizophrenia; BD, patients with bipolar disorder; HV, healthy 
volunteer; p, Bonferroni post-hoc analysis; Left Df left eye fractal dimension; Right Df, 
right eye fractal dimension; Df, average fractal dimension.
4.3.3. Relation between clinical variables and retinal  
vascular Df
Pearson’s correlational analysis showed no significant correlation between the Df and 
clinical variables (BPRS score, YMRS score, HDRS score, age at onset of illness, duration 
of illness, and CPZ equivalent of antipsychotic dose) (p > 0.05) (Supplementary Table 
S6).
4.4. DISCUSSION
Ours is the first study to examine retinal vascular Df in SCZ and BD in comparison with 
HV. Results of our study shows increased Df in both BD and SCZ when compared to 
HV. As hypothesized, there was no significant difference between SCZ and BD in the 
same. Importantly, the findings remained significant even after controlling for potential 
confounding factors. There was no significant relation with clinical severity suggesting 
the possibility that Df may be independent of ongoing psychopathology.
Our findings further add to the existing research demonstrating abnormal retinal 
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vascular calibre in SCZ and BD9,11,41. We sought to examine retinal vascular Df as several 
previous studies have reported that the geometric parameters of retinal vasculature, 
such as the bifurcation angle, number of bifurcations, and length to diameter ratio, are 
also related to vascular disease processes and could prove to be potential markers of 
microvascular pathology42,43. Although the measurement of retinal vascular Df is more 
complicated and challenging, it offers several advantages24; (a) It is not influenced by the 
phase of the pulse cycle; pulse to pulse variations may pose problems during vascular 
calibre measurement (b) It is also independent of other confounding factors like axial 
length and camera magnification that could influence retinal vessel calibre values (c) 
Df measurement does not involve assessing individual vessels unlike vessel calibre
3,17,44. 
Hence, Df is considered a suitable measure to study individuals longitudinally and 
across centres in multicentric studies. 
Table 4.
Mean difference of retinal fractal dimension between groups adjusted for age and sex
Variable Group
Not adjusted for age and sex Adjusted for age and sex
β (95% CI) p β (95% CI) p
Left Df
HV SCZ 0.192 (0.012 to 0.067) 0.005
0.234 
(0.02 to 0.076) 0.001
HV BD 0.274 (0.03 to 0.086) <0.001
0.312 
(0.037 to 0.095) <0.001
SCZ BD 0.088 ( -0.009 to 0.046) 0.189
0.085 
( -0.01 to 0.046) 0.199
Right Df
HV SCZ 0.212 (0.017 to 0.073) 0.002
0.234
 (0.02 to 0.079) 0.001
HV BD 0.230 (0.021 to 0.079) 0.001
0.249
 (0.024 to 0.084) <0.001
SCZ BD 0.024( -0.024 to 0.034) 0.719
0.022 
( -0.024 to 0.034) 0.774
Average 
Df
HV SCZ 0.247 (0.02 to 0.065) <0.001
0.285 
(0.026 to 0.072) <0.001
HV BD 0.307 (0.031 to 0.077) <0.001
0.342 
(0.037 to 0.084) <0.001
SCZ BD 0.068 ( -0.011 to 0.035) 0.306
0.065 
( -0.011 to 0.034) 0.323
SCZ, patients with schizophrenia; BD, patients with bipolar disorder; HV, healthy 
volunteer; β, regression coefficient, 95% CI, 95% confidence interval; Left Df, left eye 
fractal dimension; Right Df, right eye fractal dimension; Df, average fractal dimension.
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Several studies have reported association of increased Df with systemic and 
cerebrovascular pathologies; increased Df is independently associated with lacunar 
stroke after adjusting for age, sex, other vascular risk factors18, diabetes45, and early 
diabetic retinopathy36. However, few studies have reported discrepant findings46,47. As 
Df varies significantly based on the method used for analysis, differences in technique 
could account for these discrepancies24. The finding of a positive association between 
retinal vascular Df and white matter hyperintensities provides direct evidence that 
retinal vascular Df could be a proxy measure of cerebral vasculature abnormalities
48.  In 
the background of these studies, our findings could have important implications in SCZ 
and BD. In conjunction with several other studies along similar lines of research1,2,11,41,49-52, 
our findings of altered Df suggest increased risk of adverse vascular events in SCZ and BD. 
While all patients with BD and SCZ are at risk of developing an adverse vascular event, 
a few may be at greater risk and it is important to identify these individuals to initiate 
preventive interventions. Interestingly, retinal vascular Df is shown to be associated 
with increased risk of adverse vascular events in previous studies18,36,45. Considering 
the affordability and easy accessibility of retinal imaging, retinal microvascular Df 
examination could serve as a potential screening tool to identify individuals at risk for 
adverse vascular events. Future studies need to prospectively examine whether retinal 
vascular Df has the potential to identify individuals with SCZ and BD at greater risk of 
development of adverse vascular events.
The reason for increased retinal vascular Df in BD and SCZ is not completely known 
at this stage. An important factor influencing the retinal vascular branching pattern is 
tissue hypoxia. Optimally timed hypoxia is critical during normal development of retinal 
vasculature and tissue architecture, but ill-timed hypoxia can result in the pathological 
changes seen in proliferative diabetic retinopathy, retinopathy of prematurity, and 
wet form of age-related macular degeneration53. Thus, an increased Df could result 
from either early developmental or late life causes. The underlying mechanisms for 
increased Df in SCZ and BD are not completely known. Considering the increased 
prevalence of metabolic syndrome and adverse vascular events in SCZ and BD1,2, it is 
possible that these adverse metabolic risk factors remodel the retinal vascular pattern. 
However, perinatal hypoxia which has been implicated in psychoses54,55 could also have 
influenced the retinal vascular branching pattern. Our study being cross-sectional, it 
is not possible to rule out either of these reasons. A longitudinal study using a birth 
cohort could provide further insights. 
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Several studies in the recent past have suggested shared risk factors and considerable 
overlap between pathophysiological processes in SCZ and BD56. Considering the 
common developmental origin of these disorders and the significant vascular 
comorbidity in both, we expected similarities in retinal vascular Df also. Previous 
studies have reported considerable overlap between BD-I and SCZ in neuroimaging, 
electrophysiological measures, and susceptibility genes56,57. Hence, our finding of 
no significant difference between SCZ and BD in Df is in accordance with the recent 
literature suggesting overlap between the two disorders. However, future studies are 
required as our recent study suggested significant difference between SCZ and BD 
in retinal vascular calibre11. We did not find any relation between retinal vascular Df 
and severity of clinical variables. However, as all patients were on medications and the 
study design was cross sectional, our findings need to be considered preliminary and 
longitudinal studies are required to understand whether the abnormalities in retinal 
vascular Df are progressive or not.
4.4.1. Limitations
Our findings need to be interpreted in the background of a few limitations. All patients 
were on pharmacological treatment and the effects of medications on Df is not known. 
80 (82%) out of 98 SCZ patients and 48 (55%) out of 87 BD patients were taking atypical 
antipsychotic medications. As atypical antipsychotics are associated with increased 
metabolic risk in BD and SCZ58,59 one cannot rule out the confounding effect of these 
medications on retinal vascular Df. To examine the potential confounding effect of these 
medications, we examined the relation between retinal vascular Df and CPZ equivalents 
of antipsychotic medications using Pearson’s correlation. Similarly, we examined the 
correlation between retinal vascular Df and duration of antipsychotic therapy. There 
was neither a significant correlation with antipsychotic dose (left Df: r = 0.02, p = 
0.85; right Df: r = -0.14, p = 0.12; Average Df: r = -0.08, p = 0.36) nor with duration of 
treatment (left Df: r = 0.02, p = 0.82; right Df: r = -0.05, p = 0.53; Average Df: r = -0.02, p 
= 0.78) suggesting absence of significant confounding effect. Examining drug-naive 
patients could overcome this limitation and needs to be considered in future studies. 
As the participants were young, we excluded participants with hypertension, diabetes, 
and chronic renal disease based solely on history. Hence, sub clinical (pre-diabetic or 
pre-hypertensive) or undiagnosed hypertension/diabetes may have been missed60,61. 
However, we had measured BMI and blood pressure on the day of acquisition of 
images in a sub-sample and the results remained significant on analysing this sub-
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sample alone. Future studies need to consider recording blood pressure, fasting blood 
glucose, renal functions, and life style factors such as diet and exercise to complement 
image acquisition. Future studies also need to consider larger samples as the current 
sample was inadequate to perform sub-group analyses (e.g., BD-I vs BD-II vs SCZ; BD 
with psychotic symptoms vs BD without psychotic symptoms vs SCZ etc.). As branching 
patterns of retinal arteries and veins are similar, and to avoid possible human error, we 
summarized the entire complexity of the retinal vascular structure into a single value of 
retinal vascular Df. Future studies may consider examining the Df of arteries and veins 
separately. 
4.5. Conclusion
This germinal study of retinal vascular Df in SCZ and BD suggests increased complexity 
of the retinal microvasculature branching pattern in SCZ and BD when compared to 
HV. There was no significant difference between SCZ and BD further supporting the 
shared pathophysiology and comorbidity in these disorders. Further prospective 
studies are needed to confirm these findings. However, these preliminary findings 
provide strong rationale to further examine retinal vascular fractal dimension in SCZ 
and BD. Considering the easy accessibility, non-invasive nature of examination, and 
affordability, the examination of retinal vascular Df could serve as a surrogate marker for 
abnormalities in cerebral vasculature. The findings of this preliminary study examining 
the retinal vascular Df in SCZ and BD need to be replicated in an independent sample for 
definitive scientific validation. If shown to be of predictive utility in future longitudinal 
studies, the examination of Df has the potential to identify BD and SCZ patients at risk 
of developing adverse vascular events.
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Supplementary Materials
Figure S1. 
Box plot of three groups depicting average fractal dimensions
Supplementary Table S1.
Retinal vascular fractal dimension across the three groups in a sub-sample matched 
for age and sex 
Retinal 
fractal 
dimension
HV
(n = 66)
SCZ
(n = 92)
BD
(n = 78) F p
Left Df 1.288 ± 0.090 1.320 ± 0.088 1.341 ± 0.103 5.66 0.004
Right Df 1.268 ± 0.081 1.312 ± 0.089 1.316 ± 0.128 4.80 0.009
Average Df 1.278 ± 0.077 1.316 ± 0.067 1.328 ± 0.09 7.88 <0.001
SCZ, patients with schizophrenia; BD, patients with bipolar disorder; HV, healthy 
volunteer; F, ANOVA; p, Bonferroni post-hoc analysis; Left Dv, left eye fractal dimension; 
Right Df, right eye fractal dimension; Df – average fractal dimension.
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Supplementary Table S2A.
Retinal vascular fractal dimension in the three groups after excluding participants who 
had nicotine dependence
Retinal 
fractal 
dimension
HV
(n = 92)
SCZ
(n = 85)
BD
(n = 83) F p
Left Df 1.281 ± 0.096 1.324 ± 0.093 1.0339 ± 0.01 8.74 <0.001
Right Df 1.266 ± 0.082 1.309 ± 0.086 1.319 ± 0.13 7.34 0.001
Average Df 1.273 ± 0.081 1.317 ± 0.067 1.329 ± 0.087 12.24 <0.001
SCZ, patients with schizophrenia; BD, patients with bipolar disorder; HV, healthy 
volunteer; F, ANOVA; p, Bonferroni post-hoc analysis; Left Df, left eye fractal dimension; 
Right Df, right eye fractal dimension; Dv – average fractal dimension.
Table S2B: 
Post Hoc Analysis of fractal dimension in the three groups after excluding participants 
who had nicotine dependence
Retinal 
fractal 
dimension
Group Mean Difference Std. Error p
Left Df
HV SCZ -0.04 0.014 0.01
HV BD -0.058 0.015 <0.001
SCZ BD -0.015 0.015 0.893
Right Df
HV SCZ -0.044 0.014 0.011
HV BD -0.054 0.015 0.001
SCZ BD -0.001 0.015 1.000
Average Df
HV SCZ -0.043 0.012 0.001
HV BD -0.056 0.012 <0.001
SCZ BD -0.013 0.012 0.914
SCZ, patients with schizophrenia; BD, patients with bipolar disorder; HV, healthy 
volunteer; F, ANOVA; p, Bonferroni post-hoc analysis; Left Df, left eye fractal dimension; 
Right Df, right eye fractal dimension; Df – average fractal dimension.
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Supplement S3: 
Analysis between groups with BMI as covariate
ANCOVA was performed on a subgroup HV and patients of which BMI was measured 
(48 HV, 81 SCZ and 60 BD). The results were still significant after adding BMI as covariate 
for right eye Df (HV: 1.263 ± 0.088; SCZ: 1.306 ± 0.080; BD: 1.326 ± 0.134; F = 4.11; p = 
0.007) and average eye Df (HV: 1.275 ± 0.087; SCZ: 1.310 ± 0.066; BD: 1.33 ± 0.093; F = 
3.87, p = 0.01) but it was not significant for left eye Df among the three groups (HV: 
1.287 ± 0.104; SCZ: 1.314 ± 0.093; BD: 1.329 ± 0.104, F = 1.72, p = 0.165).
Supplementary Table S4. 
Details of regression coefficient between groups with BMI as additional regresso
Average Df Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 1.293 0.033 39.714 < .001
Group 0.026 0.008 0.240 3.322 0.001
BMI -0.001 0.001 -0.031 -0.433 0.665
Supplementary Table S5. 
Details of regression coefficient between groups with systolic blood pressure as 
covariates (SCZ = 28; BD = 57)
Average Df Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) 1.428 0.101 14.138 < .001
Group (SCZ 
vs BD) 0.015 0.019 0.087 0.794 0.429
Systolic BP -0.001 0.001 -0.144 -1.311 0.193
103CHAPTER 4
Supplementary Table S6.
Correlation between Df and clinical variables
Clinical 
variable
Left Df Right Df Average Df
r p r p r p
BPRS 0.04 0.6 0.11 0.13 0.1 0.17
YMRS 0.04 0.62 -0.02 0.81 0.11 0.88
HDRS 0.15 0.04 0.04 0.61 0.12 0.1
CPZ 
Equivalent 0.017 0.85 -0.14 0.12 -0.08 0.36
Age at onset 
of illness -0.07 0.37 -0.02 0.82 -0.06 0.48
Duration of 
illness 0.01 0.93 0.02 0.78 0.02 0.8
BPRS, The Brief Psychiatric Rating Scale (BPRS); YMRS, Young Mania Rating Scale; 
HDRS, Hamilton Depression Rating Scale; CPZ, Chlorpromazine; Left Df, left eye fractal 
dimension; Right Df, right eye fractal dimension; Df, average fractal dimension; r, 
correlation coefficient.
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Abstract
Aim:
Evidence suggests microvascular dysfunction (wider retinal venules and narrower 
arterioles) in schizophrenia (SCZ) and bipolar disorder (BD). The vascular development 
is synchronous with neuronal development in the retina and brain. The retinal 
vessel trajectory is related to retinal nerve fiber layer thinning and cerebrovascular 
abnormalities in SCZ and BD and has not yet been examined. Hence, in this study we 
examined the retinal vascular trajectory in SCZ and BD in comparison with healthy 
volunteers (HV).
Methods:
Retinal images were acquired from 100 HV, SCZ patients, and BD patients, respectively, 
with a non-mydriatic fundus camera. Images were quantified to obtain the retinal 
arterial and venous trajectories using a validated, semiautomated algorithm. Analysis 
of covariance and regression analyses were conducted to examine group differences. 
A supervised machine-learning ensemble of bagged-trees method was used for 
automated classification of trajectory values.
Results:
There was a significant difference among groups in both the retinal venous trajectory 
(HV: 0.17 ± 0.08; SCZ: 0.25 ± 0.17; BD: 0.27 ± 0.20; P < 0.001) and the arterial trajectory 
(HV: 0.34 ± 0.15; SCZ: 0.29 ± 0.10; BD: 0.29 ± 0.11; P = 0.003) even after adjusting for 
age and sex (P < 0.001). On post-hoc analysis, the SCZ and BD groups differed from 
the HV on retinal venous and arterial trajectories, but there was no difference between 
SCZ and BD patients. The machine learning showed an accuracy of 86% and 73% for 
classifying HV versus SCZ and BD, respectively.
Conclusion:
Smaller trajectories of retinal arteries indicate wider and flatter curves in SCZ and BD. 
Considering the relation between retinal/cerebral vasculatures and retinal nerve fiber 
layer thinness, the retinal vascular trajectory is a potential marker for SCZ and BD. As 
a relatively affordable investigation, retinal fundus photography should be further 
explored in SCZ and BD as a potential screening measure.
Keywords:  bipolar disorder, machine learning, retinal nerve fiber layer, retinal vascular 
trajectory, schizophrenia.
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5.1. INTRODUCTION
 The retina, an embryonic extension of the central nervous system, is often considered 
as a ‘window to the brain’ due to its easy accessibility1. Retinal imaging is safer, faster 
and less expensive technique compared to other imaging modalities, like magnetic 
resonance imaging (MRI), used for psychiatric disorders2.  The retinal nerve fiber layer 
(RNFL) which is composed of axons from the retinal ganglion cells, shares embryonic 
origin with the brain thus permitting surrogate examination of axonal histopathology3. 
Studies have reported thinning of the RNFL as measured by optical coherence 
tomography (OCT) in several neuropsychiatric conditions1,3. RNFL thinning has also 
been found to be associated with brain atrophy in multiple sclerosis validating its use 
as a marker for brain abnormality4. Several studies in the last decade have reported 
RNFL thinning in patients with schizophrenia (SCZ) and bipolar disorder (BD)5-9 but 
not in major depressive disorder10,11 suggesting that RNFL abnormalities are limited 
to SCZ and BD. A recent study has also reported an overlap in genes implicated in 
macular thickness and systemic diseases, including SCZ12. Two genetic loci, rs7432375 
and rs7523273, are associated with risk for both age-related macular degeneration 
and SCZ13-15. Though the functional significance of these genes in the pathogenesis 
of SCZ is not completely known, it is interesting to note that rs7523273 is associated 
with functional brain activation in the precuneus-posterior cingulate cortex of SCZ 
patients16. Hence, though preliminary, these findings suggest a pleiotropy effect of 
these genes between RNFL thickness and SCZ.
However, the measurement of RNFL thickness requires OCT17. Though less expensive 
than brain imaging, the cost of OCT still limits its utility in a wider community under 
resource constrained settings. Fundus imaging is less expensive than the OCT and 
ideally suited for its use in community settings. An earlier study has reported significant 
association of the retinal arterial trajectory measured as retinal artery angle (angle 
between the supratemporal and infratemporal arteries) with RNFL thickness18. This 
contribution to RNFL thickness by retinal blood vessels could either be direct or indirect 
and may be bidirectional. An earlier study has suggested that the blood vessels directly 
contribute to the inter-individual variations in the RNFL thickness in healthy individuals 
and patients19,20. In addition to this direct contribution, because the development 
of retinal vessels is influenced by axonal distribution, the location of blood vessels 
influence the variations in RNFL thickness19,20.
108 RETINAL VASCULAR FEATURES AS A BIOMARKER FOR PSYCHIATRIC DISORDERS
The retinal arterial trajectory can be measured using a relatively inexpensive fundus 
camera21,22, and this provides an opportunity to indirectly examine abnormalities in 
RNFL thickness.
Former studies using fundus cameras have reported abnormalities in retinal vasculature; 
venular calibers were found to be increased in SCZ patients and unaffected co-twins of 
SCZ patients23-25. Recently, we also reported wider venules and narrower arterioles in 
SCZ, and BD patients compared to healthy volunteers (HV)26. The trajectories of retinal 
vessels in SCZ and BD patients are yet to be examined, despite their relations with RNFL 
abnormalities. Hence, in this study we examined retinal vessel trajectory in patients 
with SCZ and BD in comparison with HV. Based on the literature suggestive of RNFL 
thinning in SCZ and BD, we hypothesized that these patients would have wider retinal 
arterial trajectories (in other words flatter curve, with the arms of the curve farther from 
the fovea) when compared to HV. Several lines of research in the past decade have 
suggested considerable overlap in the genetic and pathogenic factors across SCZ and 
BD; though there are a few differences between these two disorders, it is interesting 
to note that there are considerable similarities as well27. Considering these similarities 
between SCZ and BD, our secondary hypothesis was that there would be no significant 
difference in retinal arterial trajectories between these two groups. In addition, a 
proof-of-concept machine-learning method using an ensemble of bagged trees was 
employed for automated classification of patients and HV based on their vascular 
trajectory values.
5.2. METHODS
5.2.1. Subjects 
One hundred patients with SCZ and BD, respectively, were recruited from the clinical 
services of the National Institute of Mental Health and Neurosciences, Bangalore, 
India. Patients were examined by a board-certified psychiatrist and diagnosed as per 
the ICD-1028. Patients who had an ongoing psychiatric comorbidity or had substance 
abuse or dependence (except nicotine) in the previous 12 months were excluded from 
the study. One hundred HV were recruited using flyers and word of mouth from the 
same geographical area. None of the HV had a lifetime history of psychiatric disorder, 
neurological illness, or family history of psychoses in first-degree relatives. All HV 
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were interviewed by a qualified psychiatrist and also completed the Cross-Cutting 
Symptom Scale29,30 to rule out any Axis I disorders. Participants diagnosed or treated for 
hypertension, diabetes, stroke, or history of eye surgery/trauma were excluded from the 
study. The patients and HV were also excluded for other ophthalmologic disorders, such 
as macular degeneration, and glaucoma, based on their medical history. Ophthalmic 
examinations including refraction, axial length and intraocular pressure were not 
carried out. All participants were adults, aged 18 to 50 years. The study was approved 
by the institute ethics board and all participants provided written informed consent.
5.2.2. Clinical assessments
The severity of positive symptoms, negative symptoms, and general psychopathology 
in SCZ was measured using the Brief Psychiatric Rating Scale (BPRS)31. In BD, the severity 
of clinical symptoms was measured using Young’s mania rating scale (YMRS)32 and 
Hamilton Depression rating scale (HDRS)33. Functioning was assessed using Global 
Assessment of Functioning (GAF)34 and the Clinical Global Impression (CGI)35 in both 
SCZ and BD.
5.2.3. Retinal image acquisition
The procedure of retinal image acquisition was explained to those who agreed 
to participate in the study. They were seated in a dark room for 5 min prior to the 
procedure to facilitate auto dilation of pupils through accommodation. Optic-disk-
centered retinal images of both the eyes were acquired with a valid method by a trained 
individual using a fundus camera with a 40 degree field of view36. The retinal images 
were acquired using a non-mydriatic 3Nethra device (Forus Health, Bangalore, India) by 
an experienced operator. Each participant was asked to sit in front of the fundus camera 
and to rest his/her chin on its chin rest. The camera was adjusted to acquire the left 
eye retina by flashing a light and the image was captured and saved in the computer. 
This image-acquisition method was based on fundus illumination through light flashes 
forming a color image. The same procedure was repeated for the right eye26.
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5.2.4. Measurement of trajectory of retinal vessels
All images were visually examined by a board-certified ophthalmologist and 
pathological conditions of the retina, such as macular degeneration and glaucoma, 
were ruled out. Experienced raters differentiated the vessels as arteries and veins using 
an established method37. The following criteria were used to differentiate the arteries 
and veins in accord with previous studies: (i)  arteries are brighter in color than veins; 
(ii) arteries have a smaller caliber than veins; (iii) the central reflex (the light reflex of
the inner parts of the vessel) is wider in arteries and narrower in veins; and (iv) arteries
and veins usually alternate near the optic disk before branching out. The trajectories
of arteries and veins for both the eyes were calculated using a validated mathematical
model described in a previous study38. A semiautomated software was formulated
using MATLAB 2018a (MathWorks, Natick, MA, USA). Initially, the retinal images of the
right and left eyes were rotated 90° clockwise and anticlockwise, respectively. Following 
this, a minimum of 20 points were marked on the vascular trajectories passing through 
the infratemporal and supratemporal margin areas of the retinal images such that each 
arm to the right and left of the optic disk had a minimum of 10 points each (shown in
Figure 1). The infratemporal and supratemporal margins/peaks of the optic disk were
chosen in view of the thick retinal nerve fiber bundles in this area. The fovea is located
between these two peaks/margins, so the retina stretches more horizontally and/or
vertically in some eyes due to tension on fovea, resulting in a greater distance between 
these two peaks where the retinal vessel trajectories are measured. This results in a
thinner retina38,39. The x and y coordinates of the marked points were automatically
detected in MATLAB and were converted to new coordinates by shifting the origin
to the center of the optic disk. Thereafter, this data of converted coordinates were
fitted to a second-degree polynomial         curve-fitting equation based on
the best-fit second-degree polynomial by the least squares method as shown in Figure
1. In cases where the retinal artery or vein were branched, and the main artery was
larger than the branch artery, the main artery was plotted for the trajectory. However,
if the branch artery was as large as the main artery, marking was not done beyond
the branching point. In such cases also, a minimum of 20 points were marked. Under
these conditions, a larger P1 indicated that the curve of retinal vascular trajectory was
steeper and narrower, and that the arms of the curve would be closer to the fovea.
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A smaller P1 indicated that the curve of the trajectory was flatter and wider, and the 
arms of the curve would be farther from the fovea. Hence, the value of P1 was used as 
a single measure of the retinal vascular trajectory to indicate the steepness and width 
of the trajectory parabola. The average of the retinal vascular trajectories of the right 
and left eyes was used as the primary outcome measure. The procedure described 
above was adopted for both retinal arteries and veins separately. A subsample of 30 
participant images was analyzed by two independent evaluators to check interrater 
reliability. A good interrater reliability of 0.83 (intraclass correlation for average artery; 
kappa=0.85; P < 0.001; for average vein; kappa = 0.81; P< 0.001) was obtained for the 
vascular trajectories.
Figure 1. 
Marking of retinal trajectory in a representative fundus image (left) and least 
square second-degree polynomial Curve fitting (right); (.) cy versus cx; (______) least-
square fitting.
5.2.5. Statistical analysis
All statistical analyses were performed using the SPSS version 24 (IBM, Armonk, NY, 
USA). The Shapiro-Wilk test was used to examine the data for normative distribution. 
Parametric statistical tests were used as the data were found to be normatively 
distributed. Differences in age and sex distribution across the groups were analyzed 
using one-way analysis of variance (ANOVA) and χ2-test respectively. Differences in 
retinal vascular trajectory across the groups were measured using analysis of covariance 
(ANCOVA). As we compared trajectories of both retinal arteries and veins, we applied the 
Bonferroni correction for multiple comparisons (three groups and two measures) and 
considered a corrected P-value of ≤ 0.05/6 = 0.0083 to be significant. The contribution 
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of age and sex as potential confounding variables was assessed using regression 
coefficients with 95% confidence interval between the groups, both with and without 
these as covariates. The relation between retinal trajectories and clinical/demographic 
variables was assessed using Pearson’s correlation analyses using the scores on BPRS, 
YMRS, HDRS, as well as age at onset of illness, duration of illness, and chlorpromazine 
equivalent of antipsychotic as predictor variables. A P-value of < 0.01 was considered 
significant in view of the multiple variables. To control for the confounding effects of 
nicotine dependence, a sub analysis was performed after excluding twelve subjects 
with SCZ and four subjects with BD who had nicotine dependence. 
5.2.6. Machine-learning analysis
We conducted a proof-of-concept machine-learning analysis to examine the utility of 
retinal vascular measures in differentiating the three groups. The machine-learning 
algorithm was implemented through MATLAB 2018a using a supervised machine-
learning approach. The labels used for training were based on the three groups 
(SCZ, BD, and HV). A total of six features from both the left and right eye were used 
for classification namely, left and right retinal arterial trajectories, left and right retinal 
venous trajectories, and their respective averages. The supervised machine-learning 
model was created by feeding a known set of input data (features) and the known 
group of the data (i.e., labels or classes). This model was then used to classify the new 
unknown data into one of the three groups through cross-validation. We used five 
default folds which partitioned the data into five disjoint sets; each fold trains the 
model using out-of-fold observations and assesses model performance using in-fold 
data followed by calculation of the average test error of overall folds. The data was 
partitioned into five equal folds out of which four folds were taken for training and one-
fold was taken for testing/validation. This process was repeated five times with each 
fold being used exactly once as the validation fold. This validation model was chosen 
to avoid overfitting of the data. The method provides good predictive accuracy to the 
final model trained using all the data. The usage of multiple fits ensures efficient use of 
all the available data despite small numbers. The learning rate was chosen as 0.1. The 
bagged decision trees ensemble method was used for classification. We also conducted 
a support-vector machine (SVM) analysis to independently confirm the findings. We 
chose SVM and the ensemble of bagged trees as these methods have good speed, high 
model flexibility, and can be implemented with moderate computational power40,41, 
translating to feasibility in real life clinical scenarios.
113CHAPTER 5
5.3. RESULTS
5.3.1. Comparison of demographic variables
Out of the 300 participants recruited, 31 were excluded following quality check of retinal 
images and ambiguity in retinal vascular trajectory marking. Thus, 87 HV, 94 SCZ, and 
88 BD were included for the analysis, totaling 269 participants. Demographic details 
and clinical measures are provided in Table 1. We found a significant difference in age 
(p = 0.005) across the three groups and no difference in sex distribution (P = 0.053).
Table 1.
Comparison of demographic and clinical details between the groups
HV 
(n = 87)
SCZ 
(n = 94)
BD 
(n = 88) F/t/χ
2 p
Age (years) 30.2 ± 7.6 32.5 ± 6.0 33.4 ± 6.0 5.4 0.005
Sex ratio (M/F) 41/46 61/33 51/37 5.87 0.053
Age at onset (years) — 25.0 ± 5.2 23.8 ± 6.0 1.7 0.196
Duration of illness 
(years) — 7.6 ± 5.2 9.1 ± 5.6 2.6 0.11
BPRS — 25.83 ± 5.4 — — —
HDRS — — 3.97 ± 5.6 — —
YMRS — — 1.75 ± 2.9 — —
BD, bipolar disorder patients; BPRS, Brief Psychiatric Rating Scale; F, analysis of variance; 
HDRS, Hamilton Depression Rating Scale; HV, healthy volunteer; SCZ, schizophrenia 
patients; t, independent t-test; YMRS, Young’s Mania Rating Scale.
5.3.2. Differences in trajectory of retinal vessels between HV 
and patients
ANCOVA showed a significant difference across the three groups in trajectories of 
retinal artery (constant P1 of HV: 0.34 ± 0.15; SCZ: 0.29 ± 0.10; BD: 0.29 ± 0.11; F = 4.1; 
P = 0.003). The results showed that the value P1 of the retinal arterial trajectory was 
significantly smaller in SCZ (0.29 ± 0.10) and BD (0.29 ± 0.11) patients as compared 
to HV (0.34 ± 0.15), indicating flatter and wider retinal arterial trajectories in patients. 
There was a significant difference across the three groups in the trajectories of retinal 
veins as well (constant P1 of HV: 0.17 ± 0.08; SCZ: 0.25 ± 0.17; BD: 0.27 ± 0.20; F = 5.2; 
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P < 0.001). However, the value P1 of the retinal venous trajectory was significantly 
greater in SCZ (0.25 ± 0.17) and BD (0.27 ± 0.20) patients as compared to HV (0.17 ± 
0.08) indicating steeper and narrower retinal venous trajectories in patients. Post-hoc 
analysis revealed that while there was a significant difference between HV and both 
SCZ and BD patients in the trajectories of retinal arteries (P < 0.01) and veins (P < 0.01), 
there was no significant difference between the two patient groups, SCZ and BD (P > 
0.05) on these measures (Figure S1 and Table S1). 
The contribution of age and sex as potential confounding variables was assessed using 
regression analysis. There was no considerable difference in the regression coefficients 
and significance values either with or without age and sex as additional regressors 
on separate linear regression analyses (Table 2) suggesting absence of any significant 
effect of these potential confounders. Further details are provided in Table S2. Similarly, 
nicotine dependence did not show significant effects either (Appendix S1).
Table 2. 
Mean difference of retinal trajectories among HV, SCZ patients, and BD patients 
adjusted for age and sex
Parameter Group
Not adjusted for age and sex Adjusted for age and sex
β† (95%CI) P β† (95%CI) P
Retinal 
vein 
trajectory
HV SCZ 0.08 (0.041 to 0.119) <0.001
0.075 
(0.035 to 0.115) <0.001
HV BD 0.102 (0.041 to 0.119) <0.001
0.107 
(0.06 to 0.153) <0.001
SCZ BD 0.022 (−0.031 to 0.076) 0.417
0.022 
(−0.032 to 0.076) 0.415
Retinal 
artery 
trajectory
HV SCZ −0.058 (−0.096 to −0.019) 0.003
−0.049 
(−0.088 to −0.010) 0.014
HV BD −0.056 (−0.096 to −0.016) 0.006
−0.042 
(−0.083 to −0.002) 0.041
SCZ BD 0.002 (−0.030 to 0.033) 0.915
0.00 
(−0.031 to 0.032) 0.985
†Regression coefficient; BD, bipolar disorder patients; CI, confidence interval; HV, 
healthy volunteers; SCZ, schizophrenia patients.
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5.3.3. Relation between clinical variables and retinal vascular 
trajectory
There was no significant correlation between clinical variables (duration of illness, age 
at onset, total score on YMRS, HDRS, BPRS, and antipsychotic dose) and trajectories of 
retinal arteries and veins (P > 0.01) on Pearson’s partial correlation analyses with and 
without age and sex as covariates (Table S3).
5.3.4. Machine learning analyses
Ensemble of bagged trees had an accuracy of 86% with sensitivity of 88% and specificity 
of 85% for differentiating HV and SCZ. A lower but considerably good accuracy of 73% 
with sensitivity of 78% and specificity of 76% was obtained for differentiating HV and 
BD. For differentiating SCZ and BD, the accuracy was 77% with a sensitivity of 81% and 
specificity of 86%. The exploratory SVM analysis showed a similar, but relatively lesser 
accuracy than the ensemble of bagged trees (Appendix S2). 
5.4. DISCUSSION
This is the first study to assess the trajectories of retinal vessels in SCZ and BD patients 
in comparison with HV. The results show that P1 of the retinal arterial trajectory was 
significantly lesser and P1 of the retinal venous trajectory was significantly greater in 
SCZ and BD patients as compared to HV. This indicates wider and flatter parabola of 
the arteries and steeper and narrower parabola of the veins in the patients than in the 
HV. Neither the arterial nor venous trajectories differed between patients with SCZ and 
those with BD.
Our findings of wider retinal arterial trajectories are in accord with our hypothesis and 
previous findings. During embryonic development, common mechanisms underlie the 
vascularization of both retina and the brain as the retina is embryologically an extension 
of the diencephalon42. In both the retina and the brain, the vascular development 
is synchronous to neuronal development; the neurovascular coupling assures 
simultaneous generation of neuroblasts and blood vessels43. In addition, endothelial 
cells play a critical role in migration and differentiation of oligodendrocytes43. 
Interestingly, emerging evidence suggests the role of angiogenesis and blood vessel 
pathologies in the pathogenesis of psychoses, importantly SCZ. Preliminary evidence 
from genetic, post-mortem and imaging studies suggests a vascular remodeling and 
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hypoxia signaling as risk factors for SCZ43,44.   Considering these relations, it is possible 
that retinal vascular abnormalities are indicative of cerebral vascular abnormalities 
which in turn are implicated in the pathogenesis of psychoses.
In addition, the retinal arterial trajectory measured as the retinal artery angle has been 
shown to have significant association with thinner RNFL18 and several studies have 
reported wider retinal artery trajectories to be associated with RNFL defects38,39,45,46. 
A few studies have examined RNFL thickness using OCT in SCZ and BD and have 
reported thinning of the RNFL5,9,47-49 and the inner nuclear layer50 in patients compared 
to HV.
Hence, our findings of wider retinal artery trajectories in SCZ and BD patients suggest 
that the retinal arterial trajectory could be a potential surrogate measure of RNFL 
thickness seen in psychoses. Our findings provide rationale for further examination of 
the association between retinal vascular trajectory and RNFL thickness using OCT in 
SCZ and BD.
Based on the common developmental origins between the retina and the brain51, a few 
studies have examined the relation between RNFL thickness and brain structure.  In a 
large population-based study, a thinner RNFL and ganglion cell layer was shown to be 
associated with lower gray matter density in the visual cortex and a thinner ganglion cell 
layer was associated with lower gray matter density in the thalamus51. In addition, lower 
fractional anisotropy of the corpus callosum and optic radiation were associated with 
thinner RNFL51,52. While the definitive mechanisms are still unclear, axonal degeneration 
has been postulated to be responsible for both thinning of the RNFL and decreased 
gray matter volume in the brain53. However, the brain correlates of thin RNFL have not 
directly been examined in SCZ and BD to date. Considering the relation between retinal 
arterial trajectory and RNFL thickness, it is possible that the abnormalities in retinal 
vascular trajectory may also be related to the structural brain abnormalities seen in 
SCZ and BD54-56. However, this speculation is based on indirect evidence as the relation 
between retinal vascular trajectory and brain structure/function in SCZ or BD remains 
to be explored. 
While several studies have examined retinal arterial trajectories, retinal venous 
trajectories have taken the backseat. Our findings suggest an inverse relation between 
the trajectories of retinal artery and vein between the groups. This finding is similar 
to the inverse relation see in retinal vascular calibre; while patients with psychoses 
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had narrower arterioles than HV, they had wider venules26. In the absence of joint 
examination of retinal venous trajectory and RNFL, definitive conclusions cannot be 
drawn regarding the reasons or pathophysiological mechanisms behind the differential 
findings across the arteries and veins. Studies employing multimodal examination 
using fundus photography, OCT, and magnetic resonance imaging in SCZ and BD 
patients are needed for direct evidence and definitive understanding of these relations.
Our secondary aim was to examine the utility of machine learning techniques to 
differentiate patients from HV using retinal vessel trajectory as the input variable. 
Several studies have used the machine learning approach to classify SCZ/BD and 
HV using neuroimaging/ electrophysiologic / cognitive data as input variables57-61. A 
recent study reported prediction accuracy of 76% to differentiate SCZ from HV using 
a multisite machine-learning analysis62. Another study reported use of machine-
learning analysis and structural MRI to differentiate treatment non-responders from 
treatment responders with a sensitivity of 71% and specificity of 68%63. Similar to 
structural imaging, functional imaging is also used to classify SCZ and HV; a recent 
study using functional connectivity measure reported an accuracy of 75% with a 
sensitivity of 74% and specificity of 84%64. While several studies have examined the 
use of machine-learning approach in SCZ, it is relatively less examined in BD. A few 
studies using neuroimaging measures have reported an accuracy of 70% - 80% to 
classify BD and HV65. A higher accuracy of 95% was reported to classify BD and HV 
using a combination of neuropsychological tests and plasma markers66. On the other 
hand, a few studies have explored the utility of machine learning analyses using retinal 
images in ophthalmology67-71. The machine-learning approach has been successfully 
used to classify healthy versus diabetic retinopathy, age related macular degeneration 
(AMD), glaucoma, retinopathy of prematurity, and so forth72-74. Ours is the first study to 
utilize machine-learning analysis to differentiate SCZ/BD from HV using retinal vessel 
trajectory as the input factor. Findings of our study provide proof of concept to use 
machine learning techniques using retinal vessel trajectory as an input factor to classify 
SCZ/BD and HV. The ensemble of bagged trees method of classification crossed the 
critical threshold of more than 80% for classifying HV and SCZ75,76. However, our sample 
size being small, these findings need to be replicated in future studies with larger 
samples. 
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A few limitations should be considered in relation to our study findings. All patients 
were on treatment with medication and the confounding effect of pharmacotherapy 
cannot be ruled out. However, as shown in Table S3, there was no significant correlation 
between retinal vessel trajectories and chlorpromazine dose equivalents suggesting 
absence of significant effect of antipsychotics. Future studies with a subsample of 
drug-naïve subjects can control for this confounder. The representation of BD-I and 
BD-II patients were not uniform. There were 65 patients with BD-I and rest had BD-II. 
Considering the small number of participants in each subgroup we could not examine 
whether the subtypes of BD differ on these parameters. Future studies with larger 
samples including both BD-I and BD-II patients are needed for the same. The groups 
were not age matched. However, even after controlling for age, the results remained 
significant. As shown in Table 2, the regression coefficients were comparable both 
with and without age and sex as covariates. Sixteen patients had nicotine dependence 
(four BD and 12 SCZ) which could have confounded the results considering that 
previous studies have reported an association between long-term nicotine use and 
RNFL thickness77,78. However, as nicotine dependence being a common comorbidity 
in schizophrenia79, exclusion of patients with nicotine use would have affected the 
generalizability of findings. It is important to note that the differences between groups 
remained significant even after excluding these 16 participants (details in Appendix 
S1). We did not measure blood pressure, body mass index, or glucose levels of all the 
participants on the day of examination. Though participants were young and those 
with a history of hypertension or diabetes mellitus were excluded, one cannot rule out 
the possibility of undiagnosed hypertension or diabetes mellitus. To control for the 
potential confound, we measured blood pressure and body mass index in a subgroup 
of patients and conducted a sub analysis including these measures. The results 
remained the same even after inclusion of these measures (details in Appendix S3). 
Future studies need to consider measurement of these parameters on the day of retinal 
image acquisition. Another major limitation of the study is that we did not measure 
other ophthalmologic parameters including refraction, axial length and intraocular 
pressure. It is important to note that ophthalmologic comorbidities are seen commonly 
in schizophrenia80 and may have confounded the findings. Hence, it will be important to 
measure these parameters in the future. We did not measure the axial length of the eye 
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or visual acuity/ refraction which could have influenced the retinal vascular trajectory 
measurements. However, it is important to note that a previous study has reported a 
significant association between the retinal arterial trajectory and RNFL thickness even 
after controlling for the axial length18. Moreover, another study has reported that SCZ 
patients and HV do not differ in axial length of the eye or disorders of refraction81. 
Hence, axial length is not likely to have significant confounding effects on the findings. 
However, it would be ideal if future studies concurrently measured the axial length and 
refraction to correct for their effects. 
Our study findings have important implications. Retinal vascular abnormalities bear 
relation to abnormalities in RNFL thickness, which in turn is related to brain abnormalities 
seen in SCZ and BD82,83. Fundus photography is relatively inexpensive when compared 
to OCT or neuroimaging. In addition, the portable nature of the equipment also makes 
it an ideal tool for use in peripheral centers or where resources are limited. These 
advantages of fundus photography, together with our findings from machine-learning 
analysis, indicate the potential utility of this method in wider, resource constrained 
settings and warrant further studies with larger sample sizes. Machine-learning analysis 
with the use of a single measure (retinal vessel trajectory) demonstrated reasonable 
accuracy despite the potential confounding factors, suggesting its potential utility as 
a clinical marker84. Considerable increase in accuracy may be obtained with increase in 
sample size along with dynamic learning and deep learning. These preliminary findings 
provide sufficient rationale for future studies along similar lines on larger samples.
5.5. Conclusion
The findings of our study indicate significant differences between the retinal vessel 
trajectories in patients (SCZ and BD) and HV. Both SCZ and BD patients, compared to 
HV, had smaller P1 for arterial trajectories indicating flatter and wider curves of retinal 
arteries. As retinal fundoscopic imaging is affordable, accessible, and easy to perform, 
it could prove to be useful as a surrogate investigation for the RNFL thinning seen in 
SCZ and BD. The findings from machine-learning analysis provide proof of concept and 
preliminary support towards its potential to differentiate patients with SCZ and BD from 
HV. Future studies need to consider examining the relation between retinal vascular 
trajectory and RNFL using OCT. Also, the relation between retinal vascular trajectory 
and brain structure and function need to be considered in the future.
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Supplementary Materials
Table S1: 
Post-hoc analysis of variance of retinal trajectory in the three groups
Parameter Group Mean difference Std error p
Retinal Vein Trajectory
HV vs SCZ -0.080 0.023 0.002
HV vs BD -0.102 0.024 <0.001
SCZ vs BD -0.022 0.023 1.000
Retinal Artery Trajectory
HV vs SCZ 0.058 0.019 0.006
HV vs BD 0.056 .01882 0.010
SCZ vs BD -0.002 .01846 1.000
Table S2:
Details of regression coefficient between groups with and without age and sex as 
predictor variables.
S2a – Mean difference between HV:SCZ, HV:BD and SCZ:BD without age and sex as 
predictors
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .171 .014 11.991 .000
HV SCZ .080 .020 .289 4.034 .000
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .171 .016 10.576 .000
HV BD .102 .023 .322 4.470 .000
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .251 .019 13.271 .000
SCZ BD .022 .027 .061 .813 .417
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Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .344 .014 24.585 .000
HV SCZ -.058 .019 -.216 -2.965 .003
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .344 .014 23.960 .000
HV BD -.056 .020 -.205 -2.758 .006
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .286 .011 25.764 .000
SCZ BD .002 .016 .008 .107 .915
S2b – Mean difference between HV:SCZ, HV:BD and SCZ:BD with age and sex as 
predictors
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .188 .057 3.268 .001
HV SCZ .075 .020 .271 3.674 .000
Age .000 .001 .025 .340 .734
Gender -.021 .020 -.076 -1.034 .302
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Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .211 .064 3.293 .001
HV BD .107 .024 .338 4.535 .000
Age -.002 .002 -.067 -.902 .368
Gender .003 .023 .011 .145 .885
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .215 .079 2.708 .007
SCZ BD .022 .027 .061 .817 .415
Age .002 .002 .081 1.055 .293
Gender -.034 .029 -.090 -1.168 .244
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .406 .056 7.250 .000
HV SCZ -.049 .020 -.184 -2.470 .014
Age -.003 .001 -.140 -1.904 .059
Gender .013 .020 .049 .668 .505
Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .461 .056 8.247 .000
HV BD -.042 .021 -.155 -2.059 .041
Gender .005 .020 .019 .257 .798
Age -.004 .001 -.213 -2.831 .005
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Retinal 
Vein 
Trajectory
Unstandardized Coefficients Standardized Coefficients t Sig.
B Std. Error Beta
(Constant) .241 .047 5.142 .000
SCZ BD .000 .016 .001 .019 .985
Gender .006 .017 .029 .378 .706
Age .001 .001 .062 .806 .421
Table S3:
Relation between clinical variables and trajectory of retinal vessels.
Variable Trajectory of retinal vein
Trajectory of 
retinal artery
Trajectory of 
retinal vein 
(adjusted for 
age & sex)
Trajectory of 
retinal artery
(adjusted for 
age & sex)
YMRS r = -0.035, p = 0.649
r = 0.068, 
p = 0.382
r = -0.185, 
p = 0.32
r = 0.45, 
p = 0.011
HDRS r = -0.031, p = 0.691
r = 0.12, 
p = 0.873
r = -0.063, 
p = 0.735
r = 0.189, 
p = 0.310
BPRS r = -0.006, p = 0.959
r = -0.057, 
p = 0.621
r = -0.274, 
p = 0.136
r = 0.078, 
p = 0.677
Age at onset of illness r = -0.113, p = 0.18
r = -0.009, 
p = 0.918
r = 0.01, 
p = 0.998
r = 0.029, 
p = 0.877
Duration of illness r = 0.129, p = 0.125
r = 0.066, 
p = 0.437
r = -0.001, 
p = 0.998
r = -0.29, 
p = 0.877
Chlorpromazine 
equivalent of 
antipsychotic
r = -0.038, 
p = 0.681
r = -0.117, 
p = 0.204
r = -0.182, 
p = 0.327
r = 0.063, 
p = 0.746
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Appendix S1. Effect of nicotine use on retinal trajectory measurements
While subjects with nicotine dependence were not included in the study, 12 subjects 
with SCZ and 4 subjects with BD had nicotine use. Analysis of variance was conducted 
to examine the differences between groups after exclusion of these subjects to rule out 
the possible confounding effect of nicotine use with 87 HV, 82 SCZ and 84 BD. There 
were significant differences between groups in retinal vein trajectory (HV=0.17±0.08; 
SCZ=0.25±0.17; BD=0.27±0.20 and p<0.001) and retinal artery trajectory (HV=0.34±0.15; 
SCZ=0.29±0.10; BD=0.28±0.11 and p=0.003). Overall regression model was still 
significant except for SCZ and BD (similar to main results) for both retinal vein trajectory 
(HV:SCZ R2 = 0.077, F(1,167) = 13.972, p < 0.001;  HV:BD R
2 = 0.107, F(1,169) = 20.257, p < 0.001; 
SCZ:BD R2 = 0.005, F(1,164) = 0.891, p = 0.347) and retinal artery trajectory (HV:SCZ R
2 = 
0.045, F(1,167) = 7.797, p = 0.006; HV:BD R
2 = 0.046, F(1,169) = 8.236, p = 0.005; SCZ:BD R
2 = 
0.00, F(1,164) = 0.025, p = 0.874).
Appendix S2. Support vector machine (SVM) performance for classification.
Supervised SVM model has accuracy of 82%; sensitivity of 81% and specificity of 82% for 
classifying HV and SCZ whereas supervised SVM model has accuracy of 75%, sensitivity 
of 74% and specificity of 76% for classifying SCZ and BD. The results for HV and BD 
classification using SVM has accuracy of 68%, sensitivity of 64% and specificity of 75%. 
Appendix S3. Relation between retinal vascular trajectory, body mass index, and 
blood pressure.
For a subgroup of patients height and weight was measured and body mass index 
(BMI) was calculated on the day of retinal examination. BMI details were available for 44 
healthy volunteers, 77 patients with SCZ and 58 patients with BD. Mean BMI for HV was 
23.9±4.4, for SCZ was 25.2±4.9 and for BD was 25.8±4.4. On analysis of variance, there 
was no significant difference between the groups on BMI (F=2.27, p=0.11). As mentioned 
in the manuscript patients with hypertension were excluded from the study. Among 
those who participated, blood pressure was recorded in 28 patients with SCZ and 54 
patients with BD on the day of retinal examination. On independent t test, mean systolic 
blood pressure between the groups was not significantly different [SCZ=115.2±7.6, 
BD=119.0±11.8; t=-1.55, p=0.12]. Even after inclusion of the BMI and blood pressure as 
covariates, the results remained the same. There was no significant difference between 
SCZ and BD on Retinal Vein Trajectory (SCZ=0.22±0.15; BD=0.23±0.16; F=0.31; p=0.82) 
and Retinal Artery Trajectory (SCZ=0.29±0.11; BD=0.27±0.11; F=1.17; p=0.327).
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Figure S1: 
Diagrammatic representation of group means of trajectory of retinal veins and retinal 
arteries.
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Abstract
Emerging evidence indicates abnormal retinal micro-vasculature in schizophrenia 
(SCZ) and bipolar disorder (BD) and its relation to cognitive functions. However, the 
association of these abnormalities with the cognitive deficits in these disorders has not 
been examined till date. Hence, we explored this aspect in patients with SCZ, BD, and 
healthy volunteers (HV). We examined 34 with SCZ, 39 with BD, and 45 HV. Retinal images 
were acquired using nonmydriatic fundus camera. The retinal images were analyzed, 
and average diameters of retinal arterioles and venules were calculated. Working 
memory was assessed using computerized one-back test from Cogstate® battery. There 
was significant difference between groups in retinal venules and arterioles caliber (p < 
0.001). Both SCZ and BD patients had wider venules and narrower arterioles. They had 
significantly lower working memory accuracy (p=0.008) and higher log mean speed 
(p < 0.001). There was significant positive correlation between one-back test accuracy 
and retinal arteriolar caliber (r = 0.22; p = 0.01) and between log mean speed score and 
retinal venular caliber (r = 0.20; p = 0.02). Findings suggest association between working 
memory and retinal vascular caliber, a potential pointer towards understanding the 
vascular pathology in cognitive deficits in SCZ and BD. Future studies need to examine 
whether retinal vascular could be a biomarker for SCZ and BD. 
Keywords:  Bipolar disorder, Cerebrovascular disorder, Cognitive impairment, Fundus, 
Retinal vasculature, Schizophrenia.
137CHAPTER 6
Highlights
• Retinal image is a proxy assessment of the cerebral vasculature. 
• The Cognitive impairments adversely affect the functional outcomes in schizophrenia 
(SCZ) and bipolar disorder (BD). 
• SCZ and BD have significantly wider veins and narrower arteries than healthy 
volunteers.
• These are associated with poorer working memory. 
• Retinal examination could help in identifying risk of vascular adverse event.
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6.1. INTRODUCTION
Schizophrenia (SCZ) and Bipolar disorder (BD) are common psychiatric conditions with 
considerable morbidity and financial burden. Cognitive impairment is considered one 
of the core features of SCZ and BD with deficits in processing speed, attention, working 
memory, reasoning, and problem solving abilities1. Cognitive impairments adversely 
affect the functional outcomes in both SCZ and BD; cognitive improvement is hence 
considered an important target in the treatment of both these disorders2. Despite being 
an important determinant of functional recovery, adequate management of cognitive 
deficits is still an unmet need in SCZ and BD, partly owing to the poor understanding 
we have regarding its neurobiology3.
While the neurobiology of cognitive deficits is not completely known, several studies 
have indicated associations between cerebrovascular and cardiovascular abnormalities 
and cognitive deficits4. Several studies have suggested vascular abnormalities and 
higher occurrence of adverse cerebrovascular/cardiovascular incidents in SCZ and 
BD5. However, assessment of cerebrovascular structure is complex and has been 
inadequately examined in SCZ and BD. Few studies have used arterial spin labelling 
and perfusion weighted imaging to examine cerebral blood flow, an indicator of 
cerebrovascular functioning6.
With recent advances in technology, fundus photography has emerged as a simple, 
non-invasive, proxy measure for assessing cerebral microvasculature. Abnormal retinal 
vasculature, particularly wider venules and narrower arterioles indicates future risk of 
stroke7. Retinal vascular abnormalities are also linked to white matter hyperintensities. 
These hyperintensities indicate cerebral microvascular abnormalities8  and are commonly 
seen in BD. A few recent studies have also reported retinal vascular abnormalities in 
SCZ8 and in twins discordant for SCZ, suggesting that retinal microvasculature may 
reflect familial vulnerability to psychotic symptoms9. Recently, we demonstrated 
narrower arterioles and wider venules in the retinae of both SCZ and BD compared 
to HV10. These findings, in conjunction with several other studies that have reported 
abnormalities in the retinal nerve fiber layer in SCZ suggests the potential use of retinal 
microvasculature examination as a window to the brain9. 
Interestingly, several studies have suggested a relation between retinal vascular 
abnormality and cognitive functions in healthy individuals as well as in patients 
with dementia11. However, the relation between cognitive deficits and retinal 
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microvasculature in SCZ and BD remains to be explored. In view of its clinical 
significance, and its relation to vascular abnormalities, we examined relation of the 
caliber of retinal arterioles and venules with cognitive function in patients with SCZ 
and BD. We examined working memory, an important cognitive domain impaired in 
both SCZ and BD12 as the indicator of cognitive deficits. We measured the working 
memory performance using a valid test, N-back test13. As emerging evidence suggests 
association between impaired cognition and wider retinal venules and narrower 
arterioles14,  we hypothesized that wider venules and narrower arterioles would be 
associated with poorer working memory performance.
6.2. METHODOLOGY
6.2.1. Participants
A total of 118 participants, 34 patients with SCZ, 39 with BD, and 45 HV were included 
in the study. They were part of a larger study that examined differences in the caliber 
of retinal arterioles and venules across these three groups. Patients were recruited from 
the inpatient and outpatient services of the National Institute of Mental Health and 
Neurosciences (NIMHANS), Bengaluru, India. Clinical interviews were conducted by a 
board-certified psychiatrist to ensure that diagnostic criteria for SCZ or BD were met 
according to the International Classification of disorders (ICD)-1015. Those meriting 
a diagnosis of substance abuse or dependence (except nicotine) or other Axis I 
psychiatric disorders were excluded. Medical and neurological disorders (hypertension, 
diabetes, stroke), and history of eye trauma were also part of the exclusion criteria. 
None of the HV had Axis I psychiatric disorder. They were also assessed by a trained 
psychiatrist and completed self-rated level 1 cross cutting symptom measure – Adult 
version16. Substance abuse, hypertension, diabetes, stroke, major neurological illnesses, 
and eye trauma were ruled out in HV also. Adults in the age range of 18 to 50 years 
with a minimum of 7 years of formal education were included in the study. Those 
above 50 years were not included as the quality of fundus image obtained through 
non-mydriatic acquisition is poor in elderly individuals. Those with less than 7 years of 
formal education were excluded owing to potential confounding effects of education 
on performance in a computerized cognitive test. Detailed description is available in 
our former publication10. We obtained approval from the institutional ethics committee 
and all participants provided informed consent.
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6.2.2. Clinical Assessments
The tools used for severity of clinical symptoms were as follows. i) The Brief 
Psychiatric Rating Scale (BPRS)17 for positive and negative symptoms, and general 
psychopathology in schizophrenia, ii) The Young mania rating scale (YMRS)18 for manic 
symptoms, iii) The Hamilton Depression rating scale (HDRS)19 for depressive symptoms, 
iv) Global assessment of functioning (GAF)20 for social, occupational, and psychological 
functioning v) Clinical Global Impression (CGI)21. 
6.2.3. Assessment of working memory
Working memory was examined using the computerized One-back test of the 
Cogstate® battery12. The one-back task is a simple version of the N-back task which is 
a commonly used for working memory task. It has been shown to detect impairments 
in patients with SCZ as well as BD13. This task requires the participant to maintain 
information in working memory and to indicate whether the card displayed is the same 
as the one displayed in the preceding trial. The number of correct responses expressed 
as a percentage of the total number of trials was calculated. Data distributions were 
then normalized by expressing the percentages as decimals and applying an arcsine 
transformation. Another related measure log mean speed was also calculated. Log 
mean speed indicates mean of the log transformed reaction times for correct responses. 
Scoring was done by the Cogstate® program and the values were noted (for details 
refer to www.cogstate.com). While lower scores indicate better performance on the log 
mean speed measure, the same in accuracy measures indicates inferior performance.
6.2.4 Retinal image acquisition and measurement of retinal 
vasculature
The detailed description of acquisition and analysis of retinal images are given in an 
earlier publication10. A brief description is given below. Image acquisition was carried out 
by competent individuals employing a non-mydriatic fundus camera which has a field 
of view of 40 degrees. Quantification of the retinal images was performed using a semi-
automated software called Vessel Assessment and Measurement Platform for Images of 
the REtina (VAMPIRE). The tool provides automatic detection of retinal landmarks (optic 
disc) and quantifies key parameters that are frequently used in investigative studies 
such as vessel diameter and vessel branching coefficients. The extended zone between 
141CHAPTER 6
0.5- and 2-disc diameters from the optic disc were used to perform the measurement of 
the diameters of the arterioles and venules. A calibration factor was used to adjust for 
possible magnification differences. Such differences may have been caused by fundus 
camera optics, image resolution, or patient’s refractive errors. The pixels to micrometers 
(μm) conversion was also calculated using the calibration factor10 and was applied for 
individual fundus images. Subsequently, the average central retinal artery equivalent 
(CRAE) and central retinal vein equivalent (CRVE) were calculated by averaging the 
arteriolar and venular diameters of the right and left eyes. The images from 40 selected 
participants were analyzed by two independent raters demonstrating good inter-rater 
reliability (Intraclass correlation = 0.831).
6.2.5. STATISTICAL ANALYSIS
The data was assessed for normative distribution using the Shapiro-Wilk test. Parametric 
statistical tests were employed for continuous variables. Chi-Square test was used to 
examine the differences in sex distribution. One-way analysis of variance (ANOVA) 
was used to analyze the age differences. ANOVA was also used to determine group 
differences in CRVE and CRAE. Difference between the groups on cognitive measures 
were compared using analysis of covariance (ANCOVA) with years of education as 
covariate, as this could confound the performance on the working memory task. 
Further post-hoc analysis was conducted to examine the difference between group 
pairs. Partial correlation analysis with years of education as co-variate was used to assess 
the relation between the retinal vascular caliber and cognitive tests. As we calculated 
the relation of working memory measures with both arteriolar and venular calibers, 
for correlation analysis, α=0.025 (0.05/2), a Bonferroni correction was considered as 
significant. To examine the relation between other clinical measures and working 
memory performance, further partial correlations were conducted between one-
back accuracy score and log mean speed score with BPRS, YMRS, HDRS, and duration 
of illness with years of education as co-variate. All analyses were performed using the 
Statistical Package for Social Sciences (SPSS) version 24.
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6.3. RESULTS
6.3.1. Comparison of demographic variables
In total 118 volunteers were recruited for the analysis. There was no difference in age 
(p = 0.80) or sex (p = 0.12) distribution between the groups. There was a significant 
difference between the three groups in years of education (p < 0.001). On Bonferroni 
post-hoc analysis, there was a significant difference between HV and SCZ (p < 0.001) as 
well as between HV and BD (p < 0.001), but there was no significant difference between 
SCZ and BD (p = 1.00) (See Table, Supplement Appendix 1). 
Table 1. 
Comparison of demographic and clinical variables between the groups
HV
(n = 45)
SCZ
(n = 34)
BD
(n = 39) F/t/χ
2 p
Age 32.8 ± 8.0 31.8 ± 5.0 32.9 ± 6.0 0.22 0.80
Gender ratio (M/F) 23/22 24/10 27/12 4.2 0.12
Years of Education 16.2 ± 3.2 12.6 ± 2.7 12.1 ± 2.7 25.5 < 0.001*
Age at onset (years) — 25.5 ± 4.6 24 ± 5.8 1.3 0.25
Duration of 
untreated illness 
(years)
— 6.4 ± 4.5 7.6 ± 4.9 3.9 0.05
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; F- Analysis of Variance; t – Independent t test; χ2 – Chi square test; *Significant 
difference
There was no significant difference between the two patient groups in duration of 
untreated illness (t = 0.03; p = 0.87) or age at onset of illness (t = 1.3; p = 0.25). SCZ 
patients had a mean score of 28.2 ± 4.1on BPRS and BD patients had mean score of 1.3 
± 2.7 on YMRS and 3.1 ± 4.9 on HDRS. Demographic and clinical variables are given in 
Table 1.
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6.3.2. Differences in working memory performance between 
groups
The one-back test performance showed a significant difference between the three 
groups both in terms of accuracy (F = 16.18; p < 0.001) and log mean speed (F = 14.72; 
p < 0.001) (Table 2). On post hoc analysis, HV had significantly higher accuracy than SCZ 
(p = 0.001) as well as BD (p < 0.001). Understandably, on analysis of log mean speed, 
HV had significantly lower scores compared to SCZ (p < 0.001) as well as BD (p < 0.001). 
There was no significant difference between SCZ and BD in either accuracy scores or 
log means speed score (p > 0.05) (See Table, Supplement Appendix 2).
Table 2. 
Retinal vascular caliber and working memory performance between the groups
HV
(n = 45)
SCZ
(n = 34)
BD
(n = 39) F p
CRVE 197.7 ± 20.9 210.7 ± 25.4 228.6 ± 24.9 18.0 < 0.001*
CRAE 116.2 ± 20.5 93.9 ± 13.0 92.6 ± 16.9 24.26 < 0.001*
One back task 
- accuracy 1.20 ± 0.26 0.92 ± 0.23 0.94 ± 0.26 5.01 0.008*
One back task 
– log mean 
speed
2.90 ± 0.10 3.00 ± 0.11 3.03 ± 0.14 8.70 < 0.001*
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; F- Analysis of Variance; CRVE- Central Retinal Vein Equivalent, CRAE- Central 
Retinal Artery Equivalent; *Significant difference
6.3.3 Differences in retinal vascular caliber
In accordance with our earlier report10, this sub-sample also showed significant 
differences between the groups in both CRVE (F = 18.00; p < 0.001) and CRAE (F = 24.26; 
p < 0.001) (Table 2). On Bonferroni post-hoc analysis, BD had greater venular diameters 
compared to both HV (p < 0.001) and SCZ (p = 0.005). The relatively greater venular 
diameter in SCZ compared to HV was only at trend level (p = 0.049). On the other hand, 
while both SCZ (p < 0.001) and BD (p < 0.001) had significantly lower arteriolar diameter 
compared to HV, there was no significant difference between BD and SCZ (p = 1.00) in 
this aspect (See Table, Supplement Appendix 1).
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6.3.4. Correlation between working memory performance 
measures and retinal vascular caliber
Even after adjusting for years of education, retinal artery diameter showed a significant 
positive partial correlation with one-back test accuracy (r = 0.22; p = 0.01) and a trend 
level negative correlation with log mean speed score (r = -0.17; p = 0.06). Retinal venular 
caliber on the contrary, had significant positive partial correlation with log mean speed 
score (r = 0.20; p = 0.02) and trend level negative correlation with accuracy score (r 
= -0.15; p = 0.08). There were no significant correlations between working memory 
performance scores and clinical variables (See Table, Supplement Appendix 3). 
6.4. DISCUSSION
This is the first study to examine the relation between cognitive deficits in the form of 
impaired working memory, and retinal arteriolar and venular caliber in SCZ and BD. 
Findings of the study suggest that wider retinal venules and narrower retinal arterioles 
are associated with working memory deficits in SCZ and BD. Findings of the study 
provide further support to the role of vascular risk factors in cognitive deficits, typically 
seen in these psychoses. There was no significant difference between SCZ and BD on 
working memory task performance as reported in several previous studies22. A few 
studies have reported greater deficits in SCZ compared to BD23. A potential reason for 
this discrepancy could be differences in participant characteristics, given that SCZ and 
BD are heterogeneous disorders. 
Previous studies in elderly individuals have reported association between wider retinal 
venules and cognitive dysfunction24. Another study reported association between 
suboptimal network geometry of the retinal vasculature and cognitive function24. 
However, the presence of similar associations in young adults with SCZ and BD had not 
been examined. Our findings suggest that wider retinal venules are associated with 
cognitive deficits in adults with SCZ and BD also, as has previously been found in other 
conditions. In addition, our findings also suggest association between narrow retinal 
arterioles and cognitive deficits in line with emerging evidence14. Cerebral small vessel 
disease has been shown to be associated with cognitive deficits25; interestingly, retinal 
arteriolar caliber is also related to cerebral small vessel disease26. Hence, our findings 
provide preliminary evidence and rationale for further examination of the relation 
between retinal vascular caliber and cognitive function in SCZ and BD. Following future 
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replication, retinal vascular examination may potentially be used to identify those at risk 
of vascular events. This could help to initiate corrective measures addressing vascular 
risk factors.
At this stage, the biological mechanisms underlying the association between retinal 
vascular changes and cognitive function deficits in SCZ and BD are not completely 
known. Cerebral and retinal microcirculations have similar anatomical, physiological, 
and embryonic origin. The retina thus provides a unique perspective of cerebral 
circulation in vivo7. Several studies have reported an association of co-morbid metabolic 
syndrome with impaired cognitive function in SCZ and BD27. Few authors have 
proposed that adverse metabolic factors may operate via vascular pathways resulting 
in impaired cognitive function28. As retinal vasculature is reflective of abnormalities in 
cerebral vasculature, it provides a non-invasive means of access to understand cerebral 
microvasculature abnormalities resulting in impaired cognition. Further longitudinal 
studies are warranted to comprehensively understand the relation between retinal 
vasculature and cognitive function.
The interpretation of these results needs to take into account our study’s limitations. 
All patients were on pharmacological therapy. Possible confounding effects of these 
medications on CRVE, CRAE, or cognitive functions cannot be eliminated. Although 
examination of drug naive patients would have been ideal, it would have decreased 
the generalizability of study findings. To assess the effects of antipsychotic medications 
on these measures, we examined the correlation between antipsychotic dosage in 
chlorpromazine equivalents and CRVE, CRAE, one-back accuracy, and log mean speed. 
There was no significant correlation with any of these measures (See Table, Supplement 
Appendix 3). However, we could not rule out the effects of other medications like 
mood stabilizers, antidepressants, and sedatives. Future studies in drug-naïve or drug 
free individuals could provide definitive answers to this question. We had excluded 
individuals with diagnosed hypertension or diabetes mellitus. However, we did not 
document blood glucose levels and blood pressure of all participants when the retinal 
images were acquired. Hence, potential confounding effects of pre-diabetic or pre-
hypertensive status29 need to be considered. Our participants belonged to the younger 
age spectrum, and the possibility of such states is remote. However, the risk of missing 
undiagnosed medical conditions remains. Future studies need to include objective 
measurements of these risk factors and control for them. We chose to measure working 
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memory deficits alone and no other cognitive domains as working memory deficits 
are commonly implicated in SCZ and BD. With our study design, it is not possible to 
infer whether the working memory deficits seen in SCZ and BD is primary, or secondary 
to deficits in other cognitive domains. Future studies need to consider the use of a 
complete neuropsychological battery including other cognitive domains in addition 
to working memory. The sample size of our study was small. Although sufficient for 
across group comparisons, the numbers were not adequate for intragroup correlations 
between cognitive functions and retinal vascular abnormality. As similar brain 
networks are recruited in SCZ, BD, and HV for working memory30, we had no rationale 
to suspect a differential effect of diagnostic status on the directionality of correlation. 
The direction of correlation being different across HV vs SCZ vs BD, we pooled all 
participants together to examine the relation between cognitive functions and retinal 
vascular caliber. Future studies with a greater number of patients could consider 
examining the relations within a diagnostic subtype or a homogeneous subgroup, e.g., 
BD with or without psychotic symptoms. Few patients had nicotine dependence; this 
could have adversely influenced the cognitive functions and retinal vascular caliber. To 
control for the effect of nicotine dependence, we re-analyzed the data after excluding 
12 patients (8 SCZ and 4 BD) who had nicotine dependence. However, the findings 
were similar in the re-analyses suggesting absence of any significant effect of nicotine 
dependence (See Table, Supplement Appendix 4). There was a significant difference in 
years of education between patients and controls. This is understandable as previous 
epidemiological studies have also reported that patients with SCZ and BD tend to 
attain lower educational levels. As education could have affected the performance on 
the working memory task, we used it as a covariate in ANCOVA analysis; the results 
however, remained significant. In addition, we conducted regression analyses between 
groups, with and without years of education as regressors. Group continued to be the 
major contributor to the model and the regression coefficients were comparable, with 
and without education as regressor. This suggests that the findings were not influenced 
by education alone (See Table, Supplement Appendix 5). Nonetheless, future studies 
with larger samples could analyze a sub-group of education-matched participants to 
elucidate the influence of education.
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6.5. Conclusion
Our study shows association between working memory and retinal vascular caliber in 
SCZ and BD. Findings indicate wider venules and narrower arterioles to be associated 
with poorer working memory. These preliminary findings, if replicated, could provide 
additional information on understanding the biology of cognitive deficits typically 
seen in SCZ and BD. Retinal vascular examination could potentially help in identifying 
those at risk of vascular adverse event. In view of the importance of targeting cognitive 
deficits for functional recovery in SCZ and BD, it is imperative to further examine the 
relation between retinal vasculature and cognitive functions in longitudinal studies. 
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Supplementary Materials
Supplement Appendix 1
Table S1: 
Mean difference between groups on demographic measures and retinal vascular 
diameter:
Group Group Mean difference Std error p
Age
HV SCZ 0.94 1.50 1.00
HV BD .130 1.44 1.00
SCZ BD -.810 1.55 1.00
Years of education
HV SCZ 3.73 .67 <0.001
HV BD 4.16 .64 <0.001
SCZ BD .43 .69 1.00
CRVE
HV SCZ -13.06 5.36 .049
HV BD -30.97 5.17 <0.001
SCZ BD -17.90 5.54 .005
CRAE
HV SCZ 22.33 3.96 <0.001
HV BD 23.58 3.81 <0.001
SCZ BD 1.24 4.09 1.00
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; p- Bonferroni post-hoc analysis; CRVE- Central Retinal Vein Equivalent, 
CRAE- Central Retinal Artery Equivalent
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Supplement Appendix 2
Table S2: 
Mean difference between groups on working memory task performance:
Group Group Mean difference Std error p
One-back task - log 
mean speed
HV SCZ -0.098 0.027 0.001
HV BD -0.13 0.026 <0.001
SCZ BD -0.04 0.027 0.584
One-back task - 
accuracy
HV SCZ 0.28 0.057 <0.001
HV BD 0.25 0.054 <0.001
SCZ BD -0.02 0.058 1.000
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; p- Bonferroni post-hoc analysis;
 Supplement Appendix 3
Table S3: 
Correlation between Retinal Vessel caliber, One back test with Clinical variables
Clinical variable
CRVE CRAE ONB –Accuracy
ONB –
Log mean 
speed
r p r p r p r p
Clinical Variables r p r p r p r p
BPRS -0.31 0.01 -0.07 0.54 -0.18 0.13 0.04 0.74
YMRS -0.08 0.51 0.06 0.63 -0.22 0.07 0.03 0.82
HDRS -0.14 0.25 0.17 0.16 0.15 0.22 -0.01 0.92
Age at onset 0.10 0.41 -0.13 0.26 -0.11 0.36 0.05 0.67
Duration of 
untreated illness 0.01 0.95 0.19 0.12 -0.10 0.40 0.17 0.15
Duration of illness 0.02 0.89 0.07 0.54 -0.13 0.30 0.13 0.28
CPZ equivalent -0.01 0.96 -0.17 0.26 -0.06 0.71 -0.07 0.64
CRVE- Central Retinal Vein Equivalent, CRAE- Central Retinal Artery Equivalent, ONB- 
One back Task; r- Pearson correlation; p- significance value; 
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Supplement Appendix 4
Table S4: 
Effect of Nicotine dependence
To control for the effect of nicotine dependence, we excluded 8 SCZ and 4 BD patients 
who had nicotine dependence and re-analysed the data. The results were still 
significant even after excluding these study participants as shown in the table below
HV
(n=45)
SCZ
(n=26)
BD
(n=35) F p
CRVE 197.7±20.9 211.2±26.5 229.7±24.5 18.20 <0.001
CRAE 116.2±20.5 92.3±13.0 92.3±17.6 21.26 <0.001
One back task 
- accuracy 1.20±0.26 0.91±0.21 0.93±0.26 16.05 <0.001
One back task 
– log mean
speed
2.90±0.10 3.00±0.11 3.05±0.14 17.03 <0.001
Supplement Appendix 5
Table S5: 
Regression Analysis for One back task between groups adjusted for years of education
Group
Not adjusted for age and sex Adjusted for age and sex
β (95%CI) P β (95%CI) p
One back 
task - 
accuracy
HV SCZ -0.28 (-0.39 to -0.17) <0.001 -0.19(-0.31 to -0.06) 0.003
HV BD -0.26 (-0.37 to -0.15) <0.001 -0.15 (-0.27 to -0.03) 0.014
SCZ BD 0.02 (-0.09 to 0.14)) 0.70 0.03 (-0.08 to 0.15) 0.55
One back 
task – log 
mean 
speed
HV SCZ 0.10 (0.05 to 0.15) <0.001 0.09(0.03 to 0.15) 0.004
HV BD 0.13 (0.08 to -0.19) <0.001 0.12 (0.06 to 0.18) <0.001
SCZ BD 0.04 (-0.19 to 0.09) 0.20 0.04 (-0.02 to 0.09) 0.55
SCZ – patients with schizophrenia; BD – patients with bipolar disorder; HV – healthy 
volunteer; β - regression coefficient, 95% CI - 95% confidence interval
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CHAPTER 7
GENERAL DISCUSSION 

General Discussion
The goal of the studies in this thesis was to use the knowledge of the retinal 
microvasculature features in the field of psychiatry for two major psychiatric conditions 
viz., Schizophrenia (SCZ) and Bipolar Disorder (BD) and explore if retinal microvascular 
features can be used as biomarker. In this chapter, a review of the main findings of the 
thesis, methodological issues, and implications for future development with respect 
to continuation of the work will be presented. This is the first kind of its study which 
examined the retinal microvasculature features in schizophrenia and bipolar disorder 
compared to healthy volunteers (HV). 
The overview of the thesis is diagrammatically represented in the figure 1 below.
Figure 1.  
Illustration of overview of thesis
The retinal microvasculatures and cerebral vasculature share common morphological, 
physiological, and pathological properties. Considering the common embryological 
origin, the retinal microvasculature examination can be considered for indirect 
assessment of cerebral vasculature abnormalities. Further, considering the cost 
effectiveness and easy accessibility of the retina vasculature it is ideally suited for 
epidemiological research studies for screening these disorders. A significant difference 
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in vessel caliber, fractal dimensions, retinal vascular tortuosity and retinal vascular 
trajectory are observed between patients with SCZ and BD when compared to healthy 
volunteers. 
It was observed that the retinal vascular parameters were different in SCZ and BD when 
compared to HV. To summarize: compared to HV, BD and SCZ had wider veins and 
narrower arteries, higher retinal arteriolar tortuosity index, higher fractal dimension 
and smaller retinal vascular (both veins and arteries) trajectory. 
It is important to note that all the above results are statistically significant even after 
controlling for age and sex. When available, effect of other confounders like BMI or 
systemic blood pressure, was also controlled in the statistical analysis. It was interesting 
to observe that there was significant difference between SCZ and BD as well in retinal 
vascular caliber (both artery and vein) and tortuosity (artery only). However, there was 
no difference between SCZ and BD in trajectory or fractal dimension.
The findings are in accord with, and support the only previous study in SCZ which also 
reported wider venules1. However, in contrast to a previous study in adolescent BD2 
which did not report significant difference, it was found that BD patients had wider 
venules and narrower arterioles in the retina. As ours is the first study to examine the 
retinal vascular tortuosity, fractal dimension and trajectory in SCZ and BD, we were not 
able to compare with any other previous studies.
In addition to these structural measures, interestingly the retinal vascular abnormalities 
were related to cognitive deficits typically seen in SCZ and BD. There was a significant 
association between working memory deficits and narrower arterioles and wider 
venules; significant positive correlation between one-back test accuracy and retinal 
arteriolar caliber and significant positive correlation between log mean speed score 
and retinal venular caliber. These findings of association between working memory 
deficits and retinal vascular caliber point towards a potential role of vascular pathology 
in cognitive deficits typically seen in SCZ and BD.
An interesting observation was abnormalities in retinal vessel trajectories. These 
trajectories are directly related to retinal artery angle which are associated with retinal 
nerve fiber layer thickness. The findings of machine learning analysis suggest that the 
retinal vascular trajectory is a potential biomarker for SCZ and BD. Considering the 
relation between retinal vascular trajectory and retinal nerve fiber layer thickness, 
there is an opportunity to use retinal fundus camera instead of expensive optical 
coherence tomography in epidemiological research settings. 
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In addition, as an exploratory analysis, machine learning using supervised ensemble 
of bagged trees was implemented to check if retinal vascular trajectories can be a 
potential utility as predictive biomarker. It had an accuracy of 86% with sensitivity 
of 88% and specificity of 85% for differentiating HV and SCZ. However, a lower but 
considerably good accuracy of 73% with sensitivity of 78% and specificity of 76% was 
obtained for differentiating HV and BD. 
These advantages of fundus photography, together with our findings from 
machine-learning analysis, indicate the potential utility of this method in wider, 
resource constrained settings and warrant further studies with larger sample sizes. 
Machine-learning analysis with the use of a single measure (retinal vessel trajectory) 
demonstrated reasonable accuracy despite the potential confounding factors.
The retina develops from the same tissue, that is, neuroectoderm as the brain. It is the 
only part of the central nervous system that can be easily seen non-invasively. The 
retinal changes may parallel or reflect the integrity of brain structure and function due 
to the common developmental origins and also because of sharing the anatomical, 
physiological, and autoregulation properties. 
The specific pathophysiological mechanism underlying the retinal vasculature 
abnormalities as seen in this thesis are not entirely understood. It is currently unclear 
whether retinal vasculature plays a causal role in the development of psychosis or 
whether it might represent an associated epiphenomenon. The understanding of the 
mechanisms underlying abnormalities in retinal vasculature may provide insight about 
the pathogenesis of psychosis symptoms. It is known from previous research that 
genetic factors influence retinal vasculatures3. Other factors including Inflammation, 
endothelial dysfunction, and hypoxia have also been found to be associated with 
retinal vasculature abnormalities, in addition to conventional cardiovascular risks, 
including dyslipidaemia, obesity, impaired fasting glucose, and smoking4-7. All of these 
factors have been implicated in psychosis as well8-12, and few of these factors occur at 
higher rates than expected in unaffected relatives of patients with psychosis13-16 and in 
individuals with symptoms of psychosis17-19. 
Although visual processing impairments are common in psychosis, it is not clear to 
what extent these originate in the eye vs. the brain. One is that there are multiple 
structural and functional disturbances of the eye in psychosis, all of which could be 
factors in the visual disturbances and retinal vasculature abnormalities of patients. 
However, some of these are likely to be illness-related, whereas others may be due 
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to medication or comorbid conditions which was used as covariate in the analysis. 
It is also important to note that retinal findings can serve as biomarkers of neural 
pathology, and disease progression, in psychosis. The strongest evidence for this to 
date involves findings of retinal vasculature changes which is also seen in this thesis.
These preliminary findings provide a strong rationale for further systematic examination 
of usage of retinal vascular features in patients with SCZ and BD. Considering the easy 
accessibility, non-invasive nature, absence of need for mydriasis and affordability, 
examination of retinal vascular features using retinal fundus images can be conducted 
in psychiatric settings, both out-patient clinics and community settings. If shown to 
be of predictive utility in future longitudinal studies, examination of retinal features 
has the potential to identify BD and SCZ patients at risk of developing adverse 
vascular events and it can be one of the easy and an inexpensive tool for prediction 
of psychoses. Further, it could potentially help clinicians or researchers in screening 
eligible patients for clinical trials, in monitoring disease progression or in evaluating 
treatment response. 
In the last decade, the search of biomarkers for psychiatric disorder has increased. 
Considering the contribution of vascular pathology to etiopathogenesis of 
neuropsychiatric disorders, cerebral vascular features are considered possible 
biomarkers for neuropsychiatric disorders. However, examination of cerebral 
vasculature is expensive and requires invasive techniques. Considering the relation 
with cerebral vasculature, retinal vascular features are potential biomarkers for 
psychoses, SCZ and BD. In the further paragraphs, the existing gaps and requirement 
of further studies in psychoses is discussed for future research.
Mediation and interaction: Previous studies as well as the studies presented in 
this thesis examined retinal vascular changes as novel biomarkers by finding the 
associations between retinal vascular abnormalities and individual diseases. While this 
way of doing research is valid, it is important to remember that this cross-sectional 
association may be influenced by other factors. Hence, it is important to continue 
the study to find out other confounding factors which may influence/interact with 
the retinal vascular pathology. Such a study which can control for other confounding 
factors help in finding apt independent and novel biomarker which could be used 
in both clinic as well as epidemiological research. A holistic approach involving 
neuropsychiatry, ophthalmology along with measurement of cardiac, metabolic and 
renal parameters, could isolate the independent biomarker.
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Comorbidities influence: The values of blood glucose, blood pressure and other 
comorbidities were taken during the patient admission and not during the acquisition 
of retinal images. It is important to examine these parameters on the day of the 
acquisition of the retinal scan. Also, we did not examine the other possible confounders 
in detail. Examination of confounding comorbidities is very important to conclude 
whether retinal vascular features are biomarkers for psychoses. Similarly, though HV 
were excluded if they had received diagnosis of any confounding comorbid medical 
condition, we did not check their blood sugar or blood pressure or other possible 
confounders such as lifestyle (exercise, diet, etc), renal function, etc. As  previous 
studies have shown association between retinal vascular features and hypertension 
and diabetes mellitus20-23, future studies need to examine these parameters. Also, 
whether sub-clinical/pre-diabetes levels of blood sugar or blood pressure have any 
effect on the retinal vascular features need to be examined in future.
Longitudinal studies: The studies discussed in this thesis are all cross-sectional. 
However, the results have to be replicated using longitudinal studies to show that the 
association between psychoses is related to the stage of the illness. The degradation of 
brain seen in psychoses has been associated with thinning of retinal layers using optical 
coherence tomography (OCT)24,25. It is also seen that the retinal neurodegeneration is 
associated with brain damage as well. Longitudinal studies will be able to clarify if 
these associations are due to shared etiology or the retina could serve as a prognostic 
factor before clinical deterioration is observed. If retinal vasculature or nerve fiber 
layer (NFL) changes before clinical psychiatric symptoms therapy could be initiated 
or changed.
Retinal Imaging methods: In this thesis, only retinal fundus imaging is presented. 
However, there are other modalities including adaptive optics, optical coherence 
tomography (OCT), Fundus Florescence Angiography (FFA), OCT-Angiography and 
retinal oximetry that can be explored. These retinal imaging methods and various 
associated algorithms can be used to explore the association of psychoses and retinal 
microvasculature. Newer retinal imaging method like hyperspectral imaging may 
help in identifying retinal amyloid-beta depositions in humans which is present in 
Alzheimer’s disease patient and not in HV26,27. Whether these newer retinal imaging 
methods can have utility in SCZ and BD needs be explored. In addition to the retinal 
vascular imaging using fundus camera, structural and functional brain imaging can 
be used to examine the relation between the retinal vascular changes and brain 
abnormalities. The brain structure can be examined for abnormalities in volume, 
thickness or area using the voxel-based morphometric or surface based morphometric 
analysis. The cerebral vasculature can be examined using Arterial Spin Labelling (ASL) 
and functional activity of the brain can be examined using the functional MRI (fMRI). 
Future studies need to examine both retinal vasculature and brain using these imaging 
methods to assess the relation between retinal vascular features and brain structure 
and function. It will also be interesting to compare the brain imaging-based features 
and retinal vascular features as biomarkers to SCZ and BD.
Additional Retinal features: In this thesis, retinal microvasculature features including 
vessel calibre, tortuosity, fractal dimension and trajectory are implemented. There 
are many other features which can be used for finding the association of retinal 
microvasculature and psychoses. One of the features which can be explored is Length 
to Diameter ratio (LDR). LDR can be calculated as the length from the midpoint of the 
first branch to the midpoint of the second branch, divided by the diameter of the parent 
vessel at the first branch28,29. Another feature is bifurcation angle which is the angle 
made between the vessels where they bifurcate. These angles may change the due 
to various systemic disease30,31. The angle made between the retinal artery trajectory 
viz., artery angle can also be explored to find if there is association with psychoses and 
recent study showed that there is variation in cup to disc ratio varies for psychoses32,33. 
Also, all the retinal features discussed in the previous chapters have to be combined 
and such a multivariate analysis may give a better outcome than individual feature. 
Another interesting parameter to be explored can be retinal vascular optimal score 
which is based on the features of calibre and fractal dimension to measure the severity 
and complexity of the vasculature34. 
Clinical research: Though there is an increase in research using retinal vasculature 
as, it is not yet in clinical practice as biomarkers for brain disorders. It is important 
to examine whether the retinal vascular features can aid the clinician for better 
diagnostic and predictive accuracy. It is also important to examine the accuracy of 
retinal vascular feature-based biomarker in comparison with other biomarkers based 
on other imaging modalities. On the other hand, retinal microvasculature features 
can be of better utility for population-based epidemiological studies considering 
their affordability and portable nature of the equipment. With further research, retinal 
vascular features can be used as preliminary screening tool.
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22q11.2 Deletion Syndrome: 22q11.2 deletion syndrome (22qDS) is a genetic 
syndrome associated with deletion of a chromosome 22q11.2. The variable phenotypic 
expression of this genetic syndrome commonly includes Schizophrenia. It is reported 
that approximately 1% of patients with SCZ have 22qDS. Individuals with a 22qDS 
form of schizophrenia have distinguishable physical features in the form of lower 
IQ and differ in auxiliary clinical features35,36. This 22qDS has shown retinal vascular 
abnormality and it would be good biomarker for examining the difference between 
22qDS and other forms of psychoses36,37.
Tool and retinal vascular index: A tool can be developed to assess the severity 
using various retinal features namely calibre, fractal dimensions, tortuosity, trajectory 
which can give the effect and severity of psychoses in the population while doing the 
screening. Apart from this, a vascular index or retinal vascular score can be derived 
based on the values of each of these features which will definitely be novel and 
interesting score for clinical research. 
First Degree Relatives: Whether the retinal microvascular abnormalities are seen 
in first degree relatives of patients with SCZ or BD as well is not examined till date. 
Examination of these measures in first degree relatives will provide definitive answers 
to the question whether these abnormalities are linked to primary pathogenic 
process or secondary to medications or medical comorbidities which will be valuable 
information in clinical research. 
Multivariate Analysis: Different features of retinal vasculature were extracted in 
SCZ and BD, and the statistically significant difference was observed for all features 
of retinal vasculature in patients when compared to HV. However, all the features are 
independently analysed, and conclusions are derived for each of them separately, 
though they are from same group of patients. Hence, a multivariate analysis for all the 
features included may help in understanding the contribution of each of the features 
as well as it will help in discovering new findings on interdependency of the features. 
Machine Learning and Biomarker: Machine learning using Supervised Support 
vector machine (SVM) and ensembled of bagged trees was implemented for retinal 
vascular trajectory. However, the similar machine learning algorithm can be applied 
with all four feature parameters namely, calibre, tortuosity, fractal dimension and 
trajectory can be combined together and fed to machine learning to see if the 
prediction is possible to classify patients and HV. Once sufficient retinal images are 
acquired, the features can be extracted automatically and the same will used for 
classification using deep learning algorithms. However, acquiring adequate retinal 
images is always a challenge in medical image processing, hence, another approach 
for this could be by pixelating (separating one image into many images in terms of 
pixels) the images and feeding these pixelated images as to machine learning may 
bring new perspective of classification. 
Correlation of existing Biomarkers in SCZ and BD with retina: SCZ is associated 
with significant cognitive impairment. BD is also associated with cognitive deficits but 
less severe than SCZ. There are been controversy on analysing the cognitive deficits 
to distinguish these two psychoses38. Hence, further correlation of neuroimaging 
and other modalities with retinal imaging is important in using retina as biomarker 
for SCZ or BD. Structural co-variance analyses identified that there is altered 
structural relationships in the thalamus, frontal, temporal and parietal cortices in 
SCZ patients39. Hence, modalities like voxel-based morphometry (VBM), tract-based 
spatial statistics (TBSS), diffusion tensor imaging (DTI), visual evoked potential (VEP)40-
42, electroencephalography (EEG)43,44 and Magnetic resonance Imaging (MRI)45 can be 
explored to find their correlation with retinal vascular features. It would be important 
to explore the accuracy of the measures using these modalities to differentiate SCZ/
BD from HV and compare them with our machine learning findings.
This thesis provides new insight for psychoses for using retinal imaging microvasculature 
as novel biomarker. Furthermore, in this chapter, an overview of the main findings 
which may serve as groundwork for future research is discussed.
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CHAPTER 8
SUMMARY

Summary
Over the last few years, retinal vascular imaging has emerged as a technique to 
investigate microvasculature abnormalities related to the neuropsychiatric disorders. 
As the microvasculature in the retina and the brain share similarities in anatomy and 
physiology, changes in the vessels in the retina may reflect similar changes in the brain. 
Importantly, the imaging of the small vessels of the brain is expensive and at times 
invasive with current neuroimaging modalities. Retinal vascular imaging however 
gives a novel and unique opportunity to study the microvasculature non-invasively. 
Several studies have reported an association between retinal and brain 
microvasculature in disorders like stroke and Alzheimer’s dementia. However, retinal 
vascular abnormalities in neuropsychiatric conditions are underexamined. A few 
studies have reported abnormalities in the thickness of the retinal layers consisting of 
neurons viz., retinal nerve fibre layer (RNFL) in schizophrenia and bipolar disorder using 
Optical Coherence Tomography (OCT). The reason for thinning of these RNFL in these 
neurodevelopmental psychiatric disorders may be due to the common developmental 
origin; the retina is embryonically formed from the neural tissue. Hence the thinning 
of the RNFL may indicate abnormal development of the brain. However, no study has 
examined the retinal microvascular features in schizophrenia and bipolar disorder in 
comparison to healthy volunteers. 
The main objective of this thesis was to investigate the use of retinal microvasculature 
abnormalities as biomarker for two important psychiatric disorders viz., Schizophrenia 
(SCZ) and Bipolar Disorder (BD) and expanding the horizon of knowledge of various 
parameters in the retinal imaging for finding its association with the SCZ and BD. The 
retinal fundus images were acquired at the National Institute of Mental Health and 
Neuroscience (NIMHANS), Bengaluru, India a tertiary care hospital. The summary of 
the thesis chapters are as below.
CHAPTER ONE gives the general introduction about psychiatric disorders and two 
major conditions namely SCZ and BD. This chapter includes prevalence, diagnosis and 
treatment of these conditions along with prevalent practices for their diagnosis. How 
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the retina vasculature is used as biomarker for other systemic diseases is also discussed 
in this chapter. The aim and outline of the thesis is described as well. 
CHAPTER TWO describes the usage of retinal vascular calibre abnormalities of both 
veins and arteries in SCZ and BD when compared to healthy volunteers (HV). It was 
found that the retinal veins were significantly wider in patients when compared to 
HV. The retinal arteries were significantly narrower in patients when compared to 
HV. Interestingly, the width was larger in BD when compared to SCZ for retinal veins 
but the width was smaller in BD when compared to SCZ. The results were significant 
event after controlling for the confounding factors. The reason for such abnormalities 
is not known but may be due to wide range of environmental, genetic, and systemic 
influences such as aging, inflammation, nitric oxide–dependent endothelial 
dysfunction, and hypoxia/ischemia.
CHAPTER THREE investigated the usage of retinal vascular tortuosity of veins and 
arteries in SCZ and BD when compared with HV. The results showed significant 
differences across the three groups in retinal artery tortuosity but not in retinal vein 
tortuosity. There was significant increase in retinal arterial tortuosity in patients when 
compared with HV. Interestingly, there was also significant difference in SCZ and BD 
with BD having higher retinal arteriolar tortuosity. The results were significant even 
after controlling for possible confounding factors. These retinal arteriolar tortuosity 
can act as surrogate marker for cerebrovascular abnormalities and have value in 
predicting patients at risk of developing adverse cerebrovascular events.
CHAPTER FOUR studied the fractal dimension of retinal microvasculature in patients 
with SCZ and BD. There was a significant difference between the three groups in 
retinal vascular fractal dimensions. While both SCZ and BD had significantly increased 
fractal dimension when compared to HV, there was no significant difference between 
SCZ and BD. Findings remained significant even after controlling for the confounding 
factors. This study suggests increased possibility of adverse vascular events in SCZ and 
BD.
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CHAPTER FIVE examines the retinal vessel trajectory as a tool for finding the 
abnormalities in retinal nerve fibre layer in patients with SCZ and BD when compared 
with HV. There was a significant difference between the groups for both retinal artery 
and retinal vein trajectories even after adjusting for age and sex. However, there was 
no significant difference between SCZ and BD. Supervised machine learning using 
ensembled of bagged trees was used to classify the three groups using retinal vascular 
trajectory measures. It showed considerably good accuracy of 86% with sensitivity 
of 88% and specificity of 85% for differentiating HV and SCZ. However, a lower but 
considerably good accuracy of 73% with sensitivity of 78% and specificity of 76% was 
obtained for differentiating HV and BD.
CHAPTER SIX gives the correlation between cognitive test (one back test) and the 
retinal vascular calibre as described in chapter 2. It was found that the performance on 
one back test, a test of working memory had significant positive correlation with retinal 
arteriolar calibre and significant negative correlation with retinal venular calibre. As 
anticipated, the patients (both SCZ and BD) had significantly lower working memory 
accuracy and higher log mean speed. This suggests the role of vascular pathology in 
cognitive deficits typically seen in SCZ and BD. 
CHAPTER SEVEN is a discussion of important findings, issues and implications for 
future studies based on the above chapters.
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CHAPTER 9
VALORISATION

Valorisation
Dealing with patients with psychosis and their caregivers who are struggling with 
their day to day activities is disheartening and emotionally draining for anybody. 
I encountered such a moment when I met one of my relatives, in his early teens, 
suffering from bipolar disorder. The grief and the burden which his parents had to 
carry on their shoulders triggered my interest to contribute to scientific research in 
this area. Considering the best outcome is seen when the treatment is initiated early, 
I decided to work on developing methods for early diagnosis so the treatment can be 
initiated at the earliest possible time.
Schizophrenia and Bipolar disorder, major psychotic disorders, are characterized by 
disturbances in cognition, perception, emotion, and motivation. Currently available 
treatment options reduce symptoms and suffering, however, there is no permanent 
cure. Mechanisms leading to psychosis are still unknown, which has hampered 
the development of curative interventions. The causes of psychosis are mostly a 
combination and interaction of genetic and environmental factors.
Clinically relevant symptoms of the psychosis spectrum have an estimated lifetime 
prevalence of 2.3% to 3.5% in the general population1. They result in high social 
disabilities and costs to the society because of significant loss of productivity2. 
Besides, societal stigmatization may result in a vicious cycle of discrimination leading 
to long-standing unemployment and social isolation, which further hinders the 
functional recovery. Therefore, early diagnosis and intervention are needed to lower 
the burden on patients with schizophrenia and bipolar disorder, their family members 
and furthermore, the society. Figure 1 depicts the share of worldwide population 
distribution for patients with schizophrenia and bipolar disorder.
Despite advances in the medical field, the diagnosis of psychosis is still dependent 
on the skill of the psychiatrist and hence involves the risk of subjective bias. Although 
psychiatric assessments have proven successful as a clinical tool for diagnosing 
psychosis, access to a trained mental health professional is difficult. This is especially 
true in developing countries including India (in particular the rural sector) where 
the doctor to patient ratio is very low and psychiatrists are hardly available. Even if a 
psychiatrist or a mental health professional is available, due to the subjective nature of 
the assessment, it may be erroneous at times.
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Figure 1.  
Share of population with Schizophrenia and Bipolar disorder in 2017
Share of population with bipolar disorder, 2017
Share of the population with bipolar disorder. This share has been age-standardized assuming a constant age
structure to compare prevalence between countries and through time. Figures attempt to provide a true estimate
(going beyond reported diagnosis) of bipolar disorder prevalence based on medical, epidemiological data, surveys
and meta-regression modelling.
No data
0.3%
0.4%
0.5%
0.6%
0.7%
0.8%
0.9%
1%
1.2%
1.4%
Source: IHME, Global Burden of Disease CC BY
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Share of population with schizophrenia, 2017
Share of the population suffering from schizophrenia. This share has been age-standardized assuming a constant
age structure to compare prevalence between countries and through time. Figures attempt to provide a true
estimate (going beyond reported diagnosis) of schizophrenia prevalence based on medical, epidemiological data,
surveys and meta-regression modelling.
No data 0% 0.05% 0.1% 0.15% 0.2% 0.25% 0.3% 0.35% 0.4%
Source: IHME, Global Burden of Disease CC BY
Currently, there is no definitive, quantitative assessment or specific biomarker 
which can help in the screening or confirmation of the diagnosis of psychiatric 
disorders. Absence of a biomarker and lack of necessary skill sets among the general 
practitioners prevents early diagnosis of individuals with psychosis or those who are at 
risk of development of psychosis. This often leads to undue delay in initiating prompt 
intervention, not only in resource-constrained societies, but also in urban areas. 
Hence, there is a requirement of a quantitative biomarker that can help in the early 
diagnosis of psychiatric disorders and serve as a screening tool for necessary referrals. 
This biomarker should be easily accessible, non-invasive and affordable to be utilised 
as a community screening tool.
While several candidate biomarkers are being examined, magnetic resonance imaging 
(MRI) is well evaluated as it is non-invasive. MRI is a sophisticated modality which 
allows the physician to visualize the structural, functional and chemical abnormality 
in the brain. MRI is routinely used as an investigation to examine brain abnormalities 
in neurological disorders. Several MRI studies have reported structural and functional 
brain abnormalities in schizophrenia and bipolar disorder, however its utility in routine 
clinical practice to diagnose psychosis is not well established. Even though MRI is 
found to be useful as a clinical tool in the diagnostic work up of psychosis, it is neither 
easily accessible nor affordable. This is notable in developing countries, including 
India, where only a handful of hospitals and advanced diagnostic centres have the 
facilities for brain imaging. Rural communities have no access to these facilities and are 
forced to travel to metropolitan cities for these investigations. Even in places where it 
is available, it is not as affordable.
Hence, several affordable and portable tools which are proxy markers of brain 
abnormalities are examined as potential biomarkers. Retinal fundus imaging presented 
in this thesis is an inexpensive, portable and easily accessible technology which has the 
potential to help in the early detection of psychosis. The cost-effectiveness, portability 
and easy accessibility makes retinal fundus imaging an ideal candidate that can be 
used even in primary and rural healthcare centres. Also, the non-invasive nature of 
retinal imaging used in this thesis gives an edge for usage in the wider community 
and paves the way for faster adaptability throughout the society. It is also objective, 
repeatable and has the potential to be utilized in community mass screening. The 
screening can be done by non-clinical personnel, as one needs minimal training to use 
the device. The imaging is non-mydriatic and does not require any kind of dilator. This 
makes the imaging even easier and does not affect patient’s work for the entire day.  
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It has been validated and published in this thesis that features from retinal fundus 
imaging are significantly different in patients with psychiatric disorders versus healthy 
volunteers. When compared to healthy volunteers (HV), schizophrenia (SCZ) and 
bipolar disorder (BD) patients had wider veins and narrower arteries (chapter 2). The 
retinal arteriolar tortuosity index was found to be higher in patients with SCZ and BD 
when compared to HV (chapter 3), and the results were similar for fractal dimensions 
(chapter 4). The retinal vascular trajectories were smaller in patients with SCZ and BD 
when compared to HV in both arterioles and venules (chapter 5). 
In addition, as an exploratory analysis, machine learning using a supervised ensemble 
of bagged trees, was implemented to check if retinal vascular trajectories can be a 
potential utility as a predictive biomarker. It had an accuracy of 86% with a sensitivity 
of 88% and a specificity of 85% for differentiating HV and SCZ. However, a lower but 
considerably good accuracy of 73% with a sensitivity of 78% and a specificity of 76% 
was obtained for differentiating HV and BD (chapter 5). These findings of machine 
learning analysis suggested that the automated analysis using retinal vascular 
trajectory can classify diagnosed patients and healthy volunteers with reasonable 
accuracy. Hence, retinal vascular trajectory is a potential biomarker for SCZ and BD. In 
addition to these structural features, the retinal vascular abnormalities were related 
to cognitive deficits typically seen in SCZ and BD. There was a significant association 
between working memory deficits, narrower arterioles and wider venules; a significant 
positive correlation between one-back test accuracy and retinal arteriolar calibre as 
well as significant positive correlation between log mean speed score and retinal 
venular calibre (chapter 6).
The machine learning algorithms were implemented using retinal vascular trajectories 
as features. However, it can be further explored to combine the other features including 
calibre, tortuosity and fractal dimensions. A combination of measures may provide a 
higher accuracy when compared to single measure. The machine learning algorithms 
can be packaged into the software which can be used across operating systems and 
aid in classifying or identifying the psychosis. The images can be acquired using the 
existing portable fundus camera or a mobile-based fundus camera in the future. The 
minimal computational requirement of the machine learning algorithms used in this 
thesis allows the algorithm to be used in a cloud based analysis and classification so it 
can be used in resource constrained settings.
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One of the main objectives of this thesis was to cater to the societies in lower- and 
middle-income countries that do not have easy access to healthcare - especially 
mental health. It is important to address this issue as the loss of productivity and the 
burden caused to the caregivers as well as the society due to psychosis is increasing 
every day due to lack of early diagnosis and prompt intervention. It is also seen that 
neurobiological changes occur earlier than the development of clinical symptoms. 
Unfortunately, the psychosis is diagnosed only in advanced stage after the clinical 
symptoms are more prominent and treatment is started subsequently. The reasons for 
delay in treatment is due to the absence of tools for early diagnosis and inaccessibility 
of experts. Hence, this novel method using retinal imaging may help in early diagnosis 
which will result in early medical intervention. This will also improve the patient’s 
functional recovery and decrease the economic and emotional burden on family and 
society.
From the present thesis, it can be concluded that retinal vascular abnormalities 
are present in schizophrenia and bipolar disorder. Fundus imaging may pave the 
way to novel screening / diagnostic tools and indirectly help in early interventions. 
Nevertheless, much work is needed before retinal imaging can be used routinely 
in the clinical setting. Advances in, and direct comparisons of the various analysis 
methods are to be further tested. While the accuracy of the machine learning analysis 
was tested in a group level in the present thesis, the efficiency of the tool has to be 
tested at an individual level for its clinical utility.
The research presented in this thesis would be of interest to the governments of 
developing countries like India where there is an immediate need to have accessible, 
inexpensive screening tools for mental health conditions. In the rural community 
without access to specialists and advanced investigations, retinal fundus imaging 
may potentially be used to screen for mental disorders. As retinal fundus imaging can 
be acquired easily, this tool can be employed by general medical practitioners thus 
increasing its utility in wider community.
Before it can be used in the community or in the clinical setting, it is important to 
completely validate the research presented in this thesis by correlating the retinal 
vascular features with the brain vascular abnormalities using well-proven techniques 
like Arterial Spin Labelling (ASL). This thesis is presented with 100 sample size in each 
patient group when compared to 100 HV. However, the results have to be replicated 
with wider populations to have scientific validity. Further longitudinal follow-up
studies will also help in identifying the stage of illness and predicting individuals who 
are at risk of developing the illness.
Even though the identification of group differences has improved our knowledge, it 
is necessary to show the difference at an individual level for the tool to be clinically 
useful. This thesis has paved the way for future individualistic classification. One 
possible approach is to generate single-subject inferences through machine learning 
classifiers3,4 using retinal vascular features. To arrive at definite conclusions about 
retinal vascular abnormalities associated with schizophrenia or bipolar disorder, 
one should replicate this finding from a different geographical location. The present 
work was conducted at a tertiary health care centre - the National Institute of Mental 
Health and Neurosciences, Bengaluru, India. Future works in primary and secondary 
care centres need to be conducted for generalizability of the findings. Subsequently, 
population-based studies are needed for application as a screening tool in community.
Translating this academic research into an economically sustainable screening and 
diagnosis program will provide real-life application. Hopefully the results of this thesis 
will inspire indigenous biomedical device companies in India to investigate further 
in creating a low-cost screening device that embeds the algorithms of this thesis as 
an application available with the device. One of the major challenges in using MRI 
for screening is the cost and the portability of the neuroimaging equipment. If the 
local products can fill this gap, by integrating the low-cost screening devices with this 
algorithm, they may increase the outreach of the tool. This Ph.D. research will open 
doors for replication studies with larger sample size and longitudinal studies. Further 
clinical validation of such devices would create a global market for the same. Smart-
phone apps can be developed for analysis and visualization of the patient data which 
can be available for the technicians, experts and paramedics. 
Within the scientific community, knowledge dissemination is done through 
publications in peer-reviewed journals and presentations at research conferences 
and other scientific forums. A part of the thesis was presented in the World Bipolar 
Day Conference on 24 March 2019 at NIMHANS, Bengaluru, India. The conference 
was attended by clinicians, mental health professionals and researchers across India. 
Several researchers expressed interest to collaborate further for the research and 
clinical validation. Research results and methodological developments can be further 
discussed with other scientists, driving international collaboration and brainstorming 
on analytic approaches. This thesis was implemented in a developing country (India)
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in collaboration with the Netherlands, but the concepts and the methodology can be 
further expanded to other countries and may become a model of reverse innovation.
This research has already been explored beyond the thesis chapters. Along with 
one of my co-supervisors, Dr. Naren P. Rao, we had submitted a research proposal 
to assess the retinal vascular abnormalities in first degree relatives of patients with 
schizophrenia. This research will provide the necessary next step to establish the 
potential of this method to identify at risk individuals and whether these abnormalities 
are endophenotypes. The research project is approved for funding by the Department 
of Science and Technology (DST), Government of India under Cognitive Science 
Research Initiative (CSRI). We are in the process of taking necessary permissions from 
institute ethics committee to start the project. Another proposal is under development 
to design a hyperspectral device that can give dynamic vessel analysis and oxygen 
saturation of retinal images which can further help to strengthen the concepts 
presented in this thesis.
Clinically, retinal fundus imaging is considered as a relatively affordable, accessible 
and workable tool for screening the patients. Hence, it is our hope that the efforts 
laid out in this thesis represent a small step in the global effort to improve the lives of 
patients with schizophrenia and bipolar disorder.
Thus I would like to conclude with a quote “Medicine is a science of uncertainty and 
an art of probability” - Sir William Osler, a Canadian physician and one of the founding 
professors of Johns Hopkins Hospital, USA.
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